{"cells":[{"cell_type":"code","execution_count":1,"metadata":{"id":"W4gtHuzbwvJr","executionInfo":{"status":"ok","timestamp":1639948092529,"user_tz":300,"elapsed":367,"user":{"displayName":"Sareen Ziyun Zhang","photoUrl":"https://lh3.googleusercontent.com/a/default-user=s64","userId":"11849688360944966671"}}},"outputs":[],"source":["from bs4 import BeautifulSoup\n","import csv\n","import json\n","import math\n","import numpy as np\n","import pandas as pd\n","import re\n","import requests\n","import collections\n","import pandas as pd\n","import os"]},{"cell_type":"code","execution_count":null,"metadata":{"collapsed":true,"id":"G4IXFURCwvJw","outputId":"0dcc9dc2-b02d-42e8-fb5e-5b7248458dc4"},"outputs":[{"data":{"text/html":["<div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>Rank</th>\n","      <th>NCT Number</th>\n","      <th>Title</th>\n","      <th>Acronym</th>\n","      <th>Status</th>\n","      <th>Study Results</th>\n","      <th>Conditions</th>\n","      <th>Interventions</th>\n","      <th>Outcome Measures</th>\n","      <th>Sponsor/Collaborators</th>\n","      <th>...</th>\n","      <th>Other IDs</th>\n","      <th>Start Date</th>\n","      <th>Primary Completion Date</th>\n","      <th>Completion Date</th>\n","      <th>First Posted</th>\n","      <th>Results First Posted</th>\n","      <th>Last Update Posted</th>\n","      <th>Locations</th>\n","      <th>Study Documents</th>\n","      <th>URL</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>1</td>\n","      <td>NCT02538471</td>\n","      <td>LY2157299 Monohydrate (LY2157299) and Radiothe...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Metastatic Breast Cancer</td>\n","      <td>Radiation: Radiation therapy|Drug: Study Drug</td>\n","      <td>Number of Participants With Adverse Events|Num...</td>\n","      <td>Weill Medical College of Cornell University|Un...</td>\n","      <td>...</td>\n","      <td>1505016222</td>\n","      <td>August 10, 2015</td>\n","      <td>September 4, 2018</td>\n","      <td>February 20, 2019</td>\n","      <td>September 2, 2015</td>\n","      <td>December 9, 2019</td>\n","      <td>December 9, 2019</td>\n","      <td>Weill Cornell Medical College, New York, New Y...</td>\n","      <td>\"Study Protocol and Statistical Analysis Plan\"...</td>\n","      <td>https://ClinicalTrials.gov/show/NCT02538471</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>2</td>\n","      <td>NCT01596530</td>\n","      <td>Evaluation of Drug Activity in Women With Brea...</td>\n","      <td>CHIVE</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Breast Neoplasm</td>\n","      <td>Drug: Drug-AZD8931|Drug: Drug-Placebo</td>\n","      <td>Comparison of the effects of AZD8931 versus pl...</td>\n","      <td>AstraZeneca</td>\n","      <td>...</td>\n","      <td>D0102C00019</td>\n","      <td>June 2012</td>\n","      <td>March 2013</td>\n","      <td>May 2013</td>\n","      <td>May 11, 2012</td>\n","      <td>NaN</td>\n","      <td>December 17, 2012</td>\n","      <td>Research Site, Dusseldorf, Germany|Research Si...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01596530</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>3</td>\n","      <td>NCT04194528</td>\n","      <td>S1916 Digital Medicine Program for Pain Contro...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Metastatic Cancer</td>\n","      <td>Drug: Oxycodone/acetaminophen 5/325 mg|Device:...</td>\n","      <td>Feasibility determined by accrual, adherence a...</td>\n","      <td>Southwest Oncology Group|Proteus Digital Healt...</td>\n","      <td>...</td>\n","      <td>S1916</td>\n","      <td>October 15, 2019</td>\n","      <td>September 16, 2020</td>\n","      <td>September 16, 2020</td>\n","      <td>December 11, 2019</td>\n","      <td>NaN</td>\n","      <td>January 13, 2021</td>\n","      <td>Decatur Memorial Hospital, Decatur, Illinois, ...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT04194528</td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>4</td>\n","      <td>NCT02578459</td>\n","      <td>A Pilot Study to Evaluate the Efficacy of ITDD...</td>\n","      <td>NaN</td>\n","      <td>Withdrawn</td>\n","      <td>No Results Available</td>\n","      <td>Pain Management|Cancer Pain</td>\n","      <td>Device: Intrathecal Drug Delivery System|Other...</td>\n","      <td>Visual Analog Scale Pain Scores|Survival Rates...</td>\n","      <td>Flowonix Medical</td>\n","      <td>...</td>\n","      <td>PM-02</td>\n","      <td>April 2016</td>\n","      <td>December 2016</td>\n","      <td>September 2018</td>\n","      <td>October 19, 2015</td>\n","      <td>NaN</td>\n","      <td>February 15, 2019</td>\n","      <td>Menorah Medical Center, Overland Park, Kansas,...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT02578459</td>\n","    </tr>\n","    <tr>\n","      <th>4</th>\n","      <td>5</td>\n","      <td>NCT01987375</td>\n","      <td>Cetuximab IRDye800 Study as an Optical Imaging...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Head and Neck Cancer</td>\n","      <td>Drug: Cetuximab-IRDye800</td>\n","      <td>Number of subjects in a cohort experiencing a ...</td>\n","      <td>Eben Rosenthal|Stanford University</td>\n","      <td>...</td>\n","      <td>IRB-35068|ENT0049</td>\n","      <td>November 2015</td>\n","      <td>April 19, 2017</td>\n","      <td>April 19, 2017</td>\n","      <td>November 19, 2013</td>\n","      <td>NaN</td>\n","      <td>June 24, 2019</td>\n","      <td>Stanford University, School of Medicine, Stanf...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01987375</td>\n","    </tr>\n","    <tr>\n","      <th>5</th>\n","      <td>6</td>\n","      <td>NCT04281290</td>\n","      <td>Electrochemotherapy of Posterior Resection Sur...</td>\n","      <td>PanECT</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Pancreas Cancer</td>\n","      <td>Procedure: Electrochemotherapy - electroporati...</td>\n","      <td>Evaluation of feasibility and safety|Disease-f...</td>\n","      <td>University Medical Centre Ljubljana|Institute ...</td>\n","      <td>...</td>\n","      <td>21K/01/20</td>\n","      <td>July 13, 2020</td>\n","      <td>March 9, 2021</td>\n","      <td>March 9, 2021</td>\n","      <td>February 24, 2020</td>\n","      <td>NaN</td>\n","      <td>March 12, 2021</td>\n","      <td>University Medical Centre Ljubljana, Ljubljana...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT04281290</td>\n","    </tr>\n","    <tr>\n","      <th>6</th>\n","      <td>7</td>\n","      <td>NCT02244112</td>\n","      <td>A Phase 1 Study of Oprozomib to Assess Food Ef...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Advanced Non-Central Nervous System (CNS) Mali...</td>\n","      <td>Drug: Oprozomib|Drug: Midazolam</td>\n","      <td>Food Effect/QTc - Cmax|Food Effect/QTc - AUC|F...</td>\n","      <td>Amgen</td>\n","      <td>...</td>\n","      <td>OPZ009</td>\n","      <td>August 2014</td>\n","      <td>May 15, 2015</td>\n","      <td>July 10, 2019</td>\n","      <td>September 18, 2014</td>\n","      <td>NaN</td>\n","      <td>February 21, 2021</td>\n","      <td>University of Colorado Anschutz Medical Campus...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT02244112</td>\n","    </tr>\n","    <tr>\n","      <th>7</th>\n","      <td>8</td>\n","      <td>NCT03370302</td>\n","      <td>A Study to Evaluate the Safety, Tolerability, ...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Advanced Nonhematological Neoplasms</td>\n","      <td>Drug: TAK-228</td>\n","      <td>Number of Participants With Treatment Emergent...</td>\n","      <td>Millennium Pharmaceuticals, Inc.|Takeda</td>\n","      <td>...</td>\n","      <td>C31008|U1111-1202-4296|1066064639|20170270241|...</td>\n","      <td>January 17, 2018</td>\n","      <td>August 28, 2019</td>\n","      <td>August 28, 2019</td>\n","      <td>December 12, 2017</td>\n","      <td>September 9, 2020</td>\n","      <td>May 11, 2021</td>\n","      <td>National Cancer Center Hospital East, Kashiwa-...</td>\n","      <td>\"Study Protocol\", https://ClinicalTrials.gov/P...</td>\n","      <td>https://ClinicalTrials.gov/show/NCT03370302</td>\n","    </tr>\n","    <tr>\n","      <th>8</th>\n","      <td>9</td>\n","      <td>NCT01060423</td>\n","      <td>TACE With Irinotecan Drug-eluting Beads and In...</td>\n","      <td>DEBIRITUX</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Colorectal Cancer</td>\n","      <td>Drug: Cetuximab|Drug: Irinotecan|Device: Irino...</td>\n","      <td>Progression free survival rate|Tumour Response...</td>\n","      <td>Hans-Joachim Schmoll, MD|Biocompatibles UK Ltd...</td>\n","      <td>...</td>\n","      <td>EudraCT: 2009-014728-44</td>\n","      <td>February 2010</td>\n","      <td>December 2012</td>\n","      <td>May 2015</td>\n","      <td>February 2, 2010</td>\n","      <td>NaN</td>\n","      <td>October 26, 2016</td>\n","      <td>Zentralklinik Bad Berka GmbH, Abteilung f√ºr In...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01060423</td>\n","    </tr>\n","    <tr>\n","      <th>9</th>\n","      <td>10</td>\n","      <td>NCT03681951</td>\n","      <td>First-time-in-human (FTIH) Study of GSK3145095...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Neoplasms, Pancreatic</td>\n","      <td>Drug: GSK3145095|Drug: Pembrolizumab</td>\n","      <td>Number of Participants With Non-serious Advers...</td>\n","      <td>GlaxoSmithKline|Parexel</td>\n","      <td>...</td>\n","      <td>205013</td>\n","      <td>November 16, 2018</td>\n","      <td>August 13, 2019</td>\n","      <td>August 13, 2019</td>\n","      <td>September 24, 2018</td>\n","      <td>July 31, 2020</td>\n","      <td>July 31, 2020</td>\n","      <td>GSK Investigational Site, Indianapolis, Indian...</td>\n","      <td>\"Study Protocol\", https://ClinicalTrials.gov/P...</td>\n","      <td>https://ClinicalTrials.gov/show/NCT03681951</td>\n","    </tr>\n","    <tr>\n","      <th>10</th>\n","      <td>11</td>\n","      <td>NCT01038752</td>\n","      <td>Evaluation of Non-cytotoxic Suramin as a Chemo...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Non-small Cell Lung Cancer</td>\n","      <td>Drug: Suramin Drug:Docetaxel Drug: Carboplatin...</td>\n","      <td>Progression-free Survival for Participants Wit...</td>\n","      <td>Optimum Therapeutics, LLC</td>\n","      <td>...</td>\n","      <td>Optimum-Suramin-1</td>\n","      <td>August 2010</td>\n","      <td>November 2012</td>\n","      <td>May 2013</td>\n","      <td>December 24, 2009</td>\n","      <td>October 21, 2014</td>\n","      <td>May 21, 2015</td>\n","      <td>John H Stroger Jr Hospital of Cook County, Chi...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01038752</td>\n","    </tr>\n","    <tr>\n","      <th>11</th>\n","      <td>12</td>\n","      <td>NCT00555984</td>\n","      <td>Intravenous Anesthesia Versus Anesthesia With ...</td>\n","      <td>TIVA</td>\n","      <td>Withdrawn</td>\n","      <td>No Results Available</td>\n","      <td>Brain Neoplasms</td>\n","      <td>Drug: Propofol + Remifentanil|Drug: Sevofluran...</td>\n","      <td>To study inflammatory changes associated with ...</td>\n","      <td>The Cleveland Clinic</td>\n","      <td>...</td>\n","      <td>Case 4306</td>\n","      <td>September 2007</td>\n","      <td>March 2010</td>\n","      <td>March 2010</td>\n","      <td>November 9, 2007</td>\n","      <td>NaN</td>\n","      <td>April 20, 2017</td>\n","      <td>Cleveland Clinic Foundation, Cleveland, Ohio, ...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00555984</td>\n","    </tr>\n","    <tr>\n","      <th>12</th>\n","      <td>13</td>\n","      <td>NCT01915472</td>\n","      <td>A Phase II Study of IMMU 130 in Patients With ...</td>\n","      <td>NaN</td>\n","      <td>Withdrawn</td>\n","      <td>No Results Available</td>\n","      <td>Metastatic Colorectal Cancer</td>\n","      <td>Drug: IMMU 130</td>\n","      <td>Safety|Assess PK</td>\n","      <td>Gilead Sciences</td>\n","      <td>...</td>\n","      <td>IMMU 130-03</td>\n","      <td>September 2013</td>\n","      <td>August 2015</td>\n","      <td>August 2015</td>\n","      <td>August 5, 2013</td>\n","      <td>NaN</td>\n","      <td>August 19, 2021</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01915472</td>\n","    </tr>\n","    <tr>\n","      <th>13</th>\n","      <td>14</td>\n","      <td>NCT00040391</td>\n","      <td>A Trial of an Investigational Drug for the Pre...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Colorectal Neoplasms|Diarrhea</td>\n","      <td>Drug: Investigational drug|Drug: Irinotecan|Dr...</td>\n","      <td>NaN</td>\n","      <td>Celgene Corporation|Pfizer</td>\n","      <td>...</td>\n","      <td>440E-ONC-0020-315</td>\n","      <td>June 2002</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>June 27, 2002</td>\n","      <td>NaN</td>\n","      <td>December 1, 2016</td>\n","      <td>Research Center, Little Rock, Arkansas, United...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00040391</td>\n","    </tr>\n","    <tr>\n","      <th>14</th>\n","      <td>15</td>\n","      <td>NCT00200382</td>\n","      <td>Phase II Study of Therapy With PS 341 in Patie...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Non-small Cell Lung Cancer</td>\n","      <td>Drug: PS-341 (Velcade-drug)</td>\n","      <td>Response rate</td>\n","      <td>Rasim Gucalp|Millennium Pharmaceuticals, Inc.|...</td>\n","      <td>...</td>\n","      <td>02-05-123</td>\n","      <td>May 2004</td>\n","      <td>May 2007</td>\n","      <td>May 2007</td>\n","      <td>September 20, 2005</td>\n","      <td>NaN</td>\n","      <td>August 2, 2018</td>\n","      <td>HealthAlliance Hospitals, Fitchburg, Massachus...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00200382</td>\n","    </tr>\n","    <tr>\n","      <th>15</th>\n","      <td>16</td>\n","      <td>NCT00575978</td>\n","      <td>Hydralazine as Demethylating Agent in Breast C...</td>\n","      <td>NaN</td>\n","      <td>Withdrawn</td>\n","      <td>No Results Available</td>\n","      <td>Breast Cancer</td>\n","      <td>Drug: Hydralazine</td>\n","      <td>To explore the potency of a clinical tolerable...</td>\n","      <td>University of Arkansas</td>\n","      <td>...</td>\n","      <td>2003-23</td>\n","      <td>June 2004</td>\n","      <td>December 2009</td>\n","      <td>December 2009</td>\n","      <td>December 18, 2007</td>\n","      <td>NaN</td>\n","      <td>March 4, 2015</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00575978</td>\n","    </tr>\n","    <tr>\n","      <th>16</th>\n","      <td>17</td>\n","      <td>NCT01575782</td>\n","      <td>Chloroquine as an Anti-autophagic Radiosensiti...</td>\n","      <td>Chloroquine</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Small Cell Lung Cancer</td>\n","      <td>Drug: Chloroquine</td>\n","      <td>Number of Participants with Adverse Events as ...</td>\n","      <td>Maastricht Radiation Oncology</td>\n","      <td>...</td>\n","      <td>CHLOROQUINE I-III</td>\n","      <td>May 2014</td>\n","      <td>July 2017</td>\n","      <td>July 2017</td>\n","      <td>April 11, 2012</td>\n","      <td>NaN</td>\n","      <td>July 18, 2017</td>\n","      <td>MAASTRO clinic, Maastricht, Limburg, Netherlands</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01575782</td>\n","    </tr>\n","    <tr>\n","      <th>17</th>\n","      <td>18</td>\n","      <td>NCT01605318</td>\n","      <td>Dose Finding Study of Once or Twice Weekly IMM...</td>\n","      <td>NaN</td>\n","      <td>Withdrawn</td>\n","      <td>No Results Available</td>\n","      <td>Metastatic Colorectal Cancer|Colon Cancer|Rect...</td>\n","      <td>Drug: IMMU-130</td>\n","      <td>Evaluate the safety and tolerability of IMMU-1...</td>\n","      <td>Gilead Sciences</td>\n","      <td>...</td>\n","      <td>IM-T-IMMU-130-02</td>\n","      <td>September 2012</td>\n","      <td>January 2016</td>\n","      <td>January 2016</td>\n","      <td>May 24, 2012</td>\n","      <td>NaN</td>\n","      <td>August 19, 2021</td>\n","      <td>UCLA Jonsson Comprehensive Cancer Center, Sant...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01605318</td>\n","    </tr>\n","    <tr>\n","      <th>18</th>\n","      <td>19</td>\n","      <td>NCT02087176</td>\n","      <td>A Placebo Controlled Study Comparing AZD1775+ ...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Previously Treated Non Small Cell Lung Cancer</td>\n","      <td>Drug: AZD1775|Drug: AZD1775 Placebo|Drug: Anti...</td>\n","      <td>Objective Response Rate|Pharmacokinetic Profil...</td>\n","      <td>AstraZeneca</td>\n","      <td>...</td>\n","      <td>D6011C00001</td>\n","      <td>March 2014</td>\n","      <td>May 2015</td>\n","      <td>May 2015</td>\n","      <td>March 14, 2014</td>\n","      <td>June 14, 2016</td>\n","      <td>June 14, 2016</td>\n","      <td>Research Site, Birmingham, Alabama, United Sta...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT02087176</td>\n","    </tr>\n","    <tr>\n","      <th>19</th>\n","      <td>20</td>\n","      <td>NCT03471286</td>\n","      <td>A Window of Opportunity Study to Investigate M...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Solid Tumor</td>\n","      <td>Drug: Epacadostat</td>\n","      <td>Pharmacodynamic effects as measured by changes...</td>\n","      <td>Sidney Kimmel Comprehensive Cancer Center at J...</td>\n","      <td>...</td>\n","      <td>J17168|IRB00156271|I-24360-17-13</td>\n","      <td>June 6, 2019</td>\n","      <td>July 30, 2021</td>\n","      <td>July 30, 2021</td>\n","      <td>March 20, 2018</td>\n","      <td>NaN</td>\n","      <td>August 26, 2021</td>\n","      <td>Sidney Kimmel Comprehensive Cancer Center at J...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT03471286</td>\n","    </tr>\n","    <tr>\n","      <th>20</th>\n","      <td>21</td>\n","      <td>NCT01329640</td>\n","      <td>Feasibility Study of Metronomic Chemotherapy f...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Locally Advanced HER2-positive Breast Cancer</td>\n","      <td>Device: Drug: Paclitaxel; trastuzumab; doxorru...</td>\n","      <td>INCIDENCE OF FEBRILE NEUTROPENIA|TUMOR SIZE</td>\n","      <td>Instituto do Cancer do Estado de S√£o Paulo|Fun...</td>\n","      <td>...</td>\n","      <td>NP 17/2010 TraQ-Me 01</td>\n","      <td>September 2010</td>\n","      <td>September 2011</td>\n","      <td>September 2012</td>\n","      <td>April 6, 2011</td>\n","      <td>NaN</td>\n","      <td>May 21, 2014</td>\n","      <td>Instituto do Cancer do Estado de Sao Paulo, Sa...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01329640</td>\n","    </tr>\n","    <tr>\n","      <th>21</th>\n","      <td>22</td>\n","      <td>NCT01209832</td>\n","      <td>A Tasisulam and Midazolam Drug Interaction Stu...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Advanced Cancer</td>\n","      <td>Drug: Tasisulam|Drug: Midazolam</td>\n","      <td>Midazolam Pharmacokinetics: Area Under the Con...</td>\n","      <td>Eli Lilly and Company</td>\n","      <td>...</td>\n","      <td>13074|H8K-MC-JZAP|2010-020090-16</td>\n","      <td>September 2010</td>\n","      <td>January 2011</td>\n","      <td>January 2011</td>\n","      <td>September 27, 2010</td>\n","      <td>March 18, 2019</td>\n","      <td>March 18, 2019</td>\n","      <td>For additional information regarding investiga...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01209832</td>\n","    </tr>\n","    <tr>\n","      <th>22</th>\n","      <td>23</td>\n","      <td>NCT01823835</td>\n","      <td>A Study of GDC-0810 Single Agent or in Combina...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Breast Cancer</td>\n","      <td>Drug: GDC-0810|Drug: LHRH Agonist|Drug: Palboc...</td>\n","      <td>Phase Ia: Maximum Tolerated Dose of GDC-0810 W...</td>\n","      <td>Genentech, Inc.</td>\n","      <td>...</td>\n","      <td>GO29642|2014-004852-77</td>\n","      <td>December 29, 2014</td>\n","      <td>March 13, 2020</td>\n","      <td>March 13, 2020</td>\n","      <td>April 4, 2013</td>\n","      <td>June 18, 2021</td>\n","      <td>June 18, 2021</td>\n","      <td>Ucsd Medical Center, San Diego, California, Un...</td>\n","      <td>\"Study Protocol and Statistical Analysis Plan\"...</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01823835</td>\n","    </tr>\n","    <tr>\n","      <th>23</th>\n","      <td>24</td>\n","      <td>NCT03745690</td>\n","      <td>Near-Infrared Image Guided Surgical Resection ...</td>\n","      <td>NaN</td>\n","      <td>Suspended</td>\n","      <td>No Results Available</td>\n","      <td>Head and Neck Carcinoma</td>\n","      <td>Procedure: Image-Guided Surgery|Drug: Indocyan...</td>\n","      <td>Safety related by type, incidence, severity, s...</td>\n","      <td>Jonsson Comprehensive Cancer Center</td>\n","      <td>...</td>\n","      <td>18-000168|NCI-2018-02094</td>\n","      <td>December 12, 2018</td>\n","      <td>February 1, 2022</td>\n","      <td>February 1, 2023</td>\n","      <td>November 19, 2018</td>\n","      <td>NaN</td>\n","      <td>March 11, 2021</td>\n","      <td>UCLA / Jonsson Comprehensive Cancer Center, Lo...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT03745690</td>\n","    </tr>\n","    <tr>\n","      <th>24</th>\n","      <td>25</td>\n","      <td>NCT01632020</td>\n","      <td>Effect of Metformin on Biomarkers of Colorecta...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Colorectal Neoplasms</td>\n","      <td>Drug: Placebo|Drug: Metformin</td>\n","      <td>Proliferation Status of CRC Tumor and Adjacent...</td>\n","      <td>University of Arkansas</td>\n","      <td>...</td>\n","      <td>134190</td>\n","      <td>August 2012</td>\n","      <td>January 2015</td>\n","      <td>January 2015</td>\n","      <td>June 29, 2012</td>\n","      <td>July 11, 2016</td>\n","      <td>July 11, 2016</td>\n","      <td>Central Arkansas Veterans Heathcare System, Li...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01632020</td>\n","    </tr>\n","    <tr>\n","      <th>25</th>\n","      <td>26</td>\n","      <td>NCT00969306</td>\n","      <td>Chloroquine as an Anti-Autophagy Drug in Stage...</td>\n","      <td>Chloroquine IV</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Small Cell Lung Cancer</td>\n","      <td>Drug: Chloroquine, A-CQ 100</td>\n","      <td>To determine the toxicity of adding chloroquin...</td>\n","      <td>Maastricht Radiation Oncology|Maastricht Unive...</td>\n","      <td>...</td>\n","      <td>Chloroquine IV</td>\n","      <td>September 2013</td>\n","      <td>June 2016</td>\n","      <td>June 2016</td>\n","      <td>September 1, 2009</td>\n","      <td>NaN</td>\n","      <td>February 15, 2019</td>\n","      <td>NKI/AvL, Amsterdam, Netherlands|VU Medical Cen...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00969306</td>\n","    </tr>\n","    <tr>\n","      <th>26</th>\n","      <td>27</td>\n","      <td>NCT01804530</td>\n","      <td>Phase 1 Study of PLX7486 as Single Agent in Pa...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Solid Tumor|Tumors of Any Histology With Activ...</td>\n","      <td>Drug: PLX7486 TsOH</td>\n","      <td>Safety of PLX7486 as single agent as measured ...</td>\n","      <td>Plexxikon</td>\n","      <td>...</td>\n","      <td>PLX119-01</td>\n","      <td>August 2013</td>\n","      <td>January 24, 2018</td>\n","      <td>January 24, 2018</td>\n","      <td>March 5, 2013</td>\n","      <td>NaN</td>\n","      <td>August 2, 2018</td>\n","      <td>Ronald Reagan UCLA Medical Center, Los Angeles...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01804530</td>\n","    </tr>\n","    <tr>\n","      <th>27</th>\n","      <td>28</td>\n","      <td>NCT04091711</td>\n","      <td>Evaluation of ReX-C¬Æ System for Medication Adh...</td>\n","      <td>NaN</td>\n","      <td>Suspended</td>\n","      <td>No Results Available</td>\n","      <td>Oncology|Adherence, Medication|Side Effect</td>\n","      <td>Device: ReX-C system</td>\n","      <td>Number of safety events during administration ...</td>\n","      <td>Dosentrx Ltd.</td>\n","      <td>...</td>\n","      <td>RXC-034-2019-CLE</td>\n","      <td>April 21, 2020</td>\n","      <td>December 2022</td>\n","      <td>February 2023</td>\n","      <td>September 17, 2019</td>\n","      <td>NaN</td>\n","      <td>September 20, 2021</td>\n","      <td>Oncology Unit, Tel Aviv Sourasky Medical Cente...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT04091711</td>\n","    </tr>\n","    <tr>\n","      <th>28</th>\n","      <td>29</td>\n","      <td>NCT01086696</td>\n","      <td>A Pilot Study of F-18 Paclitaxel (FPAC) PET fo...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Breast Cancer|Lung Cancer|Renal Cancer|Adrenal...</td>\n","      <td>Drug: FPAC</td>\n","      <td>Uptake of FPAC in tumors|Safety of FPAC</td>\n","      <td>National Cancer Institute (NCI)|National Insti...</td>\n","      <td>...</td>\n","      <td>100078|10-C-0078</td>\n","      <td>March 9, 2010</td>\n","      <td>August 20, 2014</td>\n","      <td>May 11, 2016</td>\n","      <td>March 15, 2010</td>\n","      <td>NaN</td>\n","      <td>December 17, 2019</td>\n","      <td>National Institutes of Health Clinical Center,...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01086696</td>\n","    </tr>\n","    <tr>\n","      <th>29</th>\n","      <td>30</td>\n","      <td>NCT00695370</td>\n","      <td>Evaluation of Pegfilgrastim for Stem Cell Mobi...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Solid Malignancies</td>\n","      <td>Drug: Pegfilgrastim (drug)</td>\n","      <td>percentage of children achieving at least 5x10...</td>\n","      <td>University Hospital, Clermont-Ferrand|Amgen</td>\n","      <td>...</td>\n","      <td>CHU-0035</td>\n","      <td>January 2006</td>\n","      <td>December 2007</td>\n","      <td>January 2008</td>\n","      <td>June 11, 2008</td>\n","      <td>NaN</td>\n","      <td>June 13, 2008</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00695370</td>\n","    </tr>\n","    <tr>\n","      <th>...</th>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","    </tr>\n","    <tr>\n","      <th>7660</th>\n","      <td>7661</td>\n","      <td>NCT01013961</td>\n","      <td>Rituximab and Alemtuzumab in Treating Older Pa...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Chronic Lymphocytic Leukemia</td>\n","      <td>Biological: alemtuzumab|Biological: rituximab</td>\n","      <td>Proportion of Patients With Complete Response ...</td>\n","      <td>ECOG-ACRIN Cancer Research Group|National Canc...</td>\n","      <td>...</td>\n","      <td>E1908|U10CA180794</td>\n","      <td>October 2010</td>\n","      <td>April 14, 2015</td>\n","      <td>April 14, 2015</td>\n","      <td>November 16, 2009</td>\n","      <td>January 28, 2016</td>\n","      <td>January 14, 2019</td>\n","      <td>Mayo Clinic Scottsdale, Scottsdale, Arizona, U...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01013961</td>\n","    </tr>\n","    <tr>\n","      <th>7661</th>\n","      <td>7662</td>\n","      <td>NCT00265915</td>\n","      <td>Rituximab and GM-CSF in Treating Patients With...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Leukemia</td>\n","      <td>Biological: rituximab|Biological: sargramostim</td>\n","      <td>Overall response rate</td>\n","      <td>Sidney Kimmel Comprehensive Cancer Center at J...</td>\n","      <td>...</td>\n","      <td>J0546 CDR0000450145|P01CA081534|P30CA006973|JH...</td>\n","      <td>July 2005</td>\n","      <td>March 2006</td>\n","      <td>March 2006</td>\n","      <td>December 15, 2005</td>\n","      <td>NaN</td>\n","      <td>August 12, 2014</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00265915</td>\n","    </tr>\n","    <tr>\n","      <th>7662</th>\n","      <td>7663</td>\n","      <td>NCT00036855</td>\n","      <td>Radiolabeled Monoclonal Antibody With or Witho...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>AIDS-related Peripheral/Systemic Lymphoma|AIDS...</td>\n","      <td>Biological: rituximab|Radiation: indium In 111...</td>\n","      <td>MTD, defined as that dose at which fewer than ...</td>\n","      <td>National Cancer Institute (NCI)</td>\n","      <td>...</td>\n","      <td>NCI-2012-01871|ADVL0013|U01CA097452|CDR0000069331</td>\n","      <td>June 2002</td>\n","      <td>March 2005</td>\n","      <td>NaN</td>\n","      <td>January 27, 2003</td>\n","      <td>NaN</td>\n","      <td>January 17, 2013</td>\n","      <td>Children's Oncology Group, Arcadia, California...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00036855</td>\n","    </tr>\n","    <tr>\n","      <th>7663</th>\n","      <td>7664</td>\n","      <td>NCT00022971</td>\n","      <td>Combination Antibody Therapy for Relapsed Lymp...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Diffuse Large B-Cell Lymphoma|Follicular Lymph...</td>\n","      <td>Biological: Apolizumab|Biological: Rituximab</td>\n","      <td>MTD</td>\n","      <td>National Cancer Institute (NCI)|National Insti...</td>\n","      <td>...</td>\n","      <td>010235|01-C-0235</td>\n","      <td>August 15, 2001</td>\n","      <td>January 22, 2010</td>\n","      <td>March 17, 2017</td>\n","      <td>August 20, 2001</td>\n","      <td>NaN</td>\n","      <td>December 16, 2019</td>\n","      <td>National Institutes of Health Clinical Center,...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00022971</td>\n","    </tr>\n","    <tr>\n","      <th>7664</th>\n","      <td>7665</td>\n","      <td>NCT00005788</td>\n","      <td>Interleukin-2 in Treating Patients With Mycosi...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Lymphoma</td>\n","      <td>Biological: aldesleukin</td>\n","      <td>NaN</td>\n","      <td>Northwestern University|National Cancer Instit...</td>\n","      <td>...</td>\n","      <td>NU 96H7|NU-96H7|NCI-G00-1735</td>\n","      <td>April 1997</td>\n","      <td>January 2002</td>\n","      <td>January 2002</td>\n","      <td>January 27, 2003</td>\n","      <td>NaN</td>\n","      <td>June 6, 2012</td>\n","      <td>Robert H. Lurie Comprehensive Cancer Center, N...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00005788</td>\n","    </tr>\n","    <tr>\n","      <th>7665</th>\n","      <td>7666</td>\n","      <td>NCT01820312</td>\n","      <td>A Phase II Study to Evaluate Low-Dose Fraction...</td>\n","      <td>NaN</td>\n","      <td>Withdrawn</td>\n","      <td>No Results Available</td>\n","      <td>Squamous Cell Carcinoma of the Head and Neck</td>\n","      <td>Radiation: Low-Dose Fractionated Radiation The...</td>\n","      <td>Objective Response (OR)</td>\n","      <td>University of Arkansas</td>\n","      <td>...</td>\n","      <td>136191</td>\n","      <td>January 2013</td>\n","      <td>July 2015</td>\n","      <td>July 2015</td>\n","      <td>March 28, 2013</td>\n","      <td>NaN</td>\n","      <td>August 8, 2016</td>\n","      <td>University of Arkansas for Medical Sciences, L...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01820312</td>\n","    </tr>\n","    <tr>\n","      <th>7666</th>\n","      <td>7667</td>\n","      <td>NCT00004874</td>\n","      <td>Monoclonal Antibody Therapy in Treating Patien...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Lymphoma</td>\n","      <td>Radiation: tositumomab and iodine I 131 tositu...</td>\n","      <td>Expanded Access|Safety|efficacy</td>\n","      <td>University of Nebraska|National Cancer Institu...</td>\n","      <td>...</td>\n","      <td>259-98|P30CA036727|UNMC-259-98|COULTER-CP-98-020</td>\n","      <td>November 1998</td>\n","      <td>April 2002</td>\n","      <td>November 2012</td>\n","      <td>December 16, 2003</td>\n","      <td>NaN</td>\n","      <td>January 17, 2018</td>\n","      <td>University of Nebraska Medical Center, Omaha, ...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00004874</td>\n","    </tr>\n","    <tr>\n","      <th>7667</th>\n","      <td>7668</td>\n","      <td>NCT02922283</td>\n","      <td>IL2 Imaging in Metastatic Melanoma</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Melanoma</td>\n","      <td>Device: IL2-PET scan|Procedure: Tumor biopsy|D...</td>\n","      <td>Biodistribution and kinetics of [18F]FB-IL2.|T...</td>\n","      <td>University Medical Center Groningen</td>\n","      <td>...</td>\n","      <td>22102014</td>\n","      <td>October 20, 2016</td>\n","      <td>February 14, 2020</td>\n","      <td>February 14, 2020</td>\n","      <td>October 4, 2016</td>\n","      <td>NaN</td>\n","      <td>March 23, 2020</td>\n","      <td>University Medical Center Groningen, Groningen...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT02922283</td>\n","    </tr>\n","    <tr>\n","      <th>7668</th>\n","      <td>7669</td>\n","      <td>NCT02345330</td>\n","      <td>Trial of pIL-12 Electroporation in Squamous Ce...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Head and Neck Squamous Cell Carcinoma</td>\n","      <td>Biological: Tavokinogene Telseplasmid (tavo)|D...</td>\n","      <td>Best Overall Response Rate (BORR) by RECIST v1...</td>\n","      <td>OncoSec Medical Incorporated</td>\n","      <td>...</td>\n","      <td>OMS-I130</td>\n","      <td>May 21, 2015</td>\n","      <td>November 14, 2016</td>\n","      <td>November 14, 2016</td>\n","      <td>January 26, 2015</td>\n","      <td>January 3, 2018</td>\n","      <td>January 3, 2018</td>\n","      <td>UCSF Helen Diller Family Comprehensive Cancer ...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT02345330</td>\n","    </tr>\n","    <tr>\n","      <th>7669</th>\n","      <td>7670</td>\n","      <td>NCT00724061</td>\n","      <td>Study of Pegylated Interferon-Alfa 2b in Combi...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Lymphoma</td>\n","      <td>Biological: Pegylated interferon Œ±-2b|Other: P...</td>\n","      <td>Number of Dose Limiting Toxicities (DLTs) Obse...</td>\n","      <td>Northwestern University|National Cancer Instit...</td>\n","      <td>...</td>\n","      <td>NU 07H4|P30CA060553|SPRI-NU-07H4|STU00002993</td>\n","      <td>September 2008</td>\n","      <td>June 2011</td>\n","      <td>December 2011</td>\n","      <td>July 29, 2008</td>\n","      <td>December 2, 2013</td>\n","      <td>December 12, 2018</td>\n","      <td>Robert H. Lurie Comprehensive Cancer Center at...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00724061</td>\n","    </tr>\n","    <tr>\n","      <th>7670</th>\n","      <td>7671</td>\n","      <td>NCT00722098</td>\n","      <td>Comparison Study of Dendritic Cell Vaccine Wit...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Malignant Melanoma Stage IV</td>\n","      <td>Biological: DC Vaccine &amp; Cyclophosphamide|Biol...</td>\n","      <td>Induction of melanoma-specific CD8+T Cell Immu...</td>\n","      <td>Baylor Research Institute</td>\n","      <td>...</td>\n","      <td>Baylor IRB #006-123</td>\n","      <td>June 2008</td>\n","      <td>April 2011</td>\n","      <td>July 2012</td>\n","      <td>July 25, 2008</td>\n","      <td>NaN</td>\n","      <td>July 8, 2013</td>\n","      <td>Baylor University Medical Center, Dallas, Texa...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00722098</td>\n","    </tr>\n","    <tr>\n","      <th>7671</th>\n","      <td>7672</td>\n","      <td>NCT00706992</td>\n","      <td>Anti-MART-1 F5 Lymphocytes to Treat High-Risk ...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Melanoma</td>\n","      <td>Biological: ALVAC-MART-1 vaccine|Biological: M...</td>\n","      <td>Percentage of Participants With Immunologic Re...</td>\n","      <td>National Cancer Institute (NCI)|National Insti...</td>\n","      <td>...</td>\n","      <td>080162|08-C-0162</td>\n","      <td>June 2008</td>\n","      <td>November 2012</td>\n","      <td>November 2012</td>\n","      <td>June 30, 2008</td>\n","      <td>March 19, 2013</td>\n","      <td>October 28, 2015</td>\n","      <td>National Cancer Institute (NCI), 9000 Rockvill...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00706992</td>\n","    </tr>\n","    <tr>\n","      <th>7672</th>\n","      <td>7673</td>\n","      <td>NCT01758458</td>\n","      <td>Viral Oncoprotein Targeted Autologous T Cell T...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Recurrent Merkel Cell Carcinoma|Stage IV Merke...</td>\n","      <td>Biological: Aldesleukin|Other: Laboratory Biom...</td>\n","      <td>Evidence and nature of toxicity related to the...</td>\n","      <td>Fred Hutchinson Cancer Research Center|Nationa...</td>\n","      <td>...</td>\n","      <td>2586.00|NCI-2012-02779|2586|P30CA015704</td>\n","      <td>February 2013</td>\n","      <td>May 2016</td>\n","      <td>May 2016</td>\n","      <td>January 1, 2013</td>\n","      <td>NaN</td>\n","      <td>April 19, 2017</td>\n","      <td>Fred Hutchinson Cancer Research Center/Univers...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01758458</td>\n","    </tr>\n","    <tr>\n","      <th>7673</th>\n","      <td>7674</td>\n","      <td>NCT00085579</td>\n","      <td>Interleukin-2 and Sargramostim After Chemother...</td>\n","      <td>NaN</td>\n","      <td>Withdrawn</td>\n","      <td>No Results Available</td>\n","      <td>Melanoma (Skin)</td>\n","      <td>Biological: aldesleukin|Biological: sargramost...</td>\n","      <td>NaN</td>\n","      <td>Memorial Sloan Kettering Cancer Center|Nationa...</td>\n","      <td>...</td>\n","      <td>04-027|MSKCC-04027</td>\n","      <td>March 2004</td>\n","      <td>March 2005</td>\n","      <td>March 2005</td>\n","      <td>June 11, 2004</td>\n","      <td>NaN</td>\n","      <td>December 12, 2012</td>\n","      <td>Memorial Sloan-Kettering Cancer Center, New Yo...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00085579</td>\n","    </tr>\n","    <tr>\n","      <th>7674</th>\n","      <td>7675</td>\n","      <td>NCT00945269</td>\n","      <td>Therapeutic Autologous Lymphocytes, Aldesleuki...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Recurrent Melanoma|Stage III Melanoma|Stage IV...</td>\n","      <td>Biological: therapeutic autologous lymphocytes...</td>\n","      <td>In vivo survival of CD8+ transferred T-clones</td>\n","      <td>Fred Hutchinson Cancer Research Center|Nationa...</td>\n","      <td>...</td>\n","      <td>2271.00|NCI-2010-00738|K12CA076930|R21CA137647</td>\n","      <td>July 2009</td>\n","      <td>January 2011</td>\n","      <td>January 2011</td>\n","      <td>July 24, 2009</td>\n","      <td>NaN</td>\n","      <td>December 8, 2011</td>\n","      <td>Fred Hutchinson Cancer Research Center/Univers...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00945269</td>\n","    </tr>\n","    <tr>\n","      <th>7675</th>\n","      <td>7676</td>\n","      <td>NCT00006113</td>\n","      <td>Vaccine Therapy Followed by Biological Therapy...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Melanoma (Skin)</td>\n","      <td>Biological: MART-1 antigen|Biological: aldesle...</td>\n","      <td>NaN</td>\n","      <td>University of Southern California|National Can...</td>\n","      <td>...</td>\n","      <td>CDR0000068125 (10M-99-1)|LAC-USC-10M991|NCI-G0...</td>\n","      <td>June 1999</td>\n","      <td>May 2003</td>\n","      <td>April 2006</td>\n","      <td>January 27, 2003</td>\n","      <td>NaN</td>\n","      <td>May 22, 2014</td>\n","      <td>USC/Norris Comprehensive Cancer Center and Hos...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00006113</td>\n","    </tr>\n","    <tr>\n","      <th>7676</th>\n","      <td>7677</td>\n","      <td>NCT00588822</td>\n","      <td>Rituximab in Treating Patients With Peripheral...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Precancerous Condition</td>\n","      <td>Biological: Rituximab</td>\n","      <td>Percentage of Subjects With at Least 10 Points...</td>\n","      <td>Mayo Clinic|Genentech, Inc.|Biogen|National Ce...</td>\n","      <td>...</td>\n","      <td>1191-04|UL1RR024150</td>\n","      <td>January 2005</td>\n","      <td>January 2009</td>\n","      <td>February 2011</td>\n","      <td>January 9, 2008</td>\n","      <td>May 6, 2014</td>\n","      <td>May 6, 2014</td>\n","      <td>Mayo Clinic Scottsdale, Scottsdale, Arizona, U...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00588822</td>\n","    </tr>\n","    <tr>\n","      <th>7677</th>\n","      <td>7678</td>\n","      <td>NCT00054405</td>\n","      <td>Interleukin-12 and Interleukin-2 in Treating P...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Recurrent Neuroblastoma</td>\n","      <td>Biological: recombinant interleukin-12|Biologi...</td>\n","      <td>Maximum tolerated dose (MTD) assessed by Commo...</td>\n","      <td>National Cancer Institute (NCI)</td>\n","      <td>...</td>\n","      <td>NCI-2009-00024|NANT 2001-01|CDR0000270447|P01C...</td>\n","      <td>December 2002</td>\n","      <td>May 2009</td>\n","      <td>NaN</td>\n","      <td>February 6, 2003</td>\n","      <td>NaN</td>\n","      <td>April 9, 2013</td>\n","      <td>New Approaches to Neuroblastoma Treatment (NAN...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00054405</td>\n","    </tr>\n","    <tr>\n","      <th>7678</th>\n","      <td>7679</td>\n","      <td>NCT00005787</td>\n","      <td>Peripheral Stem Cell Transplantation to Preven...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Lymphoma|Neutropenia</td>\n","      <td>Biological: epoetin alfa|Biological: filgrasti...</td>\n","      <td>NaN</td>\n","      <td>Northwestern University|National Cancer Instit...</td>\n","      <td>...</td>\n","      <td>NU 99Z1|NU-99Z1|NCI-G00-1734</td>\n","      <td>September 1999</td>\n","      <td>January 2002</td>\n","      <td>January 2002</td>\n","      <td>January 27, 2003</td>\n","      <td>NaN</td>\n","      <td>June 1, 2012</td>\n","      <td>Robert H. Lurie Comprehensive Cancer Center, N...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00005787</td>\n","    </tr>\n","    <tr>\n","      <th>7679</th>\n","      <td>7680</td>\n","      <td>NCT00676806</td>\n","      <td>A Phase II Study of Umbilical Cord Blood Trans...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Leukemia|Lymphoma|Multiple Myeloma|Aplastic An...</td>\n","      <td>Biological: Umbilical Cord Blood After Myeloab...</td>\n","      <td>Number of Participants With Neutrophil Engraft...</td>\n","      <td>Tufts Medical Center</td>\n","      <td>...</td>\n","      <td>UCBT001</td>\n","      <td>July 2005</td>\n","      <td>July 2013</td>\n","      <td>July 2014</td>\n","      <td>May 13, 2008</td>\n","      <td>July 22, 2016</td>\n","      <td>June 1, 2017</td>\n","      <td>Tufts Medical Center, Boston, Massachusetts, U...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00676806</td>\n","    </tr>\n","    <tr>\n","      <th>7680</th>\n","      <td>7681</td>\n","      <td>NCT00357461</td>\n","      <td>Ipilimumab With or Without Vaccine Therapy in ...</td>\n","      <td>NaN</td>\n","      <td>Withdrawn</td>\n","      <td>No Results Available</td>\n","      <td>Melanoma (Skin)</td>\n","      <td>Biological: gp100:209-217(210M) peptide vaccin...</td>\n","      <td>Clinical response|Safety and toxicity|Immunolo...</td>\n","      <td>Bristol-Myers Squibb|National Cancer Institute...</td>\n","      <td>...</td>\n","      <td>CDR0000486705|NCI-06-C-0159|NCI-P6951|MDX-NCI-...</td>\n","      <td>May 2006</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>July 27, 2006</td>\n","      <td>NaN</td>\n","      <td>May 15, 2013</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00357461</td>\n","    </tr>\n","    <tr>\n","      <th>7681</th>\n","      <td>7682</td>\n","      <td>NCT01307618</td>\n","      <td>Vaccine Therapy With or Without Recombinant In...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Recurrent Melanoma|Stage IV Skin Melanoma</td>\n","      <td>Biological: NA17.A2 Peptide Vaccine|Biological...</td>\n","      <td>Frequency of Vaccine-induced CD8+ T Cells Asse...</td>\n","      <td>National Cancer Institute (NCI)</td>\n","      <td>...</td>\n","      <td>NCI-2011-02580|UCCRC-10-324-B|CDR0000696233|10...</td>\n","      <td>February 2011</td>\n","      <td>January 2015</td>\n","      <td>February 2015</td>\n","      <td>March 3, 2011</td>\n","      <td>October 24, 2016</td>\n","      <td>October 24, 2016</td>\n","      <td>University of Chicago Comprehensive Cancer Cen...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01307618</td>\n","    </tr>\n","    <tr>\n","      <th>7682</th>\n","      <td>7683</td>\n","      <td>NCT03422094</td>\n","      <td>Neoantigen-based Personalized Vaccine Combined...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Glioblastoma</td>\n","      <td>Biological: NeoVax|Biological: Nivolumab|Biolo...</td>\n","      <td>Safety and tolerability of regimen as measured...</td>\n","      <td>Washington University School of Medicine|Brist...</td>\n","      <td>...</td>\n","      <td>201804195</td>\n","      <td>October 31, 2018</td>\n","      <td>April 26, 2020</td>\n","      <td>December 31, 2020</td>\n","      <td>February 5, 2018</td>\n","      <td>NaN</td>\n","      <td>April 23, 2021</td>\n","      <td>Washington University School of Medicine, Sain...</td>\n","      <td>\"Informed Consent Form\", https://ClinicalTrial...</td>\n","      <td>https://ClinicalTrials.gov/show/NCT03422094</td>\n","    </tr>\n","    <tr>\n","      <th>7683</th>\n","      <td>7684</td>\n","      <td>NCT01644253</td>\n","      <td>Phase 1b Safety and Efficacy Study of TRU-016</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Chronic Lymphocytic Leukemia|Peripheral T-cell...</td>\n","      <td>Biological: 20 mg/kg TRU-016 + Rituximab|Biolo...</td>\n","      <td>Incidence and severity of adverse events|CLL C...</td>\n","      <td>Aptevo Therapeutics</td>\n","      <td>...</td>\n","      <td>16009</td>\n","      <td>September 2012</td>\n","      <td>February 24, 2020</td>\n","      <td>April 21, 2021</td>\n","      <td>July 19, 2012</td>\n","      <td>NaN</td>\n","      <td>May 20, 2021</td>\n","      <td>Augusta, Georgia, United States|Columbus, Ohio...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01644253</td>\n","    </tr>\n","    <tr>\n","      <th>7684</th>\n","      <td>7685</td>\n","      <td>NCT00052377</td>\n","      <td>Interleukin-12 and Interleukin-2 in Treating P...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Recurrent Cutaneous T-cell Non-Hodgkin Lymphom...</td>\n","      <td>Biological: aldesleukin|Biological: recombinan...</td>\n","      <td>Clinical response rate defined as the percenta...</td>\n","      <td>National Cancer Institute (NCI)</td>\n","      <td>...</td>\n","      <td>NCI-2012-02504|10401|R01CA089442|CDR0000258239</td>\n","      <td>September 2002</td>\n","      <td>June 2005</td>\n","      <td>NaN</td>\n","      <td>January 27, 2003</td>\n","      <td>NaN</td>\n","      <td>January 16, 2013</td>\n","      <td>Abramson Cancer Center of The University of Pe...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00052377</td>\n","    </tr>\n","    <tr>\n","      <th>7685</th>\n","      <td>7686</td>\n","      <td>NCT00863395</td>\n","      <td>Recalcitrant Pruritus in Cutaneous T-Cell Lymp...</td>\n","      <td>CTCL</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Cutaneous T-Cell Lymphoma</td>\n","      <td>Procedure: skin biopsy</td>\n","      <td>Collection of biopsies from pruritic CTCL pati...</td>\n","      <td>University of Minnesota</td>\n","      <td>...</td>\n","      <td>0705M09523</td>\n","      <td>December 2008</td>\n","      <td>December 2012</td>\n","      <td>December 2012</td>\n","      <td>March 18, 2009</td>\n","      <td>NaN</td>\n","      <td>March 31, 2014</td>\n","      <td>University of Minnesota, Minneapolis, Minnesot...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00863395</td>\n","    </tr>\n","    <tr>\n","      <th>7686</th>\n","      <td>7687</td>\n","      <td>NCT00052598</td>\n","      <td>Therapeutic Allogeneic Lymphocytes and Aldesle...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Accelerated Phase Chronic Myelogenous Leukemia...</td>\n","      <td>Biological: therapeutic allogeneic lymphocytes...</td>\n","      <td>Toxicity rate associated with infusing donor C...</td>\n","      <td>Fred Hutchinson Cancer Research Center|Nationa...</td>\n","      <td>...</td>\n","      <td>1671.00|NCI-2010-00826|P01CA018029</td>\n","      <td>September 2002</td>\n","      <td>November 2009</td>\n","      <td>June 2011</td>\n","      <td>January 27, 2003</td>\n","      <td>NaN</td>\n","      <td>February 15, 2017</td>\n","      <td>Fred Hutchinson Cancer Research Center/Univers...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00052598</td>\n","    </tr>\n","    <tr>\n","      <th>7687</th>\n","      <td>7688</td>\n","      <td>NCT01579318</td>\n","      <td>Phase II Intratumoral IL12 Plasmid Electropora...</td>\n","      <td>CTCL</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Cutaneous T Cell Lymphomas (CTCL)|Mycosis Fung...</td>\n","      <td>Biological: Tavokinogene Telseplasmid (tavo)|D...</td>\n","      <td>Objective Response Rate Assessed by Modified S...</td>\n","      <td>OncoSec Medical Incorporated</td>\n","      <td>...</td>\n","      <td>OMS-I120</td>\n","      <td>June 8, 2012</td>\n","      <td>June 3, 2014</td>\n","      <td>June 3, 2014</td>\n","      <td>April 17, 2012</td>\n","      <td>January 3, 2018</td>\n","      <td>January 3, 2018</td>\n","      <td>UCSF Helen Diller Comprehensive Cancer Center,...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01579318</td>\n","    </tr>\n","    <tr>\n","      <th>7688</th>\n","      <td>7689</td>\n","      <td>NCT03316066</td>\n","      <td>Comparison of Volumes of Local Anesthetics on ...</td>\n","      <td>NaN</td>\n","      <td>Withdrawn</td>\n","      <td>No Results Available</td>\n","      <td>Complex Regional Pain Syndromes</td>\n","      <td>Procedure: stellate ganglion block with ropiva...</td>\n","      <td>Pain score|Temperature increase in the ipsilat...</td>\n","      <td>Maisonneuve-Rosemont Hospital</td>\n","      <td>...</td>\n","      <td>Maisonneuve RH</td>\n","      <td>October 20, 2018</td>\n","      <td>February 21, 2020</td>\n","      <td>February 21, 2020</td>\n","      <td>October 20, 2017</td>\n","      <td>NaN</td>\n","      <td>February 24, 2020</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT03316066</td>\n","    </tr>\n","    <tr>\n","      <th>7689</th>\n","      <td>7690</td>\n","      <td>NCT02221154</td>\n","      <td>Use of Myo-inositol as Adjuvant Therapy in Pat...</td>\n","      <td>FIV-INOPK</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Polycystic Ovary Syndrome</td>\n","      <td>Dietary Supplement: Inofolic¬Æ|Other: Gonadotro...</td>\n","      <td>Incidence of OHSS in each group, graded mild, ...</td>\n","      <td>Centre Hospitalier Departemental Vendee</td>\n","      <td>...</td>\n","      <td>CHD 096-13</td>\n","      <td>November 2014</td>\n","      <td>May 22, 2017</td>\n","      <td>May 22, 2017</td>\n","      <td>August 20, 2014</td>\n","      <td>NaN</td>\n","      <td>June 16, 2017</td>\n","      <td>CHI de Cr√©teil, Cr√©teil, France|CHD Vend√©e, La...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT02221154</td>\n","    </tr>\n","  </tbody>\n","</table>\n","<p>7690 rows √ó 27 columns</p>\n","</div>"],"text/plain":["      Rank   NCT Number                                              Title  \\\n","0        1  NCT02538471  LY2157299 Monohydrate (LY2157299) and Radiothe...   \n","1        2  NCT01596530  Evaluation of Drug Activity in Women With Brea...   \n","2        3  NCT04194528  S1916 Digital Medicine Program for Pain Contro...   \n","3        4  NCT02578459  A Pilot Study to Evaluate the Efficacy of ITDD...   \n","4        5  NCT01987375  Cetuximab IRDye800 Study as an Optical Imaging...   \n","5        6  NCT04281290  Electrochemotherapy of Posterior Resection Sur...   \n","6        7  NCT02244112  A Phase 1 Study of Oprozomib to Assess Food Ef...   \n","7        8  NCT03370302  A Study to Evaluate the Safety, Tolerability, ...   \n","8        9  NCT01060423  TACE With Irinotecan Drug-eluting Beads and In...   \n","9       10  NCT03681951  First-time-in-human (FTIH) Study of GSK3145095...   \n","10      11  NCT01038752  Evaluation of Non-cytotoxic Suramin as a Chemo...   \n","11      12  NCT00555984  Intravenous Anesthesia Versus Anesthesia With ...   \n","12      13  NCT01915472  A Phase II Study of IMMU 130 in Patients With ...   \n","13      14  NCT00040391  A Trial of an Investigational Drug for the Pre...   \n","14      15  NCT00200382  Phase II Study of Therapy With PS 341 in Patie...   \n","15      16  NCT00575978  Hydralazine as Demethylating Agent in Breast C...   \n","16      17  NCT01575782  Chloroquine as an Anti-autophagic Radiosensiti...   \n","17      18  NCT01605318  Dose Finding Study of Once or Twice Weekly IMM...   \n","18      19  NCT02087176  A Placebo Controlled Study Comparing AZD1775+ ...   \n","19      20  NCT03471286  A Window of Opportunity Study to Investigate M...   \n","20      21  NCT01329640  Feasibility Study of Metronomic Chemotherapy f...   \n","21      22  NCT01209832  A Tasisulam and Midazolam Drug Interaction Stu...   \n","22      23  NCT01823835  A Study of GDC-0810 Single Agent or in Combina...   \n","23      24  NCT03745690  Near-Infrared Image Guided Surgical Resection ...   \n","24      25  NCT01632020  Effect of Metformin on Biomarkers of Colorecta...   \n","25      26  NCT00969306  Chloroquine as an Anti-Autophagy Drug in Stage...   \n","26      27  NCT01804530  Phase 1 Study of PLX7486 as Single Agent in Pa...   \n","27      28  NCT04091711  Evaluation of ReX-C¬Æ System for Medication Adh...   \n","28      29  NCT01086696  A Pilot Study of F-18 Paclitaxel (FPAC) PET fo...   \n","29      30  NCT00695370  Evaluation of Pegfilgrastim for Stem Cell Mobi...   \n","...    ...          ...                                                ...   \n","7660  7661  NCT01013961  Rituximab and Alemtuzumab in Treating Older Pa...   \n","7661  7662  NCT00265915  Rituximab and GM-CSF in Treating Patients With...   \n","7662  7663  NCT00036855  Radiolabeled Monoclonal Antibody With or Witho...   \n","7663  7664  NCT00022971  Combination Antibody Therapy for Relapsed Lymp...   \n","7664  7665  NCT00005788  Interleukin-2 in Treating Patients With Mycosi...   \n","7665  7666  NCT01820312  A Phase II Study to Evaluate Low-Dose Fraction...   \n","7666  7667  NCT00004874  Monoclonal Antibody Therapy in Treating Patien...   \n","7667  7668  NCT02922283                 IL2 Imaging in Metastatic Melanoma   \n","7668  7669  NCT02345330  Trial of pIL-12 Electroporation in Squamous Ce...   \n","7669  7670  NCT00724061  Study of Pegylated Interferon-Alfa 2b in Combi...   \n","7670  7671  NCT00722098  Comparison Study of Dendritic Cell Vaccine Wit...   \n","7671  7672  NCT00706992  Anti-MART-1 F5 Lymphocytes to Treat High-Risk ...   \n","7672  7673  NCT01758458  Viral Oncoprotein Targeted Autologous T Cell T...   \n","7673  7674  NCT00085579  Interleukin-2 and Sargramostim After Chemother...   \n","7674  7675  NCT00945269  Therapeutic Autologous Lymphocytes, Aldesleuki...   \n","7675  7676  NCT00006113  Vaccine Therapy Followed by Biological Therapy...   \n","7676  7677  NCT00588822  Rituximab in Treating Patients With Peripheral...   \n","7677  7678  NCT00054405  Interleukin-12 and Interleukin-2 in Treating P...   \n","7678  7679  NCT00005787  Peripheral Stem Cell Transplantation to Preven...   \n","7679  7680  NCT00676806  A Phase II Study of Umbilical Cord Blood Trans...   \n","7680  7681  NCT00357461  Ipilimumab With or Without Vaccine Therapy in ...   \n","7681  7682  NCT01307618  Vaccine Therapy With or Without Recombinant In...   \n","7682  7683  NCT03422094  Neoantigen-based Personalized Vaccine Combined...   \n","7683  7684  NCT01644253      Phase 1b Safety and Efficacy Study of TRU-016   \n","7684  7685  NCT00052377  Interleukin-12 and Interleukin-2 in Treating P...   \n","7685  7686  NCT00863395  Recalcitrant Pruritus in Cutaneous T-Cell Lymp...   \n","7686  7687  NCT00052598  Therapeutic Allogeneic Lymphocytes and Aldesle...   \n","7687  7688  NCT01579318  Phase II Intratumoral IL12 Plasmid Electropora...   \n","7688  7689  NCT03316066  Comparison of Volumes of Local Anesthetics on ...   \n","7689  7690  NCT02221154  Use of Myo-inositol as Adjuvant Therapy in Pat...   \n","\n","             Acronym      Status         Study Results  \\\n","0                NaN  Terminated           Has Results   \n","1              CHIVE  Terminated  No Results Available   \n","2                NaN  Terminated  No Results Available   \n","3                NaN   Withdrawn  No Results Available   \n","4                NaN  Terminated  No Results Available   \n","5             PanECT  Terminated  No Results Available   \n","6                NaN  Terminated  No Results Available   \n","7                NaN  Terminated           Has Results   \n","8          DEBIRITUX  Terminated  No Results Available   \n","9                NaN  Terminated           Has Results   \n","10               NaN  Terminated           Has Results   \n","11              TIVA   Withdrawn  No Results Available   \n","12               NaN   Withdrawn  No Results Available   \n","13               NaN  Terminated  No Results Available   \n","14               NaN  Terminated  No Results Available   \n","15               NaN   Withdrawn  No Results Available   \n","16       Chloroquine  Terminated  No Results Available   \n","17               NaN   Withdrawn  No Results Available   \n","18               NaN  Terminated           Has Results   \n","19               NaN  Terminated  No Results Available   \n","20               NaN  Terminated  No Results Available   \n","21               NaN  Terminated           Has Results   \n","22               NaN  Terminated           Has Results   \n","23               NaN   Suspended  No Results Available   \n","24               NaN  Terminated           Has Results   \n","25    Chloroquine IV  Terminated  No Results Available   \n","26               NaN  Terminated  No Results Available   \n","27               NaN   Suspended  No Results Available   \n","28               NaN  Terminated  No Results Available   \n","29               NaN  Terminated  No Results Available   \n","...              ...         ...                   ...   \n","7660             NaN  Terminated           Has Results   \n","7661             NaN  Terminated  No Results Available   \n","7662             NaN  Terminated  No Results Available   \n","7663             NaN  Terminated  No Results Available   \n","7664             NaN  Terminated  No Results Available   \n","7665             NaN   Withdrawn  No Results Available   \n","7666             NaN  Terminated  No Results Available   \n","7667             NaN  Terminated  No Results Available   \n","7668             NaN  Terminated           Has Results   \n","7669             NaN  Terminated           Has Results   \n","7670             NaN  Terminated  No Results Available   \n","7671             NaN  Terminated           Has Results   \n","7672             NaN  Terminated  No Results Available   \n","7673             NaN   Withdrawn  No Results Available   \n","7674             NaN  Terminated  No Results Available   \n","7675             NaN  Terminated  No Results Available   \n","7676             NaN  Terminated           Has Results   \n","7677             NaN  Terminated  No Results Available   \n","7678             NaN  Terminated  No Results Available   \n","7679             NaN  Terminated           Has Results   \n","7680             NaN   Withdrawn  No Results Available   \n","7681             NaN  Terminated           Has Results   \n","7682             NaN  Terminated  No Results Available   \n","7683             NaN  Terminated  No Results Available   \n","7684             NaN  Terminated  No Results Available   \n","7685            CTCL  Terminated  No Results Available   \n","7686             NaN  Terminated  No Results Available   \n","7687            CTCL  Terminated           Has Results   \n","7688             NaN   Withdrawn  No Results Available   \n","7689       FIV-INOPK  Terminated  No Results Available   \n","\n","                                             Conditions  \\\n","0                              Metastatic Breast Cancer   \n","1                                       Breast Neoplasm   \n","2                                     Metastatic Cancer   \n","3                           Pain Management|Cancer Pain   \n","4                                  Head and Neck Cancer   \n","5                                       Pancreas Cancer   \n","6     Advanced Non-Central Nervous System (CNS) Mali...   \n","7                   Advanced Nonhematological Neoplasms   \n","8                                     Colorectal Cancer   \n","9                                 Neoplasms, Pancreatic   \n","10                           Non-small Cell Lung Cancer   \n","11                                      Brain Neoplasms   \n","12                         Metastatic Colorectal Cancer   \n","13                        Colorectal Neoplasms|Diarrhea   \n","14                           Non-small Cell Lung Cancer   \n","15                                        Breast Cancer   \n","16                               Small Cell Lung Cancer   \n","17    Metastatic Colorectal Cancer|Colon Cancer|Rect...   \n","18        Previously Treated Non Small Cell Lung Cancer   \n","19                                          Solid Tumor   \n","20         Locally Advanced HER2-positive Breast Cancer   \n","21                                      Advanced Cancer   \n","22                                        Breast Cancer   \n","23                              Head and Neck Carcinoma   \n","24                                 Colorectal Neoplasms   \n","25                               Small Cell Lung Cancer   \n","26    Solid Tumor|Tumors of Any Histology With Activ...   \n","27           Oncology|Adherence, Medication|Side Effect   \n","28    Breast Cancer|Lung Cancer|Renal Cancer|Adrenal...   \n","29                                   Solid Malignancies   \n","...                                                 ...   \n","7660                       Chronic Lymphocytic Leukemia   \n","7661                                           Leukemia   \n","7662  AIDS-related Peripheral/Systemic Lymphoma|AIDS...   \n","7663  Diffuse Large B-Cell Lymphoma|Follicular Lymph...   \n","7664                                           Lymphoma   \n","7665       Squamous Cell Carcinoma of the Head and Neck   \n","7666                                           Lymphoma   \n","7667                                           Melanoma   \n","7668              Head and Neck Squamous Cell Carcinoma   \n","7669                                           Lymphoma   \n","7670                        Malignant Melanoma Stage IV   \n","7671                                           Melanoma   \n","7672  Recurrent Merkel Cell Carcinoma|Stage IV Merke...   \n","7673                                    Melanoma (Skin)   \n","7674  Recurrent Melanoma|Stage III Melanoma|Stage IV...   \n","7675                                    Melanoma (Skin)   \n","7676                             Precancerous Condition   \n","7677                            Recurrent Neuroblastoma   \n","7678                               Lymphoma|Neutropenia   \n","7679  Leukemia|Lymphoma|Multiple Myeloma|Aplastic An...   \n","7680                                    Melanoma (Skin)   \n","7681          Recurrent Melanoma|Stage IV Skin Melanoma   \n","7682                                       Glioblastoma   \n","7683  Chronic Lymphocytic Leukemia|Peripheral T-cell...   \n","7684  Recurrent Cutaneous T-cell Non-Hodgkin Lymphom...   \n","7685                          Cutaneous T-Cell Lymphoma   \n","7686  Accelerated Phase Chronic Myelogenous Leukemia...   \n","7687  Cutaneous T Cell Lymphomas (CTCL)|Mycosis Fung...   \n","7688                    Complex Regional Pain Syndromes   \n","7689                          Polycystic Ovary Syndrome   \n","\n","                                          Interventions  \\\n","0         Radiation: Radiation therapy|Drug: Study Drug   \n","1                 Drug: Drug-AZD8931|Drug: Drug-Placebo   \n","2     Drug: Oxycodone/acetaminophen 5/325 mg|Device:...   \n","3     Device: Intrathecal Drug Delivery System|Other...   \n","4                              Drug: Cetuximab-IRDye800   \n","5     Procedure: Electrochemotherapy - electroporati...   \n","6                       Drug: Oprozomib|Drug: Midazolam   \n","7                                         Drug: TAK-228   \n","8     Drug: Cetuximab|Drug: Irinotecan|Device: Irino...   \n","9                  Drug: GSK3145095|Drug: Pembrolizumab   \n","10    Drug: Suramin Drug:Docetaxel Drug: Carboplatin...   \n","11    Drug: Propofol + Remifentanil|Drug: Sevofluran...   \n","12                                       Drug: IMMU 130   \n","13    Drug: Investigational drug|Drug: Irinotecan|Dr...   \n","14                          Drug: PS-341 (Velcade-drug)   \n","15                                    Drug: Hydralazine   \n","16                                    Drug: Chloroquine   \n","17                                       Drug: IMMU-130   \n","18    Drug: AZD1775|Drug: AZD1775 Placebo|Drug: Anti...   \n","19                                    Drug: Epacadostat   \n","20    Device: Drug: Paclitaxel; trastuzumab; doxorru...   \n","21                      Drug: Tasisulam|Drug: Midazolam   \n","22    Drug: GDC-0810|Drug: LHRH Agonist|Drug: Palboc...   \n","23    Procedure: Image-Guided Surgery|Drug: Indocyan...   \n","24                        Drug: Placebo|Drug: Metformin   \n","25                          Drug: Chloroquine, A-CQ 100   \n","26                                   Drug: PLX7486 TsOH   \n","27                                 Device: ReX-C system   \n","28                                           Drug: FPAC   \n","29                           Drug: Pegfilgrastim (drug)   \n","...                                                 ...   \n","7660      Biological: alemtuzumab|Biological: rituximab   \n","7661     Biological: rituximab|Biological: sargramostim   \n","7662  Biological: rituximab|Radiation: indium In 111...   \n","7663       Biological: Apolizumab|Biological: Rituximab   \n","7664                            Biological: aldesleukin   \n","7665  Radiation: Low-Dose Fractionated Radiation The...   \n","7666  Radiation: tositumomab and iodine I 131 tositu...   \n","7667  Device: IL2-PET scan|Procedure: Tumor biopsy|D...   \n","7668  Biological: Tavokinogene Telseplasmid (tavo)|D...   \n","7669  Biological: Pegylated interferon Œ±-2b|Other: P...   \n","7670  Biological: DC Vaccine & Cyclophosphamide|Biol...   \n","7671  Biological: ALVAC-MART-1 vaccine|Biological: M...   \n","7672  Biological: Aldesleukin|Other: Laboratory Biom...   \n","7673  Biological: aldesleukin|Biological: sargramost...   \n","7674  Biological: therapeutic autologous lymphocytes...   \n","7675  Biological: MART-1 antigen|Biological: aldesle...   \n","7676                              Biological: Rituximab   \n","7677  Biological: recombinant interleukin-12|Biologi...   \n","7678  Biological: epoetin alfa|Biological: filgrasti...   \n","7679  Biological: Umbilical Cord Blood After Myeloab...   \n","7680  Biological: gp100:209-217(210M) peptide vaccin...   \n","7681  Biological: NA17.A2 Peptide Vaccine|Biological...   \n","7682  Biological: NeoVax|Biological: Nivolumab|Biolo...   \n","7683  Biological: 20 mg/kg TRU-016 + Rituximab|Biolo...   \n","7684  Biological: aldesleukin|Biological: recombinan...   \n","7685                             Procedure: skin biopsy   \n","7686  Biological: therapeutic allogeneic lymphocytes...   \n","7687  Biological: Tavokinogene Telseplasmid (tavo)|D...   \n","7688  Procedure: stellate ganglion block with ropiva...   \n","7689  Dietary Supplement: Inofolic¬Æ|Other: Gonadotro...   \n","\n","                                       Outcome Measures  \\\n","0     Number of Participants With Adverse Events|Num...   \n","1     Comparison of the effects of AZD8931 versus pl...   \n","2     Feasibility determined by accrual, adherence a...   \n","3     Visual Analog Scale Pain Scores|Survival Rates...   \n","4     Number of subjects in a cohort experiencing a ...   \n","5     Evaluation of feasibility and safety|Disease-f...   \n","6     Food Effect/QTc - Cmax|Food Effect/QTc - AUC|F...   \n","7     Number of Participants With Treatment Emergent...   \n","8     Progression free survival rate|Tumour Response...   \n","9     Number of Participants With Non-serious Advers...   \n","10    Progression-free Survival for Participants Wit...   \n","11    To study inflammatory changes associated with ...   \n","12                                     Safety|Assess PK   \n","13                                                  NaN   \n","14                                        Response rate   \n","15    To explore the potency of a clinical tolerable...   \n","16    Number of Participants with Adverse Events as ...   \n","17    Evaluate the safety and tolerability of IMMU-1...   \n","18    Objective Response Rate|Pharmacokinetic Profil...   \n","19    Pharmacodynamic effects as measured by changes...   \n","20          INCIDENCE OF FEBRILE NEUTROPENIA|TUMOR SIZE   \n","21    Midazolam Pharmacokinetics: Area Under the Con...   \n","22    Phase Ia: Maximum Tolerated Dose of GDC-0810 W...   \n","23    Safety related by type, incidence, severity, s...   \n","24    Proliferation Status of CRC Tumor and Adjacent...   \n","25    To determine the toxicity of adding chloroquin...   \n","26    Safety of PLX7486 as single agent as measured ...   \n","27    Number of safety events during administration ...   \n","28              Uptake of FPAC in tumors|Safety of FPAC   \n","29    percentage of children achieving at least 5x10...   \n","...                                                 ...   \n","7660  Proportion of Patients With Complete Response ...   \n","7661                              Overall response rate   \n","7662  MTD, defined as that dose at which fewer than ...   \n","7663                                                MTD   \n","7664                                                NaN   \n","7665                            Objective Response (OR)   \n","7666                    Expanded Access|Safety|efficacy   \n","7667  Biodistribution and kinetics of [18F]FB-IL2.|T...   \n","7668  Best Overall Response Rate (BORR) by RECIST v1...   \n","7669  Number of Dose Limiting Toxicities (DLTs) Obse...   \n","7670  Induction of melanoma-specific CD8+T Cell Immu...   \n","7671  Percentage of Participants With Immunologic Re...   \n","7672  Evidence and nature of toxicity related to the...   \n","7673                                                NaN   \n","7674      In vivo survival of CD8+ transferred T-clones   \n","7675                                                NaN   \n","7676  Percentage of Subjects With at Least 10 Points...   \n","7677  Maximum tolerated dose (MTD) assessed by Commo...   \n","7678                                                NaN   \n","7679  Number of Participants With Neutrophil Engraft...   \n","7680  Clinical response|Safety and toxicity|Immunolo...   \n","7681  Frequency of Vaccine-induced CD8+ T Cells Asse...   \n","7682  Safety and tolerability of regimen as measured...   \n","7683  Incidence and severity of adverse events|CLL C...   \n","7684  Clinical response rate defined as the percenta...   \n","7685  Collection of biopsies from pruritic CTCL pati...   \n","7686  Toxicity rate associated with infusing donor C...   \n","7687  Objective Response Rate Assessed by Modified S...   \n","7688  Pain score|Temperature increase in the ipsilat...   \n","7689  Incidence of OHSS in each group, graded mild, ...   \n","\n","                                  Sponsor/Collaborators  ...  \\\n","0     Weill Medical College of Cornell University|Un...  ...   \n","1                                           AstraZeneca  ...   \n","2     Southwest Oncology Group|Proteus Digital Healt...  ...   \n","3                                      Flowonix Medical  ...   \n","4                    Eben Rosenthal|Stanford University  ...   \n","5     University Medical Centre Ljubljana|Institute ...  ...   \n","6                                                 Amgen  ...   \n","7               Millennium Pharmaceuticals, Inc.|Takeda  ...   \n","8     Hans-Joachim Schmoll, MD|Biocompatibles UK Ltd...  ...   \n","9                               GlaxoSmithKline|Parexel  ...   \n","10                            Optimum Therapeutics, LLC  ...   \n","11                                 The Cleveland Clinic  ...   \n","12                                      Gilead Sciences  ...   \n","13                           Celgene Corporation|Pfizer  ...   \n","14    Rasim Gucalp|Millennium Pharmaceuticals, Inc.|...  ...   \n","15                               University of Arkansas  ...   \n","16                        Maastricht Radiation Oncology  ...   \n","17                                      Gilead Sciences  ...   \n","18                                          AstraZeneca  ...   \n","19    Sidney Kimmel Comprehensive Cancer Center at J...  ...   \n","20    Instituto do Cancer do Estado de S√£o Paulo|Fun...  ...   \n","21                                Eli Lilly and Company  ...   \n","22                                      Genentech, Inc.  ...   \n","23                  Jonsson Comprehensive Cancer Center  ...   \n","24                               University of Arkansas  ...   \n","25    Maastricht Radiation Oncology|Maastricht Unive...  ...   \n","26                                            Plexxikon  ...   \n","27                                        Dosentrx Ltd.  ...   \n","28    National Cancer Institute (NCI)|National Insti...  ...   \n","29          University Hospital, Clermont-Ferrand|Amgen  ...   \n","...                                                 ...  ...   \n","7660  ECOG-ACRIN Cancer Research Group|National Canc...  ...   \n","7661  Sidney Kimmel Comprehensive Cancer Center at J...  ...   \n","7662                    National Cancer Institute (NCI)  ...   \n","7663  National Cancer Institute (NCI)|National Insti...  ...   \n","7664  Northwestern University|National Cancer Instit...  ...   \n","7665                             University of Arkansas  ...   \n","7666  University of Nebraska|National Cancer Institu...  ...   \n","7667                University Medical Center Groningen  ...   \n","7668                       OncoSec Medical Incorporated  ...   \n","7669  Northwestern University|National Cancer Instit...  ...   \n","7670                          Baylor Research Institute  ...   \n","7671  National Cancer Institute (NCI)|National Insti...  ...   \n","7672  Fred Hutchinson Cancer Research Center|Nationa...  ...   \n","7673  Memorial Sloan Kettering Cancer Center|Nationa...  ...   \n","7674  Fred Hutchinson Cancer Research Center|Nationa...  ...   \n","7675  University of Southern California|National Can...  ...   \n","7676  Mayo Clinic|Genentech, Inc.|Biogen|National Ce...  ...   \n","7677                    National Cancer Institute (NCI)  ...   \n","7678  Northwestern University|National Cancer Instit...  ...   \n","7679                               Tufts Medical Center  ...   \n","7680  Bristol-Myers Squibb|National Cancer Institute...  ...   \n","7681                    National Cancer Institute (NCI)  ...   \n","7682  Washington University School of Medicine|Brist...  ...   \n","7683                                Aptevo Therapeutics  ...   \n","7684                    National Cancer Institute (NCI)  ...   \n","7685                            University of Minnesota  ...   \n","7686  Fred Hutchinson Cancer Research Center|Nationa...  ...   \n","7687                       OncoSec Medical Incorporated  ...   \n","7688                      Maisonneuve-Rosemont Hospital  ...   \n","7689            Centre Hospitalier Departemental Vendee  ...   \n","\n","                                              Other IDs         Start Date  \\\n","0                                            1505016222    August 10, 2015   \n","1                                           D0102C00019          June 2012   \n","2                                                 S1916   October 15, 2019   \n","3                                                 PM-02         April 2016   \n","4                                     IRB-35068|ENT0049      November 2015   \n","5                                             21K/01/20      July 13, 2020   \n","6                                                OPZ009        August 2014   \n","7     C31008|U1111-1202-4296|1066064639|20170270241|...   January 17, 2018   \n","8                               EudraCT: 2009-014728-44      February 2010   \n","9                                                205013  November 16, 2018   \n","10                                    Optimum-Suramin-1        August 2010   \n","11                                            Case 4306     September 2007   \n","12                                          IMMU 130-03     September 2013   \n","13                                    440E-ONC-0020-315          June 2002   \n","14                                            02-05-123           May 2004   \n","15                                              2003-23          June 2004   \n","16                                    CHLOROQUINE I-III           May 2014   \n","17                                     IM-T-IMMU-130-02     September 2012   \n","18                                          D6011C00001         March 2014   \n","19                     J17168|IRB00156271|I-24360-17-13       June 6, 2019   \n","20                                NP 17/2010 TraQ-Me 01     September 2010   \n","21                     13074|H8K-MC-JZAP|2010-020090-16     September 2010   \n","22                               GO29642|2014-004852-77  December 29, 2014   \n","23                             18-000168|NCI-2018-02094  December 12, 2018   \n","24                                               134190        August 2012   \n","25                                       Chloroquine IV     September 2013   \n","26                                            PLX119-01        August 2013   \n","27                                     RXC-034-2019-CLE     April 21, 2020   \n","28                                     100078|10-C-0078      March 9, 2010   \n","29                                             CHU-0035       January 2006   \n","...                                                 ...                ...   \n","7660                                  E1908|U10CA180794       October 2010   \n","7661  J0546 CDR0000450145|P01CA081534|P30CA006973|JH...          July 2005   \n","7662  NCI-2012-01871|ADVL0013|U01CA097452|CDR0000069331          June 2002   \n","7663                                   010235|01-C-0235    August 15, 2001   \n","7664                       NU 96H7|NU-96H7|NCI-G00-1735         April 1997   \n","7665                                             136191       January 2013   \n","7666   259-98|P30CA036727|UNMC-259-98|COULTER-CP-98-020      November 1998   \n","7667                                           22102014   October 20, 2016   \n","7668                                           OMS-I130       May 21, 2015   \n","7669       NU 07H4|P30CA060553|SPRI-NU-07H4|STU00002993     September 2008   \n","7670                                Baylor IRB #006-123          June 2008   \n","7671                                   080162|08-C-0162          June 2008   \n","7672            2586.00|NCI-2012-02779|2586|P30CA015704      February 2013   \n","7673                                 04-027|MSKCC-04027         March 2004   \n","7674     2271.00|NCI-2010-00738|K12CA076930|R21CA137647          July 2009   \n","7675  CDR0000068125 (10M-99-1)|LAC-USC-10M991|NCI-G0...          June 1999   \n","7676                                1191-04|UL1RR024150       January 2005   \n","7677  NCI-2009-00024|NANT 2001-01|CDR0000270447|P01C...      December 2002   \n","7678                       NU 99Z1|NU-99Z1|NCI-G00-1734     September 1999   \n","7679                                            UCBT001          July 2005   \n","7680  CDR0000486705|NCI-06-C-0159|NCI-P6951|MDX-NCI-...           May 2006   \n","7681  NCI-2011-02580|UCCRC-10-324-B|CDR0000696233|10...      February 2011   \n","7682                                          201804195   October 31, 2018   \n","7683                                              16009     September 2012   \n","7684     NCI-2012-02504|10401|R01CA089442|CDR0000258239     September 2002   \n","7685                                         0705M09523      December 2008   \n","7686                 1671.00|NCI-2010-00826|P01CA018029     September 2002   \n","7687                                           OMS-I120       June 8, 2012   \n","7688                                     Maisonneuve RH   October 20, 2018   \n","7689                                         CHD 096-13      November 2014   \n","\n","     Primary Completion Date     Completion Date        First Posted  \\\n","0          September 4, 2018   February 20, 2019   September 2, 2015   \n","1                 March 2013            May 2013        May 11, 2012   \n","2         September 16, 2020  September 16, 2020   December 11, 2019   \n","3              December 2016      September 2018    October 19, 2015   \n","4             April 19, 2017      April 19, 2017   November 19, 2013   \n","5              March 9, 2021       March 9, 2021   February 24, 2020   \n","6               May 15, 2015       July 10, 2019  September 18, 2014   \n","7            August 28, 2019     August 28, 2019   December 12, 2017   \n","8              December 2012            May 2015    February 2, 2010   \n","9            August 13, 2019     August 13, 2019  September 24, 2018   \n","10             November 2012            May 2013   December 24, 2009   \n","11                March 2010          March 2010    November 9, 2007   \n","12               August 2015         August 2015      August 5, 2013   \n","13                       NaN                 NaN       June 27, 2002   \n","14                  May 2007            May 2007  September 20, 2005   \n","15             December 2009       December 2009   December 18, 2007   \n","16                 July 2017           July 2017      April 11, 2012   \n","17              January 2016        January 2016        May 24, 2012   \n","18                  May 2015            May 2015      March 14, 2014   \n","19             July 30, 2021       July 30, 2021      March 20, 2018   \n","20            September 2011      September 2012       April 6, 2011   \n","21              January 2011        January 2011  September 27, 2010   \n","22            March 13, 2020      March 13, 2020       April 4, 2013   \n","23          February 1, 2022    February 1, 2023   November 19, 2018   \n","24              January 2015        January 2015       June 29, 2012   \n","25                 June 2016           June 2016   September 1, 2009   \n","26          January 24, 2018    January 24, 2018       March 5, 2013   \n","27             December 2022       February 2023  September 17, 2019   \n","28           August 20, 2014        May 11, 2016      March 15, 2010   \n","29             December 2007        January 2008       June 11, 2008   \n","...                      ...                 ...                 ...   \n","7660          April 14, 2015      April 14, 2015   November 16, 2009   \n","7661              March 2006          March 2006   December 15, 2005   \n","7662              March 2005                 NaN    January 27, 2003   \n","7663        January 22, 2010      March 17, 2017     August 20, 2001   \n","7664            January 2002        January 2002    January 27, 2003   \n","7665               July 2015           July 2015      March 28, 2013   \n","7666              April 2002       November 2012   December 16, 2003   \n","7667       February 14, 2020   February 14, 2020     October 4, 2016   \n","7668       November 14, 2016   November 14, 2016    January 26, 2015   \n","7669               June 2011       December 2011       July 29, 2008   \n","7670              April 2011           July 2012       July 25, 2008   \n","7671           November 2012       November 2012       June 30, 2008   \n","7672                May 2016            May 2016     January 1, 2013   \n","7673              March 2005          March 2005       June 11, 2004   \n","7674            January 2011        January 2011       July 24, 2009   \n","7675                May 2003          April 2006    January 27, 2003   \n","7676            January 2009       February 2011     January 9, 2008   \n","7677                May 2009                 NaN    February 6, 2003   \n","7678            January 2002        January 2002    January 27, 2003   \n","7679               July 2013           July 2014        May 13, 2008   \n","7680                     NaN                 NaN       July 27, 2006   \n","7681            January 2015       February 2015       March 3, 2011   \n","7682          April 26, 2020   December 31, 2020    February 5, 2018   \n","7683       February 24, 2020      April 21, 2021       July 19, 2012   \n","7684               June 2005                 NaN    January 27, 2003   \n","7685           December 2012       December 2012      March 18, 2009   \n","7686           November 2009           June 2011    January 27, 2003   \n","7687            June 3, 2014        June 3, 2014      April 17, 2012   \n","7688       February 21, 2020   February 21, 2020    October 20, 2017   \n","7689            May 22, 2017        May 22, 2017     August 20, 2014   \n","\n","     Results First Posted  Last Update Posted  \\\n","0        December 9, 2019    December 9, 2019   \n","1                     NaN   December 17, 2012   \n","2                     NaN    January 13, 2021   \n","3                     NaN   February 15, 2019   \n","4                     NaN       June 24, 2019   \n","5                     NaN      March 12, 2021   \n","6                     NaN   February 21, 2021   \n","7       September 9, 2020        May 11, 2021   \n","8                     NaN    October 26, 2016   \n","9           July 31, 2020       July 31, 2020   \n","10       October 21, 2014        May 21, 2015   \n","11                    NaN      April 20, 2017   \n","12                    NaN     August 19, 2021   \n","13                    NaN    December 1, 2016   \n","14                    NaN      August 2, 2018   \n","15                    NaN       March 4, 2015   \n","16                    NaN       July 18, 2017   \n","17                    NaN     August 19, 2021   \n","18          June 14, 2016       June 14, 2016   \n","19                    NaN     August 26, 2021   \n","20                    NaN        May 21, 2014   \n","21         March 18, 2019      March 18, 2019   \n","22          June 18, 2021       June 18, 2021   \n","23                    NaN      March 11, 2021   \n","24          July 11, 2016       July 11, 2016   \n","25                    NaN   February 15, 2019   \n","26                    NaN      August 2, 2018   \n","27                    NaN  September 20, 2021   \n","28                    NaN   December 17, 2019   \n","29                    NaN       June 13, 2008   \n","...                   ...                 ...   \n","7660     January 28, 2016    January 14, 2019   \n","7661                  NaN     August 12, 2014   \n","7662                  NaN    January 17, 2013   \n","7663                  NaN   December 16, 2019   \n","7664                  NaN        June 6, 2012   \n","7665                  NaN      August 8, 2016   \n","7666                  NaN    January 17, 2018   \n","7667                  NaN      March 23, 2020   \n","7668      January 3, 2018     January 3, 2018   \n","7669     December 2, 2013   December 12, 2018   \n","7670                  NaN        July 8, 2013   \n","7671       March 19, 2013    October 28, 2015   \n","7672                  NaN      April 19, 2017   \n","7673                  NaN   December 12, 2012   \n","7674                  NaN    December 8, 2011   \n","7675                  NaN        May 22, 2014   \n","7676          May 6, 2014         May 6, 2014   \n","7677                  NaN       April 9, 2013   \n","7678                  NaN        June 1, 2012   \n","7679        July 22, 2016        June 1, 2017   \n","7680                  NaN        May 15, 2013   \n","7681     October 24, 2016    October 24, 2016   \n","7682                  NaN      April 23, 2021   \n","7683                  NaN        May 20, 2021   \n","7684                  NaN    January 16, 2013   \n","7685                  NaN      March 31, 2014   \n","7686                  NaN   February 15, 2017   \n","7687      January 3, 2018     January 3, 2018   \n","7688                  NaN   February 24, 2020   \n","7689                  NaN       June 16, 2017   \n","\n","                                              Locations  \\\n","0     Weill Cornell Medical College, New York, New Y...   \n","1     Research Site, Dusseldorf, Germany|Research Si...   \n","2     Decatur Memorial Hospital, Decatur, Illinois, ...   \n","3     Menorah Medical Center, Overland Park, Kansas,...   \n","4     Stanford University, School of Medicine, Stanf...   \n","5     University Medical Centre Ljubljana, Ljubljana...   \n","6     University of Colorado Anschutz Medical Campus...   \n","7     National Cancer Center Hospital East, Kashiwa-...   \n","8     Zentralklinik Bad Berka GmbH, Abteilung f√ºr In...   \n","9     GSK Investigational Site, Indianapolis, Indian...   \n","10    John H Stroger Jr Hospital of Cook County, Chi...   \n","11    Cleveland Clinic Foundation, Cleveland, Ohio, ...   \n","12                                                  NaN   \n","13    Research Center, Little Rock, Arkansas, United...   \n","14    HealthAlliance Hospitals, Fitchburg, Massachus...   \n","15                                                  NaN   \n","16     MAASTRO clinic, Maastricht, Limburg, Netherlands   \n","17    UCLA Jonsson Comprehensive Cancer Center, Sant...   \n","18    Research Site, Birmingham, Alabama, United Sta...   \n","19    Sidney Kimmel Comprehensive Cancer Center at J...   \n","20    Instituto do Cancer do Estado de Sao Paulo, Sa...   \n","21    For additional information regarding investiga...   \n","22    Ucsd Medical Center, San Diego, California, Un...   \n","23    UCLA / Jonsson Comprehensive Cancer Center, Lo...   \n","24    Central Arkansas Veterans Heathcare System, Li...   \n","25    NKI/AvL, Amsterdam, Netherlands|VU Medical Cen...   \n","26    Ronald Reagan UCLA Medical Center, Los Angeles...   \n","27    Oncology Unit, Tel Aviv Sourasky Medical Cente...   \n","28    National Institutes of Health Clinical Center,...   \n","29                                                  NaN   \n","...                                                 ...   \n","7660  Mayo Clinic Scottsdale, Scottsdale, Arizona, U...   \n","7661                                                NaN   \n","7662  Children's Oncology Group, Arcadia, California...   \n","7663  National Institutes of Health Clinical Center,...   \n","7664  Robert H. Lurie Comprehensive Cancer Center, N...   \n","7665  University of Arkansas for Medical Sciences, L...   \n","7666  University of Nebraska Medical Center, Omaha, ...   \n","7667  University Medical Center Groningen, Groningen...   \n","7668  UCSF Helen Diller Family Comprehensive Cancer ...   \n","7669  Robert H. Lurie Comprehensive Cancer Center at...   \n","7670  Baylor University Medical Center, Dallas, Texa...   \n","7671  National Cancer Institute (NCI), 9000 Rockvill...   \n","7672  Fred Hutchinson Cancer Research Center/Univers...   \n","7673  Memorial Sloan-Kettering Cancer Center, New Yo...   \n","7674  Fred Hutchinson Cancer Research Center/Univers...   \n","7675  USC/Norris Comprehensive Cancer Center and Hos...   \n","7676  Mayo Clinic Scottsdale, Scottsdale, Arizona, U...   \n","7677  New Approaches to Neuroblastoma Treatment (NAN...   \n","7678  Robert H. Lurie Comprehensive Cancer Center, N...   \n","7679  Tufts Medical Center, Boston, Massachusetts, U...   \n","7680                                                NaN   \n","7681  University of Chicago Comprehensive Cancer Cen...   \n","7682  Washington University School of Medicine, Sain...   \n","7683  Augusta, Georgia, United States|Columbus, Ohio...   \n","7684  Abramson Cancer Center of The University of Pe...   \n","7685  University of Minnesota, Minneapolis, Minnesot...   \n","7686  Fred Hutchinson Cancer Research Center/Univers...   \n","7687  UCSF Helen Diller Comprehensive Cancer Center,...   \n","7688                                                NaN   \n","7689  CHI de Cr√©teil, Cr√©teil, France|CHD Vend√©e, La...   \n","\n","                                        Study Documents  \\\n","0     \"Study Protocol and Statistical Analysis Plan\"...   \n","1                                                   NaN   \n","2                                                   NaN   \n","3                                                   NaN   \n","4                                                   NaN   \n","5                                                   NaN   \n","6                                                   NaN   \n","7     \"Study Protocol\", https://ClinicalTrials.gov/P...   \n","8                                                   NaN   \n","9     \"Study Protocol\", https://ClinicalTrials.gov/P...   \n","10                                                  NaN   \n","11                                                  NaN   \n","12                                                  NaN   \n","13                                                  NaN   \n","14                                                  NaN   \n","15                                                  NaN   \n","16                                                  NaN   \n","17                                                  NaN   \n","18                                                  NaN   \n","19                                                  NaN   \n","20                                                  NaN   \n","21                                                  NaN   \n","22    \"Study Protocol and Statistical Analysis Plan\"...   \n","23                                                  NaN   \n","24                                                  NaN   \n","25                                                  NaN   \n","26                                                  NaN   \n","27                                                  NaN   \n","28                                                  NaN   \n","29                                                  NaN   \n","...                                                 ...   \n","7660                                                NaN   \n","7661                                                NaN   \n","7662                                                NaN   \n","7663                                                NaN   \n","7664                                                NaN   \n","7665                                                NaN   \n","7666                                                NaN   \n","7667                                                NaN   \n","7668                                                NaN   \n","7669                                                NaN   \n","7670                                                NaN   \n","7671                                                NaN   \n","7672                                                NaN   \n","7673                                                NaN   \n","7674                                                NaN   \n","7675                                                NaN   \n","7676                                                NaN   \n","7677                                                NaN   \n","7678                                                NaN   \n","7679                                                NaN   \n","7680                                                NaN   \n","7681                                                NaN   \n","7682  \"Informed Consent Form\", https://ClinicalTrial...   \n","7683                                                NaN   \n","7684                                                NaN   \n","7685                                                NaN   \n","7686                                                NaN   \n","7687                                                NaN   \n","7688                                                NaN   \n","7689                                                NaN   \n","\n","                                              URL  \n","0     https://ClinicalTrials.gov/show/NCT02538471  \n","1     https://ClinicalTrials.gov/show/NCT01596530  \n","2     https://ClinicalTrials.gov/show/NCT04194528  \n","3     https://ClinicalTrials.gov/show/NCT02578459  \n","4     https://ClinicalTrials.gov/show/NCT01987375  \n","5     https://ClinicalTrials.gov/show/NCT04281290  \n","6     https://ClinicalTrials.gov/show/NCT02244112  \n","7     https://ClinicalTrials.gov/show/NCT03370302  \n","8     https://ClinicalTrials.gov/show/NCT01060423  \n","9     https://ClinicalTrials.gov/show/NCT03681951  \n","10    https://ClinicalTrials.gov/show/NCT01038752  \n","11    https://ClinicalTrials.gov/show/NCT00555984  \n","12    https://ClinicalTrials.gov/show/NCT01915472  \n","13    https://ClinicalTrials.gov/show/NCT00040391  \n","14    https://ClinicalTrials.gov/show/NCT00200382  \n","15    https://ClinicalTrials.gov/show/NCT00575978  \n","16    https://ClinicalTrials.gov/show/NCT01575782  \n","17    https://ClinicalTrials.gov/show/NCT01605318  \n","18    https://ClinicalTrials.gov/show/NCT02087176  \n","19    https://ClinicalTrials.gov/show/NCT03471286  \n","20    https://ClinicalTrials.gov/show/NCT01329640  \n","21    https://ClinicalTrials.gov/show/NCT01209832  \n","22    https://ClinicalTrials.gov/show/NCT01823835  \n","23    https://ClinicalTrials.gov/show/NCT03745690  \n","24    https://ClinicalTrials.gov/show/NCT01632020  \n","25    https://ClinicalTrials.gov/show/NCT00969306  \n","26    https://ClinicalTrials.gov/show/NCT01804530  \n","27    https://ClinicalTrials.gov/show/NCT04091711  \n","28    https://ClinicalTrials.gov/show/NCT01086696  \n","29    https://ClinicalTrials.gov/show/NCT00695370  \n","...                                           ...  \n","7660  https://ClinicalTrials.gov/show/NCT01013961  \n","7661  https://ClinicalTrials.gov/show/NCT00265915  \n","7662  https://ClinicalTrials.gov/show/NCT00036855  \n","7663  https://ClinicalTrials.gov/show/NCT00022971  \n","7664  https://ClinicalTrials.gov/show/NCT00005788  \n","7665  https://ClinicalTrials.gov/show/NCT01820312  \n","7666  https://ClinicalTrials.gov/show/NCT00004874  \n","7667  https://ClinicalTrials.gov/show/NCT02922283  \n","7668  https://ClinicalTrials.gov/show/NCT02345330  \n","7669  https://ClinicalTrials.gov/show/NCT00724061  \n","7670  https://ClinicalTrials.gov/show/NCT00722098  \n","7671  https://ClinicalTrials.gov/show/NCT00706992  \n","7672  https://ClinicalTrials.gov/show/NCT01758458  \n","7673  https://ClinicalTrials.gov/show/NCT00085579  \n","7674  https://ClinicalTrials.gov/show/NCT00945269  \n","7675  https://ClinicalTrials.gov/show/NCT00006113  \n","7676  https://ClinicalTrials.gov/show/NCT00588822  \n","7677  https://ClinicalTrials.gov/show/NCT00054405  \n","7678  https://ClinicalTrials.gov/show/NCT00005787  \n","7679  https://ClinicalTrials.gov/show/NCT00676806  \n","7680  https://ClinicalTrials.gov/show/NCT00357461  \n","7681  https://ClinicalTrials.gov/show/NCT01307618  \n","7682  https://ClinicalTrials.gov/show/NCT03422094  \n","7683  https://ClinicalTrials.gov/show/NCT01644253  \n","7684  https://ClinicalTrials.gov/show/NCT00052377  \n","7685  https://ClinicalTrials.gov/show/NCT00863395  \n","7686  https://ClinicalTrials.gov/show/NCT00052598  \n","7687  https://ClinicalTrials.gov/show/NCT01579318  \n","7688  https://ClinicalTrials.gov/show/NCT03316066  \n","7689  https://ClinicalTrials.gov/show/NCT02221154  \n","\n","[7690 rows x 27 columns]"]},"execution_count":82,"metadata":{},"output_type":"execute_result"}],"source":["# load csv downloaded from https://clinicaltrials.gov\n","df = pd.read_csv(\"Data/clinical_trials_orginal/clinicaltrials_data_direct_download.csv\")\n","df"]},{"cell_type":"code","execution_count":null,"metadata":{"collapsed":true,"id":"9-ygvW3twvJy","outputId":"39ad4d11-a037-44b0-cc08-e67ca89e343e"},"outputs":[{"name":"stdout","output_type":"stream","text":["1\n","2\n","3\n","4\n","5\n","6\n","7\n","8\n","9\n","10\n","11\n","12\n","13\n","14\n","15\n","16\n","17\n","18\n","19\n","20\n","21\n","22\n","23\n","24\n","25\n","26\n","27\n","28\n","29\n","30\n","31\n","32\n","33\n","34\n","35\n","36\n","37\n","38\n","39\n","40\n","41\n","42\n","43\n","44\n","45\n","46\n","47\n","48\n","49\n","50\n","51\n","52\n","53\n","54\n","55\n","56\n","57\n","58\n","59\n","60\n","61\n","62\n","63\n","64\n","65\n","66\n","67\n","68\n","69\n","70\n","71\n","72\n","73\n","74\n","75\n","76\n","77\n","78\n","79\n","80\n","81\n","82\n","83\n","84\n","85\n","86\n","87\n","88\n","89\n","90\n","91\n","92\n","93\n","94\n","95\n","96\n","97\n","98\n","99\n","100\n","101\n","102\n","103\n","104\n","105\n","106\n","107\n","108\n","109\n","110\n","111\n","112\n","113\n","114\n","115\n","116\n","117\n","118\n","119\n","120\n","121\n","122\n","123\n","124\n","125\n","126\n","127\n","128\n","129\n","130\n","131\n","132\n","133\n","134\n","135\n","136\n","137\n","138\n","139\n","140\n","141\n","142\n","143\n","144\n","145\n","146\n","147\n","148\n","149\n","150\n","151\n","152\n","153\n","154\n","155\n","156\n","157\n","158\n","159\n","160\n","161\n","162\n","163\n","164\n","165\n","166\n","167\n","168\n","169\n","170\n","171\n","172\n","173\n","174\n","175\n","176\n","177\n","178\n","179\n","180\n","181\n","182\n","183\n","184\n","185\n","186\n","187\n","188\n","189\n","190\n","191\n","192\n","193\n","194\n","195\n","196\n","197\n","198\n","199\n","200\n","201\n","202\n","203\n","204\n","205\n","206\n","207\n","208\n","209\n","210\n","211\n","212\n","213\n","214\n","215\n","216\n","217\n","218\n","219\n","220\n","221\n","222\n","223\n","224\n","225\n","226\n","227\n","228\n","229\n","230\n","231\n","232\n","233\n","234\n","235\n","236\n","237\n","238\n","239\n","240\n","241\n","242\n","243\n","244\n","245\n","246\n","247\n","248\n","249\n","250\n","251\n","252\n","253\n","254\n","255\n","256\n","257\n","258\n","259\n","260\n","261\n","262\n","263\n","264\n","265\n","266\n","267\n","268\n","269\n","270\n","271\n","272\n","273\n","274\n","275\n","276\n","277\n","278\n","279\n","280\n","281\n","282\n","283\n","284\n","285\n","286\n","287\n","288\n","289\n","290\n","291\n","292\n","293\n","294\n","295\n","296\n","297\n","298\n","299\n","300\n","301\n","302\n","303\n","304\n","305\n","306\n","307\n","308\n","309\n","310\n","311\n","312\n","313\n","314\n","315\n","316\n","317\n","318\n","319\n","320\n","321\n","322\n","323\n","324\n","325\n","326\n","327\n","328\n","329\n","330\n","331\n","332\n","333\n","334\n","335\n","336\n","337\n","338\n","339\n","340\n","341\n","342\n","343\n","344\n","345\n","346\n","347\n","348\n","349\n","350\n","351\n","352\n","353\n","354\n","355\n","356\n","357\n","358\n","359\n","360\n","361\n","362\n","363\n","364\n","365\n","366\n","367\n","368\n","369\n","370\n","371\n","372\n","373\n","374\n","375\n","376\n","377\n","378\n","379\n","380\n","381\n","382\n","383\n","384\n","385\n","386\n","387\n","388\n","389\n","390\n","391\n","392\n","393\n","394\n","395\n","396\n","397\n","398\n","399\n","400\n","401\n","402\n","403\n","404\n","405\n","406\n","407\n","408\n","409\n","410\n","411\n","412\n","413\n","414\n","415\n","416\n","417\n","418\n","419\n","420\n","421\n","422\n","423\n","424\n","425\n","426\n","427\n","428\n","429\n","430\n","431\n","432\n","433\n","434\n","435\n","436\n","437\n","438\n","439\n","440\n","441\n","442\n","443\n","444\n","445\n","446\n","447\n","448\n","449\n","450\n","451\n","452\n","453\n","454\n","455\n","456\n","457\n","458\n","459\n","460\n","461\n","462\n","463\n","464\n","465\n","466\n","467\n","468\n","469\n","470\n","471\n","472\n","473\n","474\n","475\n","476\n","477\n","478\n","479\n","480\n","481\n","482\n","483\n","484\n","485\n","486\n","487\n","488\n","489\n","490\n","491\n","492\n","493\n","494\n","495\n","496\n","497\n","498\n","499\n","500\n","501\n","502\n","503\n","504\n","505\n","506\n","507\n","508\n","509\n","510\n","511\n","512\n","513\n","514\n","515\n","516\n","517\n","518\n","519\n","520\n","521\n","522\n","523\n","524\n","525\n","526\n","527\n","528\n","529\n","530\n","531\n","532\n","533\n","534\n","535\n","536\n","537\n","538\n","539\n","540\n","541\n","542\n","543\n","544\n","545\n","546\n","547\n","548\n","549\n","550\n","551\n","552\n","553\n","554\n","555\n","556\n","557\n","558\n","559\n","560\n","561\n","562\n","563\n","564\n","565\n","566\n","567\n","568\n","569\n","570\n","571\n","572\n","573\n","574\n","575\n","576\n","577\n","578\n","579\n","580\n","581\n","582\n","583\n","584\n","585\n","586\n","587\n","588\n","589\n","590\n","591\n","592\n","593\n","594\n","595\n","596\n","597\n","598\n","599\n","600\n","601\n","602\n","603\n","604\n","605\n","606\n","607\n","608\n","609\n","610\n","611\n","612\n","613\n","614\n","615\n","616\n","617\n","618\n","619\n","620\n","621\n","622\n","623\n","624\n","625\n","626\n","627\n","628\n","629\n","630\n","631\n","632\n","633\n","634\n","635\n","636\n","637\n","638\n","639\n","640\n","641\n","642\n","643\n","644\n","645\n","646\n","647\n","648\n","649\n","650\n","651\n","652\n","653\n","654\n","655\n","656\n","657\n","658\n","659\n","660\n","661\n","662\n","663\n","664\n","665\n","666\n","667\n","668\n","669\n","670\n","671\n","672\n","673\n","674\n","675\n","676\n","677\n","678\n","679\n","680\n","681\n","682\n","683\n","684\n","685\n","686\n","687\n","688\n","689\n","690\n","691\n","692\n","693\n","694\n","695\n","696\n","697\n","698\n","699\n","700\n","701\n","702\n","703\n","704\n","705\n","706\n","707\n","708\n","709\n","710\n","711\n","712\n","713\n","714\n","715\n","716\n","717\n","718\n","719\n","720\n","721\n","722\n","723\n","724\n","725\n","726\n","727\n","728\n","729\n","730\n","731\n","732\n","733\n","734\n","735\n","736\n","737\n","738\n","739\n","740\n","741\n","742\n","743\n","744\n","745\n","746\n","747\n","748\n","749\n","750\n","751\n","752\n","753\n","754\n","755\n","756\n","757\n","758\n","759\n","760\n","761\n","762\n","763\n","764\n","765\n","766\n","767\n","768\n","769\n","770\n","771\n","772\n","773\n","774\n","775\n","776\n","777\n","778\n","779\n","780\n","781\n","782\n","783\n","784\n","785\n","786\n","787\n","788\n","789\n","790\n","791\n","792\n","793\n","794\n","795\n","796\n","797\n","798\n","799\n","800\n","801\n","802\n","803\n","804\n","805\n","806\n","807\n","808\n","809\n","810\n","811\n","812\n","813\n","814\n","815\n","816\n","817\n","818\n","819\n","820\n","821\n","822\n","823\n","824\n","825\n","826\n","827\n","828\n","829\n","830\n","831\n","832\n","833\n","834\n","835\n","836\n","837\n","838\n","839\n","840\n","841\n","842\n","843\n","844\n","845\n","846\n","847\n","848\n","849\n","850\n","851\n","852\n","853\n","854\n","855\n","856\n","857\n","858\n","859\n","860\n","861\n","862\n","863\n","864\n","865\n","866\n","867\n","868\n","869\n","870\n","871\n","872\n","873\n","874\n","875\n","876\n","877\n","878\n","879\n","880\n","881\n","882\n","883\n","884\n","885\n","886\n","887\n","888\n","889\n","890\n","891\n","892\n","893\n","894\n","895\n","896\n","897\n","898\n","899\n","900\n","901\n","902\n","903\n","904\n","905\n","906\n","907\n","908\n","909\n","910\n","911\n","912\n","913\n","914\n","915\n","916\n","917\n","918\n","919\n","920\n","921\n","922\n","923\n","924\n","925\n","926\n","927\n","928\n","929\n","930\n","931\n","932\n","933\n","934\n","935\n","936\n","937\n","938\n","939\n","940\n","941\n","942\n","943\n","944\n","945\n","946\n","947\n","948\n","949\n","950\n","951\n","952\n","953\n","954\n","955\n","956\n","957\n","958\n","959\n","960\n","961\n","962\n","963\n","964\n","965\n","966\n","967\n","968\n","969\n","970\n","971\n","972\n","973\n","974\n","975\n","976\n","977\n","978\n","979\n","980\n","981\n","982\n","983\n","984\n","985\n","986\n","987\n","988\n","989\n","990\n","991\n","992\n","993\n","994\n","995\n","996\n","997\n","998\n","999\n","1000\n","1001\n","1002\n","1003\n","1004\n","1005\n","1006\n","1007\n","1008\n","1009\n","1010\n","1011\n","1012\n","1013\n","1014\n","1015\n","1016\n","1017\n","1018\n","1019\n","1020\n","1021\n","1022\n","1023\n","1024\n","1025\n","1026\n","1027\n","1028\n","1029\n","1030\n","1031\n","1032\n","1033\n","1034\n","1035\n","1036\n","1037\n","1038\n","1039\n","1040\n","1041\n","1042\n","1043\n","1044\n","1045\n","1046\n","1047\n","1048\n","1049\n","1050\n","1051\n","1052\n","1053\n","1054\n","1055\n","1056\n","1057\n","1058\n","1059\n","1060\n","1061\n","1062\n","1063\n","1064\n","1065\n","1066\n","1067\n","1068\n","1069\n","1070\n","1071\n","1072\n","1073\n","1074\n","1075\n","1076\n","1077\n","1078\n","1079\n","1080\n","1081\n","1082\n","1083\n","1084\n","1085\n","1086\n","1087\n","1088\n","1089\n","1090\n","1091\n","1092\n","1093\n","1094\n","1095\n","1096\n","1097\n","1098\n","1099\n","1100\n","1101\n","1102\n","1103\n","1104\n","1105\n","1106\n","1107\n","1108\n","1109\n","1110\n","1111\n","1112\n","1113\n","1114\n","1115\n","1116\n","1117\n","1118\n","1119\n","1120\n","1121\n","1122\n","1123\n","1124\n","1125\n","1126\n","1127\n","1128\n","1129\n","1130\n","1131\n","1132\n","1133\n","1134\n","1135\n","1136\n","1137\n","1138\n","1139\n","1140\n","1141\n","1142\n","1143\n","1144\n","1145\n","1146\n","1147\n","1148\n","1149\n","1150\n","1151\n","1152\n","1153\n","1154\n","1155\n","1156\n","1157\n","1158\n","1159\n","1160\n","1161\n","1162\n","1163\n","1164\n","1165\n","1166\n","1167\n","1168\n","1169\n","1170\n","1171\n","1172\n","1173\n","1174\n","1175\n","1176\n","1177\n","1178\n","1179\n","1180\n","1181\n","1182\n","1183\n","1184\n","1185\n","1186\n","1187\n","1188\n","1189\n","1190\n","1191\n","1192\n","1193\n","1194\n","1195\n","1196\n","1197\n","1198\n","1199\n","1200\n","1201\n","1202\n","1203\n","1204\n","1205\n","1206\n","1207\n","1208\n","1209\n","1210\n","1211\n","1212\n","1213\n","1214\n","1215\n","1216\n","1217\n","1218\n","1219\n","1220\n","1221\n","1222\n","1223\n","1224\n","1225\n","1226\n","1227\n","1228\n","1229\n","1230\n","1231\n","1232\n","1233\n","1234\n","1235\n","1236\n","1237\n","1238\n","1239\n","1240\n","1241\n","1242\n","1243\n","1244\n","1245\n","1246\n","1247\n","1248\n","1249\n","1250\n","1251\n","1252\n","1253\n","1254\n","1255\n","1256\n","1257\n","1258\n","1259\n","1260\n","1261\n","1262\n","1263\n","1264\n","1265\n","1266\n","1267\n","1268\n","1269\n","1270\n","1271\n","1272\n","1273\n","1274\n","1275\n","1276\n","1277\n","1278\n","1279\n","1280\n","1281\n","1282\n","1283\n","1284\n","1285\n","1286\n","1287\n","1288\n","1289\n","1290\n","1291\n","1292\n","1293\n","1294\n","1295\n","1296\n","1297\n","1298\n","1299\n","1300\n","1301\n","1302\n","1303\n","1304\n","1305\n","1306\n","1307\n","1308\n","1309\n","1310\n","1311\n","1312\n","1313\n","1314\n","1315\n","1316\n","1317\n","1318\n","1319\n","1320\n","1321\n","1322\n","1323\n","1324\n","1325\n","1326\n","1327\n","1328\n","1329\n","1330\n","1331\n","1332\n","1333\n","1334\n","1335\n","1336\n","1337\n","1338\n","1339\n","1340\n","1341\n","1342\n","1343\n","1344\n","1345\n","1346\n","1347\n","1348\n","1349\n","1350\n","1351\n","1352\n","1353\n","1354\n","1355\n","1356\n","1357\n","1358\n","1359\n","1360\n","1361\n","1362\n","1363\n","1364\n","1365\n","1366\n","1367\n","1368\n","1369\n","1370\n","1371\n","1372\n","1373\n","1374\n","1375\n","1376\n","1377\n","1378\n","1379\n","1380\n","1381\n","1382\n","1383\n","1384\n","1385\n","1386\n","1387\n","1388\n","1389\n","1390\n","1391\n","1392\n","1393\n","1394\n","1395\n","1396\n","1397\n","1398\n","1399\n","1400\n","1401\n","1402\n","1403\n","1404\n","1405\n","1406\n","1407\n","1408\n","1409\n","1410\n","1411\n","1412\n","1413\n","1414\n","1415\n","1416\n","1417\n","1418\n","1419\n","1420\n","1421\n","1422\n","1423\n","1424\n","1425\n","1426\n","1427\n","1428\n","1429\n","1430\n","1431\n","1432\n","1433\n","1434\n","1435\n","1436\n","1437\n","1438\n","1439\n","1440\n","1441\n","1442\n","1443\n","1444\n","1445\n","1446\n","1447\n","1448\n","1449\n","1450\n","1451\n","1452\n","1453\n","1454\n","1455\n","1456\n","1457\n","1458\n","1459\n","1460\n","1461\n","1462\n","1463\n","1464\n","1465\n","1466\n","1467\n","1468\n","1469\n","1470\n","1471\n","1472\n","1473\n","1474\n","1475\n","1476\n","1477\n","1478\n","1479\n","1480\n","1481\n","1482\n","1483\n","1484\n","1485\n","1486\n","1487\n","1488\n","1489\n","1490\n","1491\n","1492\n","1493\n","1494\n","1495\n","1496\n","1497\n","1498\n","1499\n","1500\n","1501\n","1502\n","1503\n","1504\n","1505\n","1506\n","1507\n","1508\n","1509\n","1510\n","1511\n","1512\n","1513\n","1514\n","1515\n","1516\n","1517\n","1518\n","1519\n","1520\n","1521\n","1522\n","1523\n","1524\n","1525\n","1526\n","1527\n","1528\n","1529\n","1530\n","1531\n","1532\n","1533\n","1534\n","1535\n","1536\n","1537\n","1538\n","1539\n","1540\n","1541\n","1542\n","1543\n","1544\n","1545\n","1546\n","1547\n","1548\n","1549\n","1550\n","1551\n","1552\n","1553\n","1554\n","1555\n","1556\n","1557\n","1558\n","1559\n","1560\n","1561\n","1562\n","1563\n","1564\n","1565\n","1566\n","1567\n","1568\n","1569\n","1570\n","1571\n","1572\n","1573\n","1574\n","1575\n","1576\n","1577\n","1578\n","1579\n","1580\n","1581\n","1582\n","1583\n","1584\n","1585\n","1586\n","1587\n","1588\n","1589\n","1590\n","1591\n","1592\n","1593\n","1594\n","1595\n","1596\n","1597\n","1598\n","1599\n","1600\n","1601\n","1602\n","1603\n","1604\n","1605\n","1606\n","1607\n","1608\n","1609\n","1610\n","1611\n","1612\n","1613\n","1614\n","1615\n","1616\n","1617\n","1618\n","1619\n","1620\n","1621\n","1622\n","1623\n","1624\n","1625\n","1626\n","1627\n","1628\n","1629\n","1630\n","1631\n","1632\n","1633\n","1634\n","1635\n","1636\n","1637\n","1638\n","1639\n","1640\n","1641\n","1642\n","1643\n","1644\n","1645\n","1646\n","1647\n","1648\n","1649\n","1650\n","1651\n","1652\n","1653\n","1654\n","1655\n","1656\n","1657\n","1658\n","1659\n","1660\n","1661\n","1662\n","1663\n","1664\n","1665\n","1666\n","1667\n","1668\n","1669\n","1670\n","1671\n","1672\n","1673\n","1674\n","1675\n","1676\n","1677\n","1678\n","1679\n","1680\n","1681\n","1682\n","1683\n","1684\n","1685\n","1686\n","1687\n","1688\n","1689\n","1690\n","1691\n","1692\n","1693\n","1694\n","1695\n","1696\n","1697\n","1698\n","1699\n","1700\n","1701\n","1702\n","1703\n","1704\n","1705\n","1706\n","1707\n","1708\n","1709\n","1710\n","1711\n","1712\n","1713\n","1714\n","1715\n","1716\n","1717\n","1718\n","1719\n","1720\n","1721\n","1722\n","1723\n","1724\n","1725\n","1726\n","1727\n","1728\n","1729\n","1730\n","1731\n","1732\n","1733\n","1734\n","1735\n","1736\n","1737\n","1738\n","1739\n","1740\n","1741\n","1742\n","1743\n","1744\n","1745\n","1746\n","1747\n","1748\n","1749\n","1750\n","1751\n","1752\n","1753\n","1754\n","1755\n","1756\n","1757\n","1758\n","1759\n","1760\n","1761\n","1762\n","1763\n","1764\n","1765\n","1766\n","1767\n","1768\n","1769\n","1770\n","1771\n","1772\n","1773\n","1774\n","1775\n","1776\n","1777\n","1778\n","1779\n","1780\n","1781\n","1782\n","1783\n","1784\n","1785\n","1786\n","1787\n","1788\n","1789\n","1790\n","1791\n","1792\n","1793\n","1794\n","1795\n","1796\n","1797\n","1798\n","1799\n","1800\n","1801\n","1802\n","1803\n","1804\n","1805\n","1806\n","1807\n","1808\n","1809\n","1810\n","1811\n","1812\n","1813\n","1814\n","1815\n","1816\n","1817\n","1818\n","1819\n","1820\n","1821\n","1822\n","1823\n","1824\n","1825\n","1826\n","1827\n","1828\n","1829\n","1830\n","1831\n","1832\n","1833\n","1834\n","1835\n","1836\n","1837\n","1838\n","1839\n","1840\n","1841\n","1842\n","1843\n","1844\n","1845\n","1846\n","1847\n","1848\n","1849\n","1850\n","1851\n","1852\n","1853\n","1854\n","1855\n","1856\n","1857\n","1858\n","1859\n","1860\n"]},{"name":"stdout","output_type":"stream","text":["1861\n","1862\n","1863\n","1864\n","1865\n","1866\n","1867\n","1868\n","1869\n","1870\n","1871\n","1872\n","1873\n","1874\n","1875\n","1876\n","1877\n","1878\n","1879\n","1880\n","1881\n","1882\n","1883\n","1884\n","1885\n","1886\n","1887\n","1888\n","1889\n","1890\n","1891\n","1892\n","1893\n","1894\n","1895\n","1896\n","1897\n","1898\n","1899\n","1900\n","1901\n","1902\n","1903\n","1904\n","1905\n","1906\n","1907\n","1908\n","1909\n","1910\n","1911\n","1912\n","1913\n","1914\n","1915\n","1916\n","1917\n","1918\n","1919\n","1920\n","1921\n","1922\n","1923\n","1924\n","1925\n","1926\n","1927\n","1928\n","1929\n","1930\n","1931\n","1932\n","1933\n","1934\n","1935\n","1936\n","1937\n","1938\n","1939\n","1940\n","1941\n","1942\n","1943\n","1944\n","1945\n","1946\n","1947\n","1948\n","1949\n","1950\n","1951\n","1952\n","1953\n","1954\n","1955\n","1956\n","1957\n","1958\n","1959\n","1960\n","1961\n","1962\n","1963\n","1964\n","1965\n","1966\n","1967\n","1968\n","1969\n","1970\n","1971\n","1972\n","1973\n","1974\n","1975\n","1976\n","1977\n","1978\n","1979\n","1980\n","1981\n","1982\n","1983\n","1984\n","1985\n","1986\n","1987\n","1988\n","1989\n","1990\n","1991\n","1992\n","1993\n","1994\n","1995\n","1996\n","1997\n","1998\n","1999\n","2000\n"]}],"source":["# scrape recruitment status details(reason for inactivity/termination)\n","details = []\n","start = 0\n","end = 2000\n","i=0\n","for url in df['URL'][start:end]: \n","    response1 = requests.get(url)\n","    soup1 = BeautifulSoup(response1.content, \"lxml\")\n","    recruitment_status = soup1.find(\"div\",class_=\"tr-status tr-not-recruiting-colors\").get_text().split('\\n')\n","    details.append(recruitment_status[5].strip()[1:-1])\n","    i=i+1\n","    print(i) #know how many are scraped"]},{"cell_type":"code","execution_count":null,"metadata":{"collapsed":true,"id":"S8hEym7PwvJz","outputId":"c18f7f57-49c3-4c6d-fb26-34bbec4cb35a"},"outputs":[{"name":"stderr","output_type":"stream","text":["/opt/miniconda3/lib/python3.7/site-packages/ipykernel_launcher.py:4: SettingWithCopyWarning: \n","A value is trying to be set on a copy of a slice from a DataFrame\n","\n","See the caveats in the documentation: http://pandas.pydata.org/pandas-docs/stable/indexing.html#indexing-view-versus-copy\n","  after removing the cwd from sys.path.\n","/opt/miniconda3/lib/python3.7/site-packages/ipykernel_launcher.py:5: SettingWithCopyWarning: \n","A value is trying to be set on a copy of a slice from a DataFrame\n","\n","See the caveats in the documentation: http://pandas.pydata.org/pandas-docs/stable/indexing.html#indexing-view-versus-copy\n","  \"\"\"\n"]},{"data":{"text/html":["<div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>Rank</th>\n","      <th>NCT Number</th>\n","      <th>Title</th>\n","      <th>Acronym</th>\n","      <th>Status</th>\n","      <th>Study Results</th>\n","      <th>Conditions</th>\n","      <th>Interventions</th>\n","      <th>Outcome Measures</th>\n","      <th>Sponsor/Collaborators</th>\n","      <th>...</th>\n","      <th>Primary Completion Date</th>\n","      <th>Completion Date</th>\n","      <th>First Posted</th>\n","      <th>Results First Posted</th>\n","      <th>Last Update Posted</th>\n","      <th>Locations</th>\n","      <th>Study Documents</th>\n","      <th>URL</th>\n","      <th>Recruitment Status</th>\n","      <th>Reason for Inactivity</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>1</td>\n","      <td>NCT02538471</td>\n","      <td>LY2157299 Monohydrate (LY2157299) and Radiothe...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Metastatic Breast Cancer</td>\n","      <td>Radiation: Radiation therapy|Drug: Study Drug</td>\n","      <td>Number of Participants With Adverse Events|Num...</td>\n","      <td>Weill Medical College of Cornell University|Un...</td>\n","      <td>...</td>\n","      <td>September 4, 2018</td>\n","      <td>February 20, 2019</td>\n","      <td>September 2, 2015</td>\n","      <td>December 9, 2019</td>\n","      <td>December 9, 2019</td>\n","      <td>Weill Cornell Medical College, New York, New Y...</td>\n","      <td>\"Study Protocol and Statistical Analysis Plan\"...</td>\n","      <td>https://ClinicalTrials.gov/show/NCT02538471</td>\n","      <td>Terminated</td>\n","      <td>The study was terminated due to lack of patien...</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>2</td>\n","      <td>NCT01596530</td>\n","      <td>Evaluation of Drug Activity in Women With Brea...</td>\n","      <td>CHIVE</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Breast Neoplasm</td>\n","      <td>Drug: Drug-AZD8931|Drug: Drug-Placebo</td>\n","      <td>Comparison of the effects of AZD8931 versus pl...</td>\n","      <td>AstraZeneca</td>\n","      <td>...</td>\n","      <td>March 2013</td>\n","      <td>May 2013</td>\n","      <td>May 11, 2012</td>\n","      <td>NaN</td>\n","      <td>December 17, 2012</td>\n","      <td>Research Site, Dusseldorf, Germany|Research Si...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01596530</td>\n","      <td>Terminated</td>\n","      <td>All AstraZeneca sponsored clinical trials of A...</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>3</td>\n","      <td>NCT04194528</td>\n","      <td>S1916 Digital Medicine Program for Pain Contro...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Metastatic Cancer</td>\n","      <td>Drug: Oxycodone/acetaminophen 5/325 mg|Device:...</td>\n","      <td>Feasibility determined by accrual, adherence a...</td>\n","      <td>Southwest Oncology Group|Proteus Digital Healt...</td>\n","      <td>...</td>\n","      <td>September 16, 2020</td>\n","      <td>September 16, 2020</td>\n","      <td>December 11, 2019</td>\n","      <td>NaN</td>\n","      <td>January 13, 2021</td>\n","      <td>Decatur Memorial Hospital, Decatur, Illinois, ...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT04194528</td>\n","      <td>Terminated</td>\n","      <td>Study sponsor withdrew support.</td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>4</td>\n","      <td>NCT02578459</td>\n","      <td>A Pilot Study to Evaluate the Efficacy of ITDD...</td>\n","      <td>NaN</td>\n","      <td>Withdrawn</td>\n","      <td>No Results Available</td>\n","      <td>Pain Management|Cancer Pain</td>\n","      <td>Device: Intrathecal Drug Delivery System|Other...</td>\n","      <td>Visual Analog Scale Pain Scores|Survival Rates...</td>\n","      <td>Flowonix Medical</td>\n","      <td>...</td>\n","      <td>December 2016</td>\n","      <td>September 2018</td>\n","      <td>October 19, 2015</td>\n","      <td>NaN</td>\n","      <td>February 15, 2019</td>\n","      <td>Menorah Medical Center, Overland Park, Kansas,...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT02578459</td>\n","      <td>Withdrawn</td>\n","      <td>The study was never initiated by sponsor. Pati...</td>\n","    </tr>\n","    <tr>\n","      <th>4</th>\n","      <td>5</td>\n","      <td>NCT01987375</td>\n","      <td>Cetuximab IRDye800 Study as an Optical Imaging...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Head and Neck Cancer</td>\n","      <td>Drug: Cetuximab-IRDye800</td>\n","      <td>Number of subjects in a cohort experiencing a ...</td>\n","      <td>Eben Rosenthal|Stanford University</td>\n","      <td>...</td>\n","      <td>April 19, 2017</td>\n","      <td>April 19, 2017</td>\n","      <td>November 19, 2013</td>\n","      <td>NaN</td>\n","      <td>June 24, 2019</td>\n","      <td>Stanford University, School of Medicine, Stanf...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01987375</td>\n","      <td>Terminated</td>\n","      <td>logistics</td>\n","    </tr>\n","    <tr>\n","      <th>5</th>\n","      <td>6</td>\n","      <td>NCT04281290</td>\n","      <td>Electrochemotherapy of Posterior Resection Sur...</td>\n","      <td>PanECT</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Pancreas Cancer</td>\n","      <td>Procedure: Electrochemotherapy - electroporati...</td>\n","      <td>Evaluation of feasibility and safety|Disease-f...</td>\n","      <td>University Medical Centre Ljubljana|Institute ...</td>\n","      <td>...</td>\n","      <td>March 9, 2021</td>\n","      <td>March 9, 2021</td>\n","      <td>February 24, 2020</td>\n","      <td>NaN</td>\n","      <td>March 12, 2021</td>\n","      <td>University Medical Centre Ljubljana, Ljubljana...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT04281290</td>\n","      <td>Terminated</td>\n","      <td>After enrolling 3 participants the safety and ...</td>\n","    </tr>\n","    <tr>\n","      <th>6</th>\n","      <td>7</td>\n","      <td>NCT02244112</td>\n","      <td>A Phase 1 Study of Oprozomib to Assess Food Ef...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Advanced Non-Central Nervous System (CNS) Mali...</td>\n","      <td>Drug: Oprozomib|Drug: Midazolam</td>\n","      <td>Food Effect/QTc - Cmax|Food Effect/QTc - AUC|F...</td>\n","      <td>Amgen</td>\n","      <td>...</td>\n","      <td>May 15, 2015</td>\n","      <td>July 10, 2019</td>\n","      <td>September 18, 2014</td>\n","      <td>NaN</td>\n","      <td>February 21, 2021</td>\n","      <td>University of Colorado Anschutz Medical Campus...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT02244112</td>\n","      <td>Terminated</td>\n","      <td>Why study stopped revised to \"A program evalua...</td>\n","    </tr>\n","    <tr>\n","      <th>7</th>\n","      <td>8</td>\n","      <td>NCT03370302</td>\n","      <td>A Study to Evaluate the Safety, Tolerability, ...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Advanced Nonhematological Neoplasms</td>\n","      <td>Drug: TAK-228</td>\n","      <td>Number of Participants With Treatment Emergent...</td>\n","      <td>Millennium Pharmaceuticals, Inc.|Takeda</td>\n","      <td>...</td>\n","      <td>August 28, 2019</td>\n","      <td>August 28, 2019</td>\n","      <td>December 12, 2017</td>\n","      <td>September 9, 2020</td>\n","      <td>May 11, 2021</td>\n","      <td>National Cancer Center Hospital East, Kashiwa-...</td>\n","      <td>\"Study Protocol\", https://ClinicalTrials.gov/P...</td>\n","      <td>https://ClinicalTrials.gov/show/NCT03370302</td>\n","      <td>Terminated</td>\n","      <td>More favorable safety profile was observed in ...</td>\n","    </tr>\n","    <tr>\n","      <th>8</th>\n","      <td>9</td>\n","      <td>NCT01060423</td>\n","      <td>TACE With Irinotecan Drug-eluting Beads and In...</td>\n","      <td>DEBIRITUX</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Colorectal Cancer</td>\n","      <td>Drug: Cetuximab|Drug: Irinotecan|Device: Irino...</td>\n","      <td>Progression free survival rate|Tumour Response...</td>\n","      <td>Hans-Joachim Schmoll, MD|Biocompatibles UK Ltd...</td>\n","      <td>...</td>\n","      <td>December 2012</td>\n","      <td>May 2015</td>\n","      <td>February 2, 2010</td>\n","      <td>NaN</td>\n","      <td>October 26, 2016</td>\n","      <td>Zentralklinik Bad Berka GmbH, Abteilung f√ºr In...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01060423</td>\n","      <td>Terminated</td>\n","      <td>Terminated due to poor subject enrolment</td>\n","    </tr>\n","    <tr>\n","      <th>9</th>\n","      <td>10</td>\n","      <td>NCT03681951</td>\n","      <td>First-time-in-human (FTIH) Study of GSK3145095...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Neoplasms, Pancreatic</td>\n","      <td>Drug: GSK3145095|Drug: Pembrolizumab</td>\n","      <td>Number of Participants With Non-serious Advers...</td>\n","      <td>GlaxoSmithKline|Parexel</td>\n","      <td>...</td>\n","      <td>August 13, 2019</td>\n","      <td>August 13, 2019</td>\n","      <td>September 24, 2018</td>\n","      <td>July 31, 2020</td>\n","      <td>July 31, 2020</td>\n","      <td>GSK Investigational Site, Indianapolis, Indian...</td>\n","      <td>\"Study Protocol\", https://ClinicalTrials.gov/P...</td>\n","      <td>https://ClinicalTrials.gov/show/NCT03681951</td>\n","      <td>Terminated</td>\n","      <td>The study was terminated following an internal...</td>\n","    </tr>\n","    <tr>\n","      <th>10</th>\n","      <td>11</td>\n","      <td>NCT01038752</td>\n","      <td>Evaluation of Non-cytotoxic Suramin as a Chemo...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Non-small Cell Lung Cancer</td>\n","      <td>Drug: Suramin Drug:Docetaxel Drug: Carboplatin...</td>\n","      <td>Progression-free Survival for Participants Wit...</td>\n","      <td>Optimum Therapeutics, LLC</td>\n","      <td>...</td>\n","      <td>November 2012</td>\n","      <td>May 2013</td>\n","      <td>December 24, 2009</td>\n","      <td>October 21, 2014</td>\n","      <td>May 21, 2015</td>\n","      <td>John H Stroger Jr Hospital of Cook County, Chi...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01038752</td>\n","      <td>Terminated</td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>11</th>\n","      <td>12</td>\n","      <td>NCT00555984</td>\n","      <td>Intravenous Anesthesia Versus Anesthesia With ...</td>\n","      <td>TIVA</td>\n","      <td>Withdrawn</td>\n","      <td>No Results Available</td>\n","      <td>Brain Neoplasms</td>\n","      <td>Drug: Propofol + Remifentanil|Drug: Sevofluran...</td>\n","      <td>To study inflammatory changes associated with ...</td>\n","      <td>The Cleveland Clinic</td>\n","      <td>...</td>\n","      <td>March 2010</td>\n","      <td>March 2010</td>\n","      <td>November 9, 2007</td>\n","      <td>NaN</td>\n","      <td>April 20, 2017</td>\n","      <td>Cleveland Clinic Foundation, Cleveland, Ohio, ...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00555984</td>\n","      <td>Withdrawn</td>\n","      <td>PI decision to terminate. No usable data colle...</td>\n","    </tr>\n","    <tr>\n","      <th>12</th>\n","      <td>13</td>\n","      <td>NCT01915472</td>\n","      <td>A Phase II Study of IMMU 130 in Patients With ...</td>\n","      <td>NaN</td>\n","      <td>Withdrawn</td>\n","      <td>No Results Available</td>\n","      <td>Metastatic Colorectal Cancer</td>\n","      <td>Drug: IMMU 130</td>\n","      <td>Safety|Assess PK</td>\n","      <td>Gilead Sciences</td>\n","      <td>...</td>\n","      <td>August 2015</td>\n","      <td>August 2015</td>\n","      <td>August 5, 2013</td>\n","      <td>NaN</td>\n","      <td>August 19, 2021</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01915472</td>\n","      <td>Withdrawn</td>\n","      <td>No participants enrolled</td>\n","    </tr>\n","    <tr>\n","      <th>13</th>\n","      <td>14</td>\n","      <td>NCT00040391</td>\n","      <td>A Trial of an Investigational Drug for the Pre...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Colorectal Neoplasms|Diarrhea</td>\n","      <td>Drug: Investigational drug|Drug: Irinotecan|Dr...</td>\n","      <td>NaN</td>\n","      <td>Celgene Corporation|Pfizer</td>\n","      <td>...</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>June 27, 2002</td>\n","      <td>NaN</td>\n","      <td>December 1, 2016</td>\n","      <td>Research Center, Little Rock, Arkansas, United...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00040391</td>\n","      <td>Terminated</td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>14</th>\n","      <td>15</td>\n","      <td>NCT00200382</td>\n","      <td>Phase II Study of Therapy With PS 341 in Patie...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Non-small Cell Lung Cancer</td>\n","      <td>Drug: PS-341 (Velcade-drug)</td>\n","      <td>Response rate</td>\n","      <td>Rasim Gucalp|Millennium Pharmaceuticals, Inc.|...</td>\n","      <td>...</td>\n","      <td>May 2007</td>\n","      <td>May 2007</td>\n","      <td>September 20, 2005</td>\n","      <td>NaN</td>\n","      <td>August 2, 2018</td>\n","      <td>HealthAlliance Hospitals, Fitchburg, Massachus...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00200382</td>\n","      <td>Terminated</td>\n","      <td>The study did not achieve the statistical succ...</td>\n","    </tr>\n","    <tr>\n","      <th>15</th>\n","      <td>16</td>\n","      <td>NCT00575978</td>\n","      <td>Hydralazine as Demethylating Agent in Breast C...</td>\n","      <td>NaN</td>\n","      <td>Withdrawn</td>\n","      <td>No Results Available</td>\n","      <td>Breast Cancer</td>\n","      <td>Drug: Hydralazine</td>\n","      <td>To explore the potency of a clinical tolerable...</td>\n","      <td>University of Arkansas</td>\n","      <td>...</td>\n","      <td>December 2009</td>\n","      <td>December 2009</td>\n","      <td>December 18, 2007</td>\n","      <td>NaN</td>\n","      <td>March 4, 2015</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00575978</td>\n","      <td>Withdrawn</td>\n","      <td>IRB request</td>\n","    </tr>\n","    <tr>\n","      <th>16</th>\n","      <td>17</td>\n","      <td>NCT01575782</td>\n","      <td>Chloroquine as an Anti-autophagic Radiosensiti...</td>\n","      <td>Chloroquine</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Small Cell Lung Cancer</td>\n","      <td>Drug: Chloroquine</td>\n","      <td>Number of Participants with Adverse Events as ...</td>\n","      <td>Maastricht Radiation Oncology</td>\n","      <td>...</td>\n","      <td>July 2017</td>\n","      <td>July 2017</td>\n","      <td>April 11, 2012</td>\n","      <td>NaN</td>\n","      <td>July 18, 2017</td>\n","      <td>MAASTRO clinic, Maastricht, Limburg, Netherlands</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01575782</td>\n","      <td>Terminated</td>\n","      <td>Poor accrual</td>\n","    </tr>\n","    <tr>\n","      <th>17</th>\n","      <td>18</td>\n","      <td>NCT01605318</td>\n","      <td>Dose Finding Study of Once or Twice Weekly IMM...</td>\n","      <td>NaN</td>\n","      <td>Withdrawn</td>\n","      <td>No Results Available</td>\n","      <td>Metastatic Colorectal Cancer|Colon Cancer|Rect...</td>\n","      <td>Drug: IMMU-130</td>\n","      <td>Evaluate the safety and tolerability of IMMU-1...</td>\n","      <td>Gilead Sciences</td>\n","      <td>...</td>\n","      <td>January 2016</td>\n","      <td>January 2016</td>\n","      <td>May 24, 2012</td>\n","      <td>NaN</td>\n","      <td>August 19, 2021</td>\n","      <td>UCLA Jonsson Comprehensive Cancer Center, Sant...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01605318</td>\n","      <td>Withdrawn</td>\n","      <td>No patients are enrolled in any studies conduc...</td>\n","    </tr>\n","    <tr>\n","      <th>18</th>\n","      <td>19</td>\n","      <td>NCT02087176</td>\n","      <td>A Placebo Controlled Study Comparing AZD1775+ ...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Previously Treated Non Small Cell Lung Cancer</td>\n","      <td>Drug: AZD1775|Drug: AZD1775 Placebo|Drug: Anti...</td>\n","      <td>Objective Response Rate|Pharmacokinetic Profil...</td>\n","      <td>AstraZeneca</td>\n","      <td>...</td>\n","      <td>May 2015</td>\n","      <td>May 2015</td>\n","      <td>March 14, 2014</td>\n","      <td>June 14, 2016</td>\n","      <td>June 14, 2016</td>\n","      <td>Research Site, Birmingham, Alabama, United Sta...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT02087176</td>\n","      <td>Terminated</td>\n","      <td>The study was terminated early by the sponsor.</td>\n","    </tr>\n","    <tr>\n","      <th>19</th>\n","      <td>20</td>\n","      <td>NCT03471286</td>\n","      <td>A Window of Opportunity Study to Investigate M...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Solid Tumor</td>\n","      <td>Drug: Epacadostat</td>\n","      <td>Pharmacodynamic effects as measured by changes...</td>\n","      <td>Sidney Kimmel Comprehensive Cancer Center at J...</td>\n","      <td>...</td>\n","      <td>July 30, 2021</td>\n","      <td>July 30, 2021</td>\n","      <td>March 20, 2018</td>\n","      <td>NaN</td>\n","      <td>August 26, 2021</td>\n","      <td>Sidney Kimmel Comprehensive Cancer Center at J...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT03471286</td>\n","      <td>Terminated</td>\n","      <td>Deprioritization of drug in this patient popul...</td>\n","    </tr>\n","    <tr>\n","      <th>20</th>\n","      <td>21</td>\n","      <td>NCT01329640</td>\n","      <td>Feasibility Study of Metronomic Chemotherapy f...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Locally Advanced HER2-positive Breast Cancer</td>\n","      <td>Device: Drug: Paclitaxel; trastuzumab; doxorru...</td>\n","      <td>INCIDENCE OF FEBRILE NEUTROPENIA|TUMOR SIZE</td>\n","      <td>Instituto do Cancer do Estado de S√£o Paulo|Fun...</td>\n","      <td>...</td>\n","      <td>September 2011</td>\n","      <td>September 2012</td>\n","      <td>April 6, 2011</td>\n","      <td>NaN</td>\n","      <td>May 21, 2014</td>\n","      <td>Instituto do Cancer do Estado de Sao Paulo, Sa...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01329640</td>\n","      <td>Terminated</td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>21</th>\n","      <td>22</td>\n","      <td>NCT01209832</td>\n","      <td>A Tasisulam and Midazolam Drug Interaction Stu...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Advanced Cancer</td>\n","      <td>Drug: Tasisulam|Drug: Midazolam</td>\n","      <td>Midazolam Pharmacokinetics: Area Under the Con...</td>\n","      <td>Eli Lilly and Company</td>\n","      <td>...</td>\n","      <td>January 2011</td>\n","      <td>January 2011</td>\n","      <td>September 27, 2010</td>\n","      <td>March 18, 2019</td>\n","      <td>March 18, 2019</td>\n","      <td>For additional information regarding investiga...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01209832</td>\n","      <td>Terminated</td>\n","      <td>Terminated based on safety results from anothe...</td>\n","    </tr>\n","    <tr>\n","      <th>22</th>\n","      <td>23</td>\n","      <td>NCT01823835</td>\n","      <td>A Study of GDC-0810 Single Agent or in Combina...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Breast Cancer</td>\n","      <td>Drug: GDC-0810|Drug: LHRH Agonist|Drug: Palboc...</td>\n","      <td>Phase Ia: Maximum Tolerated Dose of GDC-0810 W...</td>\n","      <td>Genentech, Inc.</td>\n","      <td>...</td>\n","      <td>March 13, 2020</td>\n","      <td>March 13, 2020</td>\n","      <td>April 4, 2013</td>\n","      <td>June 18, 2021</td>\n","      <td>June 18, 2021</td>\n","      <td>Ucsd Medical Center, San Diego, California, Un...</td>\n","      <td>\"Study Protocol and Statistical Analysis Plan\"...</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01823835</td>\n","      <td>Terminated</td>\n","      <td>The Sponsor decided to halt the development of...</td>\n","    </tr>\n","    <tr>\n","      <th>23</th>\n","      <td>24</td>\n","      <td>NCT03745690</td>\n","      <td>Near-Infrared Image Guided Surgical Resection ...</td>\n","      <td>NaN</td>\n","      <td>Suspended</td>\n","      <td>No Results Available</td>\n","      <td>Head and Neck Carcinoma</td>\n","      <td>Procedure: Image-Guided Surgery|Drug: Indocyan...</td>\n","      <td>Safety related by type, incidence, severity, s...</td>\n","      <td>Jonsson Comprehensive Cancer Center</td>\n","      <td>...</td>\n","      <td>February 1, 2022</td>\n","      <td>February 1, 2023</td>\n","      <td>November 19, 2018</td>\n","      <td>NaN</td>\n","      <td>March 11, 2021</td>\n","      <td>UCLA / Jonsson Comprehensive Cancer Center, Lo...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT03745690</td>\n","      <td>Suspended</td>\n","      <td>Safety Issue</td>\n","    </tr>\n","    <tr>\n","      <th>24</th>\n","      <td>25</td>\n","      <td>NCT01632020</td>\n","      <td>Effect of Metformin on Biomarkers of Colorecta...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Colorectal Neoplasms</td>\n","      <td>Drug: Placebo|Drug: Metformin</td>\n","      <td>Proliferation Status of CRC Tumor and Adjacent...</td>\n","      <td>University of Arkansas</td>\n","      <td>...</td>\n","      <td>January 2015</td>\n","      <td>January 2015</td>\n","      <td>June 29, 2012</td>\n","      <td>July 11, 2016</td>\n","      <td>July 11, 2016</td>\n","      <td>Central Arkansas Veterans Heathcare System, Li...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01632020</td>\n","      <td>Terminated</td>\n","      <td>Inadequate accrual</td>\n","    </tr>\n","    <tr>\n","      <th>25</th>\n","      <td>26</td>\n","      <td>NCT00969306</td>\n","      <td>Chloroquine as an Anti-Autophagy Drug in Stage...</td>\n","      <td>Chloroquine IV</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Small Cell Lung Cancer</td>\n","      <td>Drug: Chloroquine, A-CQ 100</td>\n","      <td>To determine the toxicity of adding chloroquin...</td>\n","      <td>Maastricht Radiation Oncology|Maastricht Unive...</td>\n","      <td>...</td>\n","      <td>June 2016</td>\n","      <td>June 2016</td>\n","      <td>September 1, 2009</td>\n","      <td>NaN</td>\n","      <td>February 15, 2019</td>\n","      <td>NKI/AvL, Amsterdam, Netherlands|VU Medical Cen...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00969306</td>\n","      <td>Terminated</td>\n","      <td>Poor accrual</td>\n","    </tr>\n","    <tr>\n","      <th>26</th>\n","      <td>27</td>\n","      <td>NCT01804530</td>\n","      <td>Phase 1 Study of PLX7486 as Single Agent in Pa...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Solid Tumor|Tumors of Any Histology With Activ...</td>\n","      <td>Drug: PLX7486 TsOH</td>\n","      <td>Safety of PLX7486 as single agent as measured ...</td>\n","      <td>Plexxikon</td>\n","      <td>...</td>\n","      <td>January 24, 2018</td>\n","      <td>January 24, 2018</td>\n","      <td>March 5, 2013</td>\n","      <td>NaN</td>\n","      <td>August 2, 2018</td>\n","      <td>Ronald Reagan UCLA Medical Center, Los Angeles...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01804530</td>\n","      <td>Terminated</td>\n","      <td>Discontinued</td>\n","    </tr>\n","    <tr>\n","      <th>27</th>\n","      <td>28</td>\n","      <td>NCT04091711</td>\n","      <td>Evaluation of ReX-C¬Æ System for Medication Adh...</td>\n","      <td>NaN</td>\n","      <td>Suspended</td>\n","      <td>No Results Available</td>\n","      <td>Oncology|Adherence, Medication|Side Effect</td>\n","      <td>Device: ReX-C system</td>\n","      <td>Number of safety events during administration ...</td>\n","      <td>Dosentrx Ltd.</td>\n","      <td>...</td>\n","      <td>December 2022</td>\n","      <td>February 2023</td>\n","      <td>September 17, 2019</td>\n","      <td>NaN</td>\n","      <td>September 20, 2021</td>\n","      <td>Oncology Unit, Tel Aviv Sourasky Medical Cente...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT04091711</td>\n","      <td>Suspended</td>\n","      <td>Awaiting next model of the device</td>\n","    </tr>\n","    <tr>\n","      <th>28</th>\n","      <td>29</td>\n","      <td>NCT01086696</td>\n","      <td>A Pilot Study of F-18 Paclitaxel (FPAC) PET fo...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Breast Cancer|Lung Cancer|Renal Cancer|Adrenal...</td>\n","      <td>Drug: FPAC</td>\n","      <td>Uptake of FPAC in tumors|Safety of FPAC</td>\n","      <td>National Cancer Institute (NCI)|National Insti...</td>\n","      <td>...</td>\n","      <td>August 20, 2014</td>\n","      <td>May 11, 2016</td>\n","      <td>March 15, 2010</td>\n","      <td>NaN</td>\n","      <td>December 17, 2019</td>\n","      <td>National Institutes of Health Clinical Center,...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01086696</td>\n","      <td>Terminated</td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>29</th>\n","      <td>30</td>\n","      <td>NCT00695370</td>\n","      <td>Evaluation of Pegfilgrastim for Stem Cell Mobi...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Solid Malignancies</td>\n","      <td>Drug: Pegfilgrastim (drug)</td>\n","      <td>percentage of children achieving at least 5x10...</td>\n","      <td>University Hospital, Clermont-Ferrand|Amgen</td>\n","      <td>...</td>\n","      <td>December 2007</td>\n","      <td>January 2008</td>\n","      <td>June 11, 2008</td>\n","      <td>NaN</td>\n","      <td>June 13, 2008</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00695370</td>\n","      <td>Terminated</td>\n","      <td>Recruiting or enrolling participants has halte...</td>\n","    </tr>\n","    <tr>\n","      <th>...</th>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","    </tr>\n","    <tr>\n","      <th>7660</th>\n","      <td>7661</td>\n","      <td>NCT01013961</td>\n","      <td>Rituximab and Alemtuzumab in Treating Older Pa...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Chronic Lymphocytic Leukemia</td>\n","      <td>Biological: alemtuzumab|Biological: rituximab</td>\n","      <td>Proportion of Patients With Complete Response ...</td>\n","      <td>ECOG-ACRIN Cancer Research Group|National Canc...</td>\n","      <td>...</td>\n","      <td>April 14, 2015</td>\n","      <td>April 14, 2015</td>\n","      <td>November 16, 2009</td>\n","      <td>January 28, 2016</td>\n","      <td>January 14, 2019</td>\n","      <td>Mayo Clinic Scottsdale, Scottsdale, Arizona, U...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01013961</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7661</th>\n","      <td>7662</td>\n","      <td>NCT00265915</td>\n","      <td>Rituximab and GM-CSF in Treating Patients With...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Leukemia</td>\n","      <td>Biological: rituximab|Biological: sargramostim</td>\n","      <td>Overall response rate</td>\n","      <td>Sidney Kimmel Comprehensive Cancer Center at J...</td>\n","      <td>...</td>\n","      <td>March 2006</td>\n","      <td>March 2006</td>\n","      <td>December 15, 2005</td>\n","      <td>NaN</td>\n","      <td>August 12, 2014</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00265915</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7662</th>\n","      <td>7663</td>\n","      <td>NCT00036855</td>\n","      <td>Radiolabeled Monoclonal Antibody With or Witho...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>AIDS-related Peripheral/Systemic Lymphoma|AIDS...</td>\n","      <td>Biological: rituximab|Radiation: indium In 111...</td>\n","      <td>MTD, defined as that dose at which fewer than ...</td>\n","      <td>National Cancer Institute (NCI)</td>\n","      <td>...</td>\n","      <td>March 2005</td>\n","      <td>NaN</td>\n","      <td>January 27, 2003</td>\n","      <td>NaN</td>\n","      <td>January 17, 2013</td>\n","      <td>Children's Oncology Group, Arcadia, California...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00036855</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7663</th>\n","      <td>7664</td>\n","      <td>NCT00022971</td>\n","      <td>Combination Antibody Therapy for Relapsed Lymp...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Diffuse Large B-Cell Lymphoma|Follicular Lymph...</td>\n","      <td>Biological: Apolizumab|Biological: Rituximab</td>\n","      <td>MTD</td>\n","      <td>National Cancer Institute (NCI)|National Insti...</td>\n","      <td>...</td>\n","      <td>January 22, 2010</td>\n","      <td>March 17, 2017</td>\n","      <td>August 20, 2001</td>\n","      <td>NaN</td>\n","      <td>December 16, 2019</td>\n","      <td>National Institutes of Health Clinical Center,...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00022971</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7664</th>\n","      <td>7665</td>\n","      <td>NCT00005788</td>\n","      <td>Interleukin-2 in Treating Patients With Mycosi...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Lymphoma</td>\n","      <td>Biological: aldesleukin</td>\n","      <td>NaN</td>\n","      <td>Northwestern University|National Cancer Instit...</td>\n","      <td>...</td>\n","      <td>January 2002</td>\n","      <td>January 2002</td>\n","      <td>January 27, 2003</td>\n","      <td>NaN</td>\n","      <td>June 6, 2012</td>\n","      <td>Robert H. Lurie Comprehensive Cancer Center, N...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00005788</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7665</th>\n","      <td>7666</td>\n","      <td>NCT01820312</td>\n","      <td>A Phase II Study to Evaluate Low-Dose Fraction...</td>\n","      <td>NaN</td>\n","      <td>Withdrawn</td>\n","      <td>No Results Available</td>\n","      <td>Squamous Cell Carcinoma of the Head and Neck</td>\n","      <td>Radiation: Low-Dose Fractionated Radiation The...</td>\n","      <td>Objective Response (OR)</td>\n","      <td>University of Arkansas</td>\n","      <td>...</td>\n","      <td>July 2015</td>\n","      <td>July 2015</td>\n","      <td>March 28, 2013</td>\n","      <td>NaN</td>\n","      <td>August 8, 2016</td>\n","      <td>University of Arkansas for Medical Sciences, L...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01820312</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7666</th>\n","      <td>7667</td>\n","      <td>NCT00004874</td>\n","      <td>Monoclonal Antibody Therapy in Treating Patien...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Lymphoma</td>\n","      <td>Radiation: tositumomab and iodine I 131 tositu...</td>\n","      <td>Expanded Access|Safety|efficacy</td>\n","      <td>University of Nebraska|National Cancer Institu...</td>\n","      <td>...</td>\n","      <td>April 2002</td>\n","      <td>November 2012</td>\n","      <td>December 16, 2003</td>\n","      <td>NaN</td>\n","      <td>January 17, 2018</td>\n","      <td>University of Nebraska Medical Center, Omaha, ...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00004874</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7667</th>\n","      <td>7668</td>\n","      <td>NCT02922283</td>\n","      <td>IL2 Imaging in Metastatic Melanoma</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Melanoma</td>\n","      <td>Device: IL2-PET scan|Procedure: Tumor biopsy|D...</td>\n","      <td>Biodistribution and kinetics of [18F]FB-IL2.|T...</td>\n","      <td>University Medical Center Groningen</td>\n","      <td>...</td>\n","      <td>February 14, 2020</td>\n","      <td>February 14, 2020</td>\n","      <td>October 4, 2016</td>\n","      <td>NaN</td>\n","      <td>March 23, 2020</td>\n","      <td>University Medical Center Groningen, Groningen...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT02922283</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7668</th>\n","      <td>7669</td>\n","      <td>NCT02345330</td>\n","      <td>Trial of pIL-12 Electroporation in Squamous Ce...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Head and Neck Squamous Cell Carcinoma</td>\n","      <td>Biological: Tavokinogene Telseplasmid (tavo)|D...</td>\n","      <td>Best Overall Response Rate (BORR) by RECIST v1...</td>\n","      <td>OncoSec Medical Incorporated</td>\n","      <td>...</td>\n","      <td>November 14, 2016</td>\n","      <td>November 14, 2016</td>\n","      <td>January 26, 2015</td>\n","      <td>January 3, 2018</td>\n","      <td>January 3, 2018</td>\n","      <td>UCSF Helen Diller Family Comprehensive Cancer ...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT02345330</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7669</th>\n","      <td>7670</td>\n","      <td>NCT00724061</td>\n","      <td>Study of Pegylated Interferon-Alfa 2b in Combi...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Lymphoma</td>\n","      <td>Biological: Pegylated interferon Œ±-2b|Other: P...</td>\n","      <td>Number of Dose Limiting Toxicities (DLTs) Obse...</td>\n","      <td>Northwestern University|National Cancer Instit...</td>\n","      <td>...</td>\n","      <td>June 2011</td>\n","      <td>December 2011</td>\n","      <td>July 29, 2008</td>\n","      <td>December 2, 2013</td>\n","      <td>December 12, 2018</td>\n","      <td>Robert H. Lurie Comprehensive Cancer Center at...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00724061</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7670</th>\n","      <td>7671</td>\n","      <td>NCT00722098</td>\n","      <td>Comparison Study of Dendritic Cell Vaccine Wit...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Malignant Melanoma Stage IV</td>\n","      <td>Biological: DC Vaccine &amp; Cyclophosphamide|Biol...</td>\n","      <td>Induction of melanoma-specific CD8+T Cell Immu...</td>\n","      <td>Baylor Research Institute</td>\n","      <td>...</td>\n","      <td>April 2011</td>\n","      <td>July 2012</td>\n","      <td>July 25, 2008</td>\n","      <td>NaN</td>\n","      <td>July 8, 2013</td>\n","      <td>Baylor University Medical Center, Dallas, Texa...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00722098</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7671</th>\n","      <td>7672</td>\n","      <td>NCT00706992</td>\n","      <td>Anti-MART-1 F5 Lymphocytes to Treat High-Risk ...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Melanoma</td>\n","      <td>Biological: ALVAC-MART-1 vaccine|Biological: M...</td>\n","      <td>Percentage of Participants With Immunologic Re...</td>\n","      <td>National Cancer Institute (NCI)|National Insti...</td>\n","      <td>...</td>\n","      <td>November 2012</td>\n","      <td>November 2012</td>\n","      <td>June 30, 2008</td>\n","      <td>March 19, 2013</td>\n","      <td>October 28, 2015</td>\n","      <td>National Cancer Institute (NCI), 9000 Rockvill...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00706992</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7672</th>\n","      <td>7673</td>\n","      <td>NCT01758458</td>\n","      <td>Viral Oncoprotein Targeted Autologous T Cell T...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Recurrent Merkel Cell Carcinoma|Stage IV Merke...</td>\n","      <td>Biological: Aldesleukin|Other: Laboratory Biom...</td>\n","      <td>Evidence and nature of toxicity related to the...</td>\n","      <td>Fred Hutchinson Cancer Research Center|Nationa...</td>\n","      <td>...</td>\n","      <td>May 2016</td>\n","      <td>May 2016</td>\n","      <td>January 1, 2013</td>\n","      <td>NaN</td>\n","      <td>April 19, 2017</td>\n","      <td>Fred Hutchinson Cancer Research Center/Univers...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01758458</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7673</th>\n","      <td>7674</td>\n","      <td>NCT00085579</td>\n","      <td>Interleukin-2 and Sargramostim After Chemother...</td>\n","      <td>NaN</td>\n","      <td>Withdrawn</td>\n","      <td>No Results Available</td>\n","      <td>Melanoma (Skin)</td>\n","      <td>Biological: aldesleukin|Biological: sargramost...</td>\n","      <td>NaN</td>\n","      <td>Memorial Sloan Kettering Cancer Center|Nationa...</td>\n","      <td>...</td>\n","      <td>March 2005</td>\n","      <td>March 2005</td>\n","      <td>June 11, 2004</td>\n","      <td>NaN</td>\n","      <td>December 12, 2012</td>\n","      <td>Memorial Sloan-Kettering Cancer Center, New Yo...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00085579</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7674</th>\n","      <td>7675</td>\n","      <td>NCT00945269</td>\n","      <td>Therapeutic Autologous Lymphocytes, Aldesleuki...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Recurrent Melanoma|Stage III Melanoma|Stage IV...</td>\n","      <td>Biological: therapeutic autologous lymphocytes...</td>\n","      <td>In vivo survival of CD8+ transferred T-clones</td>\n","      <td>Fred Hutchinson Cancer Research Center|Nationa...</td>\n","      <td>...</td>\n","      <td>January 2011</td>\n","      <td>January 2011</td>\n","      <td>July 24, 2009</td>\n","      <td>NaN</td>\n","      <td>December 8, 2011</td>\n","      <td>Fred Hutchinson Cancer Research Center/Univers...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00945269</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7675</th>\n","      <td>7676</td>\n","      <td>NCT00006113</td>\n","      <td>Vaccine Therapy Followed by Biological Therapy...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Melanoma (Skin)</td>\n","      <td>Biological: MART-1 antigen|Biological: aldesle...</td>\n","      <td>NaN</td>\n","      <td>University of Southern California|National Can...</td>\n","      <td>...</td>\n","      <td>May 2003</td>\n","      <td>April 2006</td>\n","      <td>January 27, 2003</td>\n","      <td>NaN</td>\n","      <td>May 22, 2014</td>\n","      <td>USC/Norris Comprehensive Cancer Center and Hos...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00006113</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7676</th>\n","      <td>7677</td>\n","      <td>NCT00588822</td>\n","      <td>Rituximab in Treating Patients With Peripheral...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Precancerous Condition</td>\n","      <td>Biological: Rituximab</td>\n","      <td>Percentage of Subjects With at Least 10 Points...</td>\n","      <td>Mayo Clinic|Genentech, Inc.|Biogen|National Ce...</td>\n","      <td>...</td>\n","      <td>January 2009</td>\n","      <td>February 2011</td>\n","      <td>January 9, 2008</td>\n","      <td>May 6, 2014</td>\n","      <td>May 6, 2014</td>\n","      <td>Mayo Clinic Scottsdale, Scottsdale, Arizona, U...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00588822</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7677</th>\n","      <td>7678</td>\n","      <td>NCT00054405</td>\n","      <td>Interleukin-12 and Interleukin-2 in Treating P...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Recurrent Neuroblastoma</td>\n","      <td>Biological: recombinant interleukin-12|Biologi...</td>\n","      <td>Maximum tolerated dose (MTD) assessed by Commo...</td>\n","      <td>National Cancer Institute (NCI)</td>\n","      <td>...</td>\n","      <td>May 2009</td>\n","      <td>NaN</td>\n","      <td>February 6, 2003</td>\n","      <td>NaN</td>\n","      <td>April 9, 2013</td>\n","      <td>New Approaches to Neuroblastoma Treatment (NAN...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00054405</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7678</th>\n","      <td>7679</td>\n","      <td>NCT00005787</td>\n","      <td>Peripheral Stem Cell Transplantation to Preven...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Lymphoma|Neutropenia</td>\n","      <td>Biological: epoetin alfa|Biological: filgrasti...</td>\n","      <td>NaN</td>\n","      <td>Northwestern University|National Cancer Instit...</td>\n","      <td>...</td>\n","      <td>January 2002</td>\n","      <td>January 2002</td>\n","      <td>January 27, 2003</td>\n","      <td>NaN</td>\n","      <td>June 1, 2012</td>\n","      <td>Robert H. Lurie Comprehensive Cancer Center, N...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00005787</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7679</th>\n","      <td>7680</td>\n","      <td>NCT00676806</td>\n","      <td>A Phase II Study of Umbilical Cord Blood Trans...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Leukemia|Lymphoma|Multiple Myeloma|Aplastic An...</td>\n","      <td>Biological: Umbilical Cord Blood After Myeloab...</td>\n","      <td>Number of Participants With Neutrophil Engraft...</td>\n","      <td>Tufts Medical Center</td>\n","      <td>...</td>\n","      <td>July 2013</td>\n","      <td>July 2014</td>\n","      <td>May 13, 2008</td>\n","      <td>July 22, 2016</td>\n","      <td>June 1, 2017</td>\n","      <td>Tufts Medical Center, Boston, Massachusetts, U...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00676806</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7680</th>\n","      <td>7681</td>\n","      <td>NCT00357461</td>\n","      <td>Ipilimumab With or Without Vaccine Therapy in ...</td>\n","      <td>NaN</td>\n","      <td>Withdrawn</td>\n","      <td>No Results Available</td>\n","      <td>Melanoma (Skin)</td>\n","      <td>Biological: gp100:209-217(210M) peptide vaccin...</td>\n","      <td>Clinical response|Safety and toxicity|Immunolo...</td>\n","      <td>Bristol-Myers Squibb|National Cancer Institute...</td>\n","      <td>...</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>July 27, 2006</td>\n","      <td>NaN</td>\n","      <td>May 15, 2013</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00357461</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7681</th>\n","      <td>7682</td>\n","      <td>NCT01307618</td>\n","      <td>Vaccine Therapy With or Without Recombinant In...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Recurrent Melanoma|Stage IV Skin Melanoma</td>\n","      <td>Biological: NA17.A2 Peptide Vaccine|Biological...</td>\n","      <td>Frequency of Vaccine-induced CD8+ T Cells Asse...</td>\n","      <td>National Cancer Institute (NCI)</td>\n","      <td>...</td>\n","      <td>January 2015</td>\n","      <td>February 2015</td>\n","      <td>March 3, 2011</td>\n","      <td>October 24, 2016</td>\n","      <td>October 24, 2016</td>\n","      <td>University of Chicago Comprehensive Cancer Cen...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01307618</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7682</th>\n","      <td>7683</td>\n","      <td>NCT03422094</td>\n","      <td>Neoantigen-based Personalized Vaccine Combined...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Glioblastoma</td>\n","      <td>Biological: NeoVax|Biological: Nivolumab|Biolo...</td>\n","      <td>Safety and tolerability of regimen as measured...</td>\n","      <td>Washington University School of Medicine|Brist...</td>\n","      <td>...</td>\n","      <td>April 26, 2020</td>\n","      <td>December 31, 2020</td>\n","      <td>February 5, 2018</td>\n","      <td>NaN</td>\n","      <td>April 23, 2021</td>\n","      <td>Washington University School of Medicine, Sain...</td>\n","      <td>\"Informed Consent Form\", https://ClinicalTrial...</td>\n","      <td>https://ClinicalTrials.gov/show/NCT03422094</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7683</th>\n","      <td>7684</td>\n","      <td>NCT01644253</td>\n","      <td>Phase 1b Safety and Efficacy Study of TRU-016</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Chronic Lymphocytic Leukemia|Peripheral T-cell...</td>\n","      <td>Biological: 20 mg/kg TRU-016 + Rituximab|Biolo...</td>\n","      <td>Incidence and severity of adverse events|CLL C...</td>\n","      <td>Aptevo Therapeutics</td>\n","      <td>...</td>\n","      <td>February 24, 2020</td>\n","      <td>April 21, 2021</td>\n","      <td>July 19, 2012</td>\n","      <td>NaN</td>\n","      <td>May 20, 2021</td>\n","      <td>Augusta, Georgia, United States|Columbus, Ohio...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01644253</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7684</th>\n","      <td>7685</td>\n","      <td>NCT00052377</td>\n","      <td>Interleukin-12 and Interleukin-2 in Treating P...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Recurrent Cutaneous T-cell Non-Hodgkin Lymphom...</td>\n","      <td>Biological: aldesleukin|Biological: recombinan...</td>\n","      <td>Clinical response rate defined as the percenta...</td>\n","      <td>National Cancer Institute (NCI)</td>\n","      <td>...</td>\n","      <td>June 2005</td>\n","      <td>NaN</td>\n","      <td>January 27, 2003</td>\n","      <td>NaN</td>\n","      <td>January 16, 2013</td>\n","      <td>Abramson Cancer Center of The University of Pe...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00052377</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7685</th>\n","      <td>7686</td>\n","      <td>NCT00863395</td>\n","      <td>Recalcitrant Pruritus in Cutaneous T-Cell Lymp...</td>\n","      <td>CTCL</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Cutaneous T-Cell Lymphoma</td>\n","      <td>Procedure: skin biopsy</td>\n","      <td>Collection of biopsies from pruritic CTCL pati...</td>\n","      <td>University of Minnesota</td>\n","      <td>...</td>\n","      <td>December 2012</td>\n","      <td>December 2012</td>\n","      <td>March 18, 2009</td>\n","      <td>NaN</td>\n","      <td>March 31, 2014</td>\n","      <td>University of Minnesota, Minneapolis, Minnesot...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00863395</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7686</th>\n","      <td>7687</td>\n","      <td>NCT00052598</td>\n","      <td>Therapeutic Allogeneic Lymphocytes and Aldesle...</td>\n","      <td>NaN</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Accelerated Phase Chronic Myelogenous Leukemia...</td>\n","      <td>Biological: therapeutic allogeneic lymphocytes...</td>\n","      <td>Toxicity rate associated with infusing donor C...</td>\n","      <td>Fred Hutchinson Cancer Research Center|Nationa...</td>\n","      <td>...</td>\n","      <td>November 2009</td>\n","      <td>June 2011</td>\n","      <td>January 27, 2003</td>\n","      <td>NaN</td>\n","      <td>February 15, 2017</td>\n","      <td>Fred Hutchinson Cancer Research Center/Univers...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT00052598</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7687</th>\n","      <td>7688</td>\n","      <td>NCT01579318</td>\n","      <td>Phase II Intratumoral IL12 Plasmid Electropora...</td>\n","      <td>CTCL</td>\n","      <td>Terminated</td>\n","      <td>Has Results</td>\n","      <td>Cutaneous T Cell Lymphomas (CTCL)|Mycosis Fung...</td>\n","      <td>Biological: Tavokinogene Telseplasmid (tavo)|D...</td>\n","      <td>Objective Response Rate Assessed by Modified S...</td>\n","      <td>OncoSec Medical Incorporated</td>\n","      <td>...</td>\n","      <td>June 3, 2014</td>\n","      <td>June 3, 2014</td>\n","      <td>April 17, 2012</td>\n","      <td>January 3, 2018</td>\n","      <td>January 3, 2018</td>\n","      <td>UCSF Helen Diller Comprehensive Cancer Center,...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT01579318</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7688</th>\n","      <td>7689</td>\n","      <td>NCT03316066</td>\n","      <td>Comparison of Volumes of Local Anesthetics on ...</td>\n","      <td>NaN</td>\n","      <td>Withdrawn</td>\n","      <td>No Results Available</td>\n","      <td>Complex Regional Pain Syndromes</td>\n","      <td>Procedure: stellate ganglion block with ropiva...</td>\n","      <td>Pain score|Temperature increase in the ipsilat...</td>\n","      <td>Maisonneuve-Rosemont Hospital</td>\n","      <td>...</td>\n","      <td>February 21, 2020</td>\n","      <td>February 21, 2020</td>\n","      <td>October 20, 2017</td>\n","      <td>NaN</td>\n","      <td>February 24, 2020</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT03316066</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>7689</th>\n","      <td>7690</td>\n","      <td>NCT02221154</td>\n","      <td>Use of Myo-inositol as Adjuvant Therapy in Pat...</td>\n","      <td>FIV-INOPK</td>\n","      <td>Terminated</td>\n","      <td>No Results Available</td>\n","      <td>Polycystic Ovary Syndrome</td>\n","      <td>Dietary Supplement: Inofolic¬Æ|Other: Gonadotro...</td>\n","      <td>Incidence of OHSS in each group, graded mild, ...</td>\n","      <td>Centre Hospitalier Departemental Vendee</td>\n","      <td>...</td>\n","      <td>May 22, 2017</td>\n","      <td>May 22, 2017</td>\n","      <td>August 20, 2014</td>\n","      <td>NaN</td>\n","      <td>June 16, 2017</td>\n","      <td>CHI de Cr√©teil, Cr√©teil, France|CHD Vend√©e, La...</td>\n","      <td>NaN</td>\n","      <td>https://ClinicalTrials.gov/show/NCT02221154</td>\n","      <td></td>\n","      <td></td>\n","    </tr>\n","  </tbody>\n","</table>\n","<p>7690 rows √ó 29 columns</p>\n","</div>"],"text/plain":["      Rank   NCT Number                                              Title  \\\n","0        1  NCT02538471  LY2157299 Monohydrate (LY2157299) and Radiothe...   \n","1        2  NCT01596530  Evaluation of Drug Activity in Women With Brea...   \n","2        3  NCT04194528  S1916 Digital Medicine Program for Pain Contro...   \n","3        4  NCT02578459  A Pilot Study to Evaluate the Efficacy of ITDD...   \n","4        5  NCT01987375  Cetuximab IRDye800 Study as an Optical Imaging...   \n","5        6  NCT04281290  Electrochemotherapy of Posterior Resection Sur...   \n","6        7  NCT02244112  A Phase 1 Study of Oprozomib to Assess Food Ef...   \n","7        8  NCT03370302  A Study to Evaluate the Safety, Tolerability, ...   \n","8        9  NCT01060423  TACE With Irinotecan Drug-eluting Beads and In...   \n","9       10  NCT03681951  First-time-in-human (FTIH) Study of GSK3145095...   \n","10      11  NCT01038752  Evaluation of Non-cytotoxic Suramin as a Chemo...   \n","11      12  NCT00555984  Intravenous Anesthesia Versus Anesthesia With ...   \n","12      13  NCT01915472  A Phase II Study of IMMU 130 in Patients With ...   \n","13      14  NCT00040391  A Trial of an Investigational Drug for the Pre...   \n","14      15  NCT00200382  Phase II Study of Therapy With PS 341 in Patie...   \n","15      16  NCT00575978  Hydralazine as Demethylating Agent in Breast C...   \n","16      17  NCT01575782  Chloroquine as an Anti-autophagic Radiosensiti...   \n","17      18  NCT01605318  Dose Finding Study of Once or Twice Weekly IMM...   \n","18      19  NCT02087176  A Placebo Controlled Study Comparing AZD1775+ ...   \n","19      20  NCT03471286  A Window of Opportunity Study to Investigate M...   \n","20      21  NCT01329640  Feasibility Study of Metronomic Chemotherapy f...   \n","21      22  NCT01209832  A Tasisulam and Midazolam Drug Interaction Stu...   \n","22      23  NCT01823835  A Study of GDC-0810 Single Agent or in Combina...   \n","23      24  NCT03745690  Near-Infrared Image Guided Surgical Resection ...   \n","24      25  NCT01632020  Effect of Metformin on Biomarkers of Colorecta...   \n","25      26  NCT00969306  Chloroquine as an Anti-Autophagy Drug in Stage...   \n","26      27  NCT01804530  Phase 1 Study of PLX7486 as Single Agent in Pa...   \n","27      28  NCT04091711  Evaluation of ReX-C¬Æ System for Medication Adh...   \n","28      29  NCT01086696  A Pilot Study of F-18 Paclitaxel (FPAC) PET fo...   \n","29      30  NCT00695370  Evaluation of Pegfilgrastim for Stem Cell Mobi...   \n","...    ...          ...                                                ...   \n","7660  7661  NCT01013961  Rituximab and Alemtuzumab in Treating Older Pa...   \n","7661  7662  NCT00265915  Rituximab and GM-CSF in Treating Patients With...   \n","7662  7663  NCT00036855  Radiolabeled Monoclonal Antibody With or Witho...   \n","7663  7664  NCT00022971  Combination Antibody Therapy for Relapsed Lymp...   \n","7664  7665  NCT00005788  Interleukin-2 in Treating Patients With Mycosi...   \n","7665  7666  NCT01820312  A Phase II Study to Evaluate Low-Dose Fraction...   \n","7666  7667  NCT00004874  Monoclonal Antibody Therapy in Treating Patien...   \n","7667  7668  NCT02922283                 IL2 Imaging in Metastatic Melanoma   \n","7668  7669  NCT02345330  Trial of pIL-12 Electroporation in Squamous Ce...   \n","7669  7670  NCT00724061  Study of Pegylated Interferon-Alfa 2b in Combi...   \n","7670  7671  NCT00722098  Comparison Study of Dendritic Cell Vaccine Wit...   \n","7671  7672  NCT00706992  Anti-MART-1 F5 Lymphocytes to Treat High-Risk ...   \n","7672  7673  NCT01758458  Viral Oncoprotein Targeted Autologous T Cell T...   \n","7673  7674  NCT00085579  Interleukin-2 and Sargramostim After Chemother...   \n","7674  7675  NCT00945269  Therapeutic Autologous Lymphocytes, Aldesleuki...   \n","7675  7676  NCT00006113  Vaccine Therapy Followed by Biological Therapy...   \n","7676  7677  NCT00588822  Rituximab in Treating Patients With Peripheral...   \n","7677  7678  NCT00054405  Interleukin-12 and Interleukin-2 in Treating P...   \n","7678  7679  NCT00005787  Peripheral Stem Cell Transplantation to Preven...   \n","7679  7680  NCT00676806  A Phase II Study of Umbilical Cord Blood Trans...   \n","7680  7681  NCT00357461  Ipilimumab With or Without Vaccine Therapy in ...   \n","7681  7682  NCT01307618  Vaccine Therapy With or Without Recombinant In...   \n","7682  7683  NCT03422094  Neoantigen-based Personalized Vaccine Combined...   \n","7683  7684  NCT01644253      Phase 1b Safety and Efficacy Study of TRU-016   \n","7684  7685  NCT00052377  Interleukin-12 and Interleukin-2 in Treating P...   \n","7685  7686  NCT00863395  Recalcitrant Pruritus in Cutaneous T-Cell Lymp...   \n","7686  7687  NCT00052598  Therapeutic Allogeneic Lymphocytes and Aldesle...   \n","7687  7688  NCT01579318  Phase II Intratumoral IL12 Plasmid Electropora...   \n","7688  7689  NCT03316066  Comparison of Volumes of Local Anesthetics on ...   \n","7689  7690  NCT02221154  Use of Myo-inositol as Adjuvant Therapy in Pat...   \n","\n","             Acronym      Status         Study Results  \\\n","0                NaN  Terminated           Has Results   \n","1              CHIVE  Terminated  No Results Available   \n","2                NaN  Terminated  No Results Available   \n","3                NaN   Withdrawn  No Results Available   \n","4                NaN  Terminated  No Results Available   \n","5             PanECT  Terminated  No Results Available   \n","6                NaN  Terminated  No Results Available   \n","7                NaN  Terminated           Has Results   \n","8          DEBIRITUX  Terminated  No Results Available   \n","9                NaN  Terminated           Has Results   \n","10               NaN  Terminated           Has Results   \n","11              TIVA   Withdrawn  No Results Available   \n","12               NaN   Withdrawn  No Results Available   \n","13               NaN  Terminated  No Results Available   \n","14               NaN  Terminated  No Results Available   \n","15               NaN   Withdrawn  No Results Available   \n","16       Chloroquine  Terminated  No Results Available   \n","17               NaN   Withdrawn  No Results Available   \n","18               NaN  Terminated           Has Results   \n","19               NaN  Terminated  No Results Available   \n","20               NaN  Terminated  No Results Available   \n","21               NaN  Terminated           Has Results   \n","22               NaN  Terminated           Has Results   \n","23               NaN   Suspended  No Results Available   \n","24               NaN  Terminated           Has Results   \n","25    Chloroquine IV  Terminated  No Results Available   \n","26               NaN  Terminated  No Results Available   \n","27               NaN   Suspended  No Results Available   \n","28               NaN  Terminated  No Results Available   \n","29               NaN  Terminated  No Results Available   \n","...              ...         ...                   ...   \n","7660             NaN  Terminated           Has Results   \n","7661             NaN  Terminated  No Results Available   \n","7662             NaN  Terminated  No Results Available   \n","7663             NaN  Terminated  No Results Available   \n","7664             NaN  Terminated  No Results Available   \n","7665             NaN   Withdrawn  No Results Available   \n","7666             NaN  Terminated  No Results Available   \n","7667             NaN  Terminated  No Results Available   \n","7668             NaN  Terminated           Has Results   \n","7669             NaN  Terminated           Has Results   \n","7670             NaN  Terminated  No Results Available   \n","7671             NaN  Terminated           Has Results   \n","7672             NaN  Terminated  No Results Available   \n","7673             NaN   Withdrawn  No Results Available   \n","7674             NaN  Terminated  No Results Available   \n","7675             NaN  Terminated  No Results Available   \n","7676             NaN  Terminated           Has Results   \n","7677             NaN  Terminated  No Results Available   \n","7678             NaN  Terminated  No Results Available   \n","7679             NaN  Terminated           Has Results   \n","7680             NaN   Withdrawn  No Results Available   \n","7681             NaN  Terminated           Has Results   \n","7682             NaN  Terminated  No Results Available   \n","7683             NaN  Terminated  No Results Available   \n","7684             NaN  Terminated  No Results Available   \n","7685            CTCL  Terminated  No Results Available   \n","7686             NaN  Terminated  No Results Available   \n","7687            CTCL  Terminated           Has Results   \n","7688             NaN   Withdrawn  No Results Available   \n","7689       FIV-INOPK  Terminated  No Results Available   \n","\n","                                             Conditions  \\\n","0                              Metastatic Breast Cancer   \n","1                                       Breast Neoplasm   \n","2                                     Metastatic Cancer   \n","3                           Pain Management|Cancer Pain   \n","4                                  Head and Neck Cancer   \n","5                                       Pancreas Cancer   \n","6     Advanced Non-Central Nervous System (CNS) Mali...   \n","7                   Advanced Nonhematological Neoplasms   \n","8                                     Colorectal Cancer   \n","9                                 Neoplasms, Pancreatic   \n","10                           Non-small Cell Lung Cancer   \n","11                                      Brain Neoplasms   \n","12                         Metastatic Colorectal Cancer   \n","13                        Colorectal Neoplasms|Diarrhea   \n","14                           Non-small Cell Lung Cancer   \n","15                                        Breast Cancer   \n","16                               Small Cell Lung Cancer   \n","17    Metastatic Colorectal Cancer|Colon Cancer|Rect...   \n","18        Previously Treated Non Small Cell Lung Cancer   \n","19                                          Solid Tumor   \n","20         Locally Advanced HER2-positive Breast Cancer   \n","21                                      Advanced Cancer   \n","22                                        Breast Cancer   \n","23                              Head and Neck Carcinoma   \n","24                                 Colorectal Neoplasms   \n","25                               Small Cell Lung Cancer   \n","26    Solid Tumor|Tumors of Any Histology With Activ...   \n","27           Oncology|Adherence, Medication|Side Effect   \n","28    Breast Cancer|Lung Cancer|Renal Cancer|Adrenal...   \n","29                                   Solid Malignancies   \n","...                                                 ...   \n","7660                       Chronic Lymphocytic Leukemia   \n","7661                                           Leukemia   \n","7662  AIDS-related Peripheral/Systemic Lymphoma|AIDS...   \n","7663  Diffuse Large B-Cell Lymphoma|Follicular Lymph...   \n","7664                                           Lymphoma   \n","7665       Squamous Cell Carcinoma of the Head and Neck   \n","7666                                           Lymphoma   \n","7667                                           Melanoma   \n","7668              Head and Neck Squamous Cell Carcinoma   \n","7669                                           Lymphoma   \n","7670                        Malignant Melanoma Stage IV   \n","7671                                           Melanoma   \n","7672  Recurrent Merkel Cell Carcinoma|Stage IV Merke...   \n","7673                                    Melanoma (Skin)   \n","7674  Recurrent Melanoma|Stage III Melanoma|Stage IV...   \n","7675                                    Melanoma (Skin)   \n","7676                             Precancerous Condition   \n","7677                            Recurrent Neuroblastoma   \n","7678                               Lymphoma|Neutropenia   \n","7679  Leukemia|Lymphoma|Multiple Myeloma|Aplastic An...   \n","7680                                    Melanoma (Skin)   \n","7681          Recurrent Melanoma|Stage IV Skin Melanoma   \n","7682                                       Glioblastoma   \n","7683  Chronic Lymphocytic Leukemia|Peripheral T-cell...   \n","7684  Recurrent Cutaneous T-cell Non-Hodgkin Lymphom...   \n","7685                          Cutaneous T-Cell Lymphoma   \n","7686  Accelerated Phase Chronic Myelogenous Leukemia...   \n","7687  Cutaneous T Cell Lymphomas (CTCL)|Mycosis Fung...   \n","7688                    Complex Regional Pain Syndromes   \n","7689                          Polycystic Ovary Syndrome   \n","\n","                                          Interventions  \\\n","0         Radiation: Radiation therapy|Drug: Study Drug   \n","1                 Drug: Drug-AZD8931|Drug: Drug-Placebo   \n","2     Drug: Oxycodone/acetaminophen 5/325 mg|Device:...   \n","3     Device: Intrathecal Drug Delivery System|Other...   \n","4                              Drug: Cetuximab-IRDye800   \n","5     Procedure: Electrochemotherapy - electroporati...   \n","6                       Drug: Oprozomib|Drug: Midazolam   \n","7                                         Drug: TAK-228   \n","8     Drug: Cetuximab|Drug: Irinotecan|Device: Irino...   \n","9                  Drug: GSK3145095|Drug: Pembrolizumab   \n","10    Drug: Suramin Drug:Docetaxel Drug: Carboplatin...   \n","11    Drug: Propofol + Remifentanil|Drug: Sevofluran...   \n","12                                       Drug: IMMU 130   \n","13    Drug: Investigational drug|Drug: Irinotecan|Dr...   \n","14                          Drug: PS-341 (Velcade-drug)   \n","15                                    Drug: Hydralazine   \n","16                                    Drug: Chloroquine   \n","17                                       Drug: IMMU-130   \n","18    Drug: AZD1775|Drug: AZD1775 Placebo|Drug: Anti...   \n","19                                    Drug: Epacadostat   \n","20    Device: Drug: Paclitaxel; trastuzumab; doxorru...   \n","21                      Drug: Tasisulam|Drug: Midazolam   \n","22    Drug: GDC-0810|Drug: LHRH Agonist|Drug: Palboc...   \n","23    Procedure: Image-Guided Surgery|Drug: Indocyan...   \n","24                        Drug: Placebo|Drug: Metformin   \n","25                          Drug: Chloroquine, A-CQ 100   \n","26                                   Drug: PLX7486 TsOH   \n","27                                 Device: ReX-C system   \n","28                                           Drug: FPAC   \n","29                           Drug: Pegfilgrastim (drug)   \n","...                                                 ...   \n","7660      Biological: alemtuzumab|Biological: rituximab   \n","7661     Biological: rituximab|Biological: sargramostim   \n","7662  Biological: rituximab|Radiation: indium In 111...   \n","7663       Biological: Apolizumab|Biological: Rituximab   \n","7664                            Biological: aldesleukin   \n","7665  Radiation: Low-Dose Fractionated Radiation The...   \n","7666  Radiation: tositumomab and iodine I 131 tositu...   \n","7667  Device: IL2-PET scan|Procedure: Tumor biopsy|D...   \n","7668  Biological: Tavokinogene Telseplasmid (tavo)|D...   \n","7669  Biological: Pegylated interferon Œ±-2b|Other: P...   \n","7670  Biological: DC Vaccine & Cyclophosphamide|Biol...   \n","7671  Biological: ALVAC-MART-1 vaccine|Biological: M...   \n","7672  Biological: Aldesleukin|Other: Laboratory Biom...   \n","7673  Biological: aldesleukin|Biological: sargramost...   \n","7674  Biological: therapeutic autologous lymphocytes...   \n","7675  Biological: MART-1 antigen|Biological: aldesle...   \n","7676                              Biological: Rituximab   \n","7677  Biological: recombinant interleukin-12|Biologi...   \n","7678  Biological: epoetin alfa|Biological: filgrasti...   \n","7679  Biological: Umbilical Cord Blood After Myeloab...   \n","7680  Biological: gp100:209-217(210M) peptide vaccin...   \n","7681  Biological: NA17.A2 Peptide Vaccine|Biological...   \n","7682  Biological: NeoVax|Biological: Nivolumab|Biolo...   \n","7683  Biological: 20 mg/kg TRU-016 + Rituximab|Biolo...   \n","7684  Biological: aldesleukin|Biological: recombinan...   \n","7685                             Procedure: skin biopsy   \n","7686  Biological: therapeutic allogeneic lymphocytes...   \n","7687  Biological: Tavokinogene Telseplasmid (tavo)|D...   \n","7688  Procedure: stellate ganglion block with ropiva...   \n","7689  Dietary Supplement: Inofolic¬Æ|Other: Gonadotro...   \n","\n","                                       Outcome Measures  \\\n","0     Number of Participants With Adverse Events|Num...   \n","1     Comparison of the effects of AZD8931 versus pl...   \n","2     Feasibility determined by accrual, adherence a...   \n","3     Visual Analog Scale Pain Scores|Survival Rates...   \n","4     Number of subjects in a cohort experiencing a ...   \n","5     Evaluation of feasibility and safety|Disease-f...   \n","6     Food Effect/QTc - Cmax|Food Effect/QTc - AUC|F...   \n","7     Number of Participants With Treatment Emergent...   \n","8     Progression free survival rate|Tumour Response...   \n","9     Number of Participants With Non-serious Advers...   \n","10    Progression-free Survival for Participants Wit...   \n","11    To study inflammatory changes associated with ...   \n","12                                     Safety|Assess PK   \n","13                                                  NaN   \n","14                                        Response rate   \n","15    To explore the potency of a clinical tolerable...   \n","16    Number of Participants with Adverse Events as ...   \n","17    Evaluate the safety and tolerability of IMMU-1...   \n","18    Objective Response Rate|Pharmacokinetic Profil...   \n","19    Pharmacodynamic effects as measured by changes...   \n","20          INCIDENCE OF FEBRILE NEUTROPENIA|TUMOR SIZE   \n","21    Midazolam Pharmacokinetics: Area Under the Con...   \n","22    Phase Ia: Maximum Tolerated Dose of GDC-0810 W...   \n","23    Safety related by type, incidence, severity, s...   \n","24    Proliferation Status of CRC Tumor and Adjacent...   \n","25    To determine the toxicity of adding chloroquin...   \n","26    Safety of PLX7486 as single agent as measured ...   \n","27    Number of safety events during administration ...   \n","28              Uptake of FPAC in tumors|Safety of FPAC   \n","29    percentage of children achieving at least 5x10...   \n","...                                                 ...   \n","7660  Proportion of Patients With Complete Response ...   \n","7661                              Overall response rate   \n","7662  MTD, defined as that dose at which fewer than ...   \n","7663                                                MTD   \n","7664                                                NaN   \n","7665                            Objective Response (OR)   \n","7666                    Expanded Access|Safety|efficacy   \n","7667  Biodistribution and kinetics of [18F]FB-IL2.|T...   \n","7668  Best Overall Response Rate (BORR) by RECIST v1...   \n","7669  Number of Dose Limiting Toxicities (DLTs) Obse...   \n","7670  Induction of melanoma-specific CD8+T Cell Immu...   \n","7671  Percentage of Participants With Immunologic Re...   \n","7672  Evidence and nature of toxicity related to the...   \n","7673                                                NaN   \n","7674      In vivo survival of CD8+ transferred T-clones   \n","7675                                                NaN   \n","7676  Percentage of Subjects With at Least 10 Points...   \n","7677  Maximum tolerated dose (MTD) assessed by Commo...   \n","7678                                                NaN   \n","7679  Number of Participants With Neutrophil Engraft...   \n","7680  Clinical response|Safety and toxicity|Immunolo...   \n","7681  Frequency of Vaccine-induced CD8+ T Cells Asse...   \n","7682  Safety and tolerability of regimen as measured...   \n","7683  Incidence and severity of adverse events|CLL C...   \n","7684  Clinical response rate defined as the percenta...   \n","7685  Collection of biopsies from pruritic CTCL pati...   \n","7686  Toxicity rate associated with infusing donor C...   \n","7687  Objective Response Rate Assessed by Modified S...   \n","7688  Pain score|Temperature increase in the ipsilat...   \n","7689  Incidence of OHSS in each group, graded mild, ...   \n","\n","                                  Sponsor/Collaborators  ...  \\\n","0     Weill Medical College of Cornell University|Un...  ...   \n","1                                           AstraZeneca  ...   \n","2     Southwest Oncology Group|Proteus Digital Healt...  ...   \n","3                                      Flowonix Medical  ...   \n","4                    Eben Rosenthal|Stanford University  ...   \n","5     University Medical Centre Ljubljana|Institute ...  ...   \n","6                                                 Amgen  ...   \n","7               Millennium Pharmaceuticals, Inc.|Takeda  ...   \n","8     Hans-Joachim Schmoll, MD|Biocompatibles UK Ltd...  ...   \n","9                               GlaxoSmithKline|Parexel  ...   \n","10                            Optimum Therapeutics, LLC  ...   \n","11                                 The Cleveland Clinic  ...   \n","12                                      Gilead Sciences  ...   \n","13                           Celgene Corporation|Pfizer  ...   \n","14    Rasim Gucalp|Millennium Pharmaceuticals, Inc.|...  ...   \n","15                               University of Arkansas  ...   \n","16                        Maastricht Radiation Oncology  ...   \n","17                                      Gilead Sciences  ...   \n","18                                          AstraZeneca  ...   \n","19    Sidney Kimmel Comprehensive Cancer Center at J...  ...   \n","20    Instituto do Cancer do Estado de S√£o Paulo|Fun...  ...   \n","21                                Eli Lilly and Company  ...   \n","22                                      Genentech, Inc.  ...   \n","23                  Jonsson Comprehensive Cancer Center  ...   \n","24                               University of Arkansas  ...   \n","25    Maastricht Radiation Oncology|Maastricht Unive...  ...   \n","26                                            Plexxikon  ...   \n","27                                        Dosentrx Ltd.  ...   \n","28    National Cancer Institute (NCI)|National Insti...  ...   \n","29          University Hospital, Clermont-Ferrand|Amgen  ...   \n","...                                                 ...  ...   \n","7660  ECOG-ACRIN Cancer Research Group|National Canc...  ...   \n","7661  Sidney Kimmel Comprehensive Cancer Center at J...  ...   \n","7662                    National Cancer Institute (NCI)  ...   \n","7663  National Cancer Institute (NCI)|National Insti...  ...   \n","7664  Northwestern University|National Cancer Instit...  ...   \n","7665                             University of Arkansas  ...   \n","7666  University of Nebraska|National Cancer Institu...  ...   \n","7667                University Medical Center Groningen  ...   \n","7668                       OncoSec Medical Incorporated  ...   \n","7669  Northwestern University|National Cancer Instit...  ...   \n","7670                          Baylor Research Institute  ...   \n","7671  National Cancer Institute (NCI)|National Insti...  ...   \n","7672  Fred Hutchinson Cancer Research Center|Nationa...  ...   \n","7673  Memorial Sloan Kettering Cancer Center|Nationa...  ...   \n","7674  Fred Hutchinson Cancer Research Center|Nationa...  ...   \n","7675  University of Southern California|National Can...  ...   \n","7676  Mayo Clinic|Genentech, Inc.|Biogen|National Ce...  ...   \n","7677                    National Cancer Institute (NCI)  ...   \n","7678  Northwestern University|National Cancer Instit...  ...   \n","7679                               Tufts Medical Center  ...   \n","7680  Bristol-Myers Squibb|National Cancer Institute...  ...   \n","7681                    National Cancer Institute (NCI)  ...   \n","7682  Washington University School of Medicine|Brist...  ...   \n","7683                                Aptevo Therapeutics  ...   \n","7684                    National Cancer Institute (NCI)  ...   \n","7685                            University of Minnesota  ...   \n","7686  Fred Hutchinson Cancer Research Center|Nationa...  ...   \n","7687                       OncoSec Medical Incorporated  ...   \n","7688                      Maisonneuve-Rosemont Hospital  ...   \n","7689            Centre Hospitalier Departemental Vendee  ...   \n","\n","     Primary Completion Date     Completion Date        First Posted  \\\n","0          September 4, 2018   February 20, 2019   September 2, 2015   \n","1                 March 2013            May 2013        May 11, 2012   \n","2         September 16, 2020  September 16, 2020   December 11, 2019   \n","3              December 2016      September 2018    October 19, 2015   \n","4             April 19, 2017      April 19, 2017   November 19, 2013   \n","5              March 9, 2021       March 9, 2021   February 24, 2020   \n","6               May 15, 2015       July 10, 2019  September 18, 2014   \n","7            August 28, 2019     August 28, 2019   December 12, 2017   \n","8              December 2012            May 2015    February 2, 2010   \n","9            August 13, 2019     August 13, 2019  September 24, 2018   \n","10             November 2012            May 2013   December 24, 2009   \n","11                March 2010          March 2010    November 9, 2007   \n","12               August 2015         August 2015      August 5, 2013   \n","13                       NaN                 NaN       June 27, 2002   \n","14                  May 2007            May 2007  September 20, 2005   \n","15             December 2009       December 2009   December 18, 2007   \n","16                 July 2017           July 2017      April 11, 2012   \n","17              January 2016        January 2016        May 24, 2012   \n","18                  May 2015            May 2015      March 14, 2014   \n","19             July 30, 2021       July 30, 2021      March 20, 2018   \n","20            September 2011      September 2012       April 6, 2011   \n","21              January 2011        January 2011  September 27, 2010   \n","22            March 13, 2020      March 13, 2020       April 4, 2013   \n","23          February 1, 2022    February 1, 2023   November 19, 2018   \n","24              January 2015        January 2015       June 29, 2012   \n","25                 June 2016           June 2016   September 1, 2009   \n","26          January 24, 2018    January 24, 2018       March 5, 2013   \n","27             December 2022       February 2023  September 17, 2019   \n","28           August 20, 2014        May 11, 2016      March 15, 2010   \n","29             December 2007        January 2008       June 11, 2008   \n","...                      ...                 ...                 ...   \n","7660          April 14, 2015      April 14, 2015   November 16, 2009   \n","7661              March 2006          March 2006   December 15, 2005   \n","7662              March 2005                 NaN    January 27, 2003   \n","7663        January 22, 2010      March 17, 2017     August 20, 2001   \n","7664            January 2002        January 2002    January 27, 2003   \n","7665               July 2015           July 2015      March 28, 2013   \n","7666              April 2002       November 2012   December 16, 2003   \n","7667       February 14, 2020   February 14, 2020     October 4, 2016   \n","7668       November 14, 2016   November 14, 2016    January 26, 2015   \n","7669               June 2011       December 2011       July 29, 2008   \n","7670              April 2011           July 2012       July 25, 2008   \n","7671           November 2012       November 2012       June 30, 2008   \n","7672                May 2016            May 2016     January 1, 2013   \n","7673              March 2005          March 2005       June 11, 2004   \n","7674            January 2011        January 2011       July 24, 2009   \n","7675                May 2003          April 2006    January 27, 2003   \n","7676            January 2009       February 2011     January 9, 2008   \n","7677                May 2009                 NaN    February 6, 2003   \n","7678            January 2002        January 2002    January 27, 2003   \n","7679               July 2013           July 2014        May 13, 2008   \n","7680                     NaN                 NaN       July 27, 2006   \n","7681            January 2015       February 2015       March 3, 2011   \n","7682          April 26, 2020   December 31, 2020    February 5, 2018   \n","7683       February 24, 2020      April 21, 2021       July 19, 2012   \n","7684               June 2005                 NaN    January 27, 2003   \n","7685           December 2012       December 2012      March 18, 2009   \n","7686           November 2009           June 2011    January 27, 2003   \n","7687            June 3, 2014        June 3, 2014      April 17, 2012   \n","7688       February 21, 2020   February 21, 2020    October 20, 2017   \n","7689            May 22, 2017        May 22, 2017     August 20, 2014   \n","\n","      Results First Posted  Last Update Posted  \\\n","0         December 9, 2019    December 9, 2019   \n","1                      NaN   December 17, 2012   \n","2                      NaN    January 13, 2021   \n","3                      NaN   February 15, 2019   \n","4                      NaN       June 24, 2019   \n","5                      NaN      March 12, 2021   \n","6                      NaN   February 21, 2021   \n","7        September 9, 2020        May 11, 2021   \n","8                      NaN    October 26, 2016   \n","9            July 31, 2020       July 31, 2020   \n","10        October 21, 2014        May 21, 2015   \n","11                     NaN      April 20, 2017   \n","12                     NaN     August 19, 2021   \n","13                     NaN    December 1, 2016   \n","14                     NaN      August 2, 2018   \n","15                     NaN       March 4, 2015   \n","16                     NaN       July 18, 2017   \n","17                     NaN     August 19, 2021   \n","18           June 14, 2016       June 14, 2016   \n","19                     NaN     August 26, 2021   \n","20                     NaN        May 21, 2014   \n","21          March 18, 2019      March 18, 2019   \n","22           June 18, 2021       June 18, 2021   \n","23                     NaN      March 11, 2021   \n","24           July 11, 2016       July 11, 2016   \n","25                     NaN   February 15, 2019   \n","26                     NaN      August 2, 2018   \n","27                     NaN  September 20, 2021   \n","28                     NaN   December 17, 2019   \n","29                     NaN       June 13, 2008   \n","...                    ...                 ...   \n","7660      January 28, 2016    January 14, 2019   \n","7661                   NaN     August 12, 2014   \n","7662                   NaN    January 17, 2013   \n","7663                   NaN   December 16, 2019   \n","7664                   NaN        June 6, 2012   \n","7665                   NaN      August 8, 2016   \n","7666                   NaN    January 17, 2018   \n","7667                   NaN      March 23, 2020   \n","7668       January 3, 2018     January 3, 2018   \n","7669      December 2, 2013   December 12, 2018   \n","7670                   NaN        July 8, 2013   \n","7671        March 19, 2013    October 28, 2015   \n","7672                   NaN      April 19, 2017   \n","7673                   NaN   December 12, 2012   \n","7674                   NaN    December 8, 2011   \n","7675                   NaN        May 22, 2014   \n","7676           May 6, 2014         May 6, 2014   \n","7677                   NaN       April 9, 2013   \n","7678                   NaN        June 1, 2012   \n","7679         July 22, 2016        June 1, 2017   \n","7680                   NaN        May 15, 2013   \n","7681      October 24, 2016    October 24, 2016   \n","7682                   NaN      April 23, 2021   \n","7683                   NaN        May 20, 2021   \n","7684                   NaN    January 16, 2013   \n","7685                   NaN      March 31, 2014   \n","7686                   NaN   February 15, 2017   \n","7687       January 3, 2018     January 3, 2018   \n","7688                   NaN   February 24, 2020   \n","7689                   NaN       June 16, 2017   \n","\n","                                              Locations  \\\n","0     Weill Cornell Medical College, New York, New Y...   \n","1     Research Site, Dusseldorf, Germany|Research Si...   \n","2     Decatur Memorial Hospital, Decatur, Illinois, ...   \n","3     Menorah Medical Center, Overland Park, Kansas,...   \n","4     Stanford University, School of Medicine, Stanf...   \n","5     University Medical Centre Ljubljana, Ljubljana...   \n","6     University of Colorado Anschutz Medical Campus...   \n","7     National Cancer Center Hospital East, Kashiwa-...   \n","8     Zentralklinik Bad Berka GmbH, Abteilung f√ºr In...   \n","9     GSK Investigational Site, Indianapolis, Indian...   \n","10    John H Stroger Jr Hospital of Cook County, Chi...   \n","11    Cleveland Clinic Foundation, Cleveland, Ohio, ...   \n","12                                                  NaN   \n","13    Research Center, Little Rock, Arkansas, United...   \n","14    HealthAlliance Hospitals, Fitchburg, Massachus...   \n","15                                                  NaN   \n","16     MAASTRO clinic, Maastricht, Limburg, Netherlands   \n","17    UCLA Jonsson Comprehensive Cancer Center, Sant...   \n","18    Research Site, Birmingham, Alabama, United Sta...   \n","19    Sidney Kimmel Comprehensive Cancer Center at J...   \n","20    Instituto do Cancer do Estado de Sao Paulo, Sa...   \n","21    For additional information regarding investiga...   \n","22    Ucsd Medical Center, San Diego, California, Un...   \n","23    UCLA / Jonsson Comprehensive Cancer Center, Lo...   \n","24    Central Arkansas Veterans Heathcare System, Li...   \n","25    NKI/AvL, Amsterdam, Netherlands|VU Medical Cen...   \n","26    Ronald Reagan UCLA Medical Center, Los Angeles...   \n","27    Oncology Unit, Tel Aviv Sourasky Medical Cente...   \n","28    National Institutes of Health Clinical Center,...   \n","29                                                  NaN   \n","...                                                 ...   \n","7660  Mayo Clinic Scottsdale, Scottsdale, Arizona, U...   \n","7661                                                NaN   \n","7662  Children's Oncology Group, Arcadia, California...   \n","7663  National Institutes of Health Clinical Center,...   \n","7664  Robert H. Lurie Comprehensive Cancer Center, N...   \n","7665  University of Arkansas for Medical Sciences, L...   \n","7666  University of Nebraska Medical Center, Omaha, ...   \n","7667  University Medical Center Groningen, Groningen...   \n","7668  UCSF Helen Diller Family Comprehensive Cancer ...   \n","7669  Robert H. Lurie Comprehensive Cancer Center at...   \n","7670  Baylor University Medical Center, Dallas, Texa...   \n","7671  National Cancer Institute (NCI), 9000 Rockvill...   \n","7672  Fred Hutchinson Cancer Research Center/Univers...   \n","7673  Memorial Sloan-Kettering Cancer Center, New Yo...   \n","7674  Fred Hutchinson Cancer Research Center/Univers...   \n","7675  USC/Norris Comprehensive Cancer Center and Hos...   \n","7676  Mayo Clinic Scottsdale, Scottsdale, Arizona, U...   \n","7677  New Approaches to Neuroblastoma Treatment (NAN...   \n","7678  Robert H. Lurie Comprehensive Cancer Center, N...   \n","7679  Tufts Medical Center, Boston, Massachusetts, U...   \n","7680                                                NaN   \n","7681  University of Chicago Comprehensive Cancer Cen...   \n","7682  Washington University School of Medicine, Sain...   \n","7683  Augusta, Georgia, United States|Columbus, Ohio...   \n","7684  Abramson Cancer Center of The University of Pe...   \n","7685  University of Minnesota, Minneapolis, Minnesot...   \n","7686  Fred Hutchinson Cancer Research Center/Univers...   \n","7687  UCSF Helen Diller Comprehensive Cancer Center,...   \n","7688                                                NaN   \n","7689  CHI de Cr√©teil, Cr√©teil, France|CHD Vend√©e, La...   \n","\n","                                        Study Documents  \\\n","0     \"Study Protocol and Statistical Analysis Plan\"...   \n","1                                                   NaN   \n","2                                                   NaN   \n","3                                                   NaN   \n","4                                                   NaN   \n","5                                                   NaN   \n","6                                                   NaN   \n","7     \"Study Protocol\", https://ClinicalTrials.gov/P...   \n","8                                                   NaN   \n","9     \"Study Protocol\", https://ClinicalTrials.gov/P...   \n","10                                                  NaN   \n","11                                                  NaN   \n","12                                                  NaN   \n","13                                                  NaN   \n","14                                                  NaN   \n","15                                                  NaN   \n","16                                                  NaN   \n","17                                                  NaN   \n","18                                                  NaN   \n","19                                                  NaN   \n","20                                                  NaN   \n","21                                                  NaN   \n","22    \"Study Protocol and Statistical Analysis Plan\"...   \n","23                                                  NaN   \n","24                                                  NaN   \n","25                                                  NaN   \n","26                                                  NaN   \n","27                                                  NaN   \n","28                                                  NaN   \n","29                                                  NaN   \n","...                                                 ...   \n","7660                                                NaN   \n","7661                                                NaN   \n","7662                                                NaN   \n","7663                                                NaN   \n","7664                                                NaN   \n","7665                                                NaN   \n","7666                                                NaN   \n","7667                                                NaN   \n","7668                                                NaN   \n","7669                                                NaN   \n","7670                                                NaN   \n","7671                                                NaN   \n","7672                                                NaN   \n","7673                                                NaN   \n","7674                                                NaN   \n","7675                                                NaN   \n","7676                                                NaN   \n","7677                                                NaN   \n","7678                                                NaN   \n","7679                                                NaN   \n","7680                                                NaN   \n","7681                                                NaN   \n","7682  \"Informed Consent Form\", https://ClinicalTrial...   \n","7683                                                NaN   \n","7684                                                NaN   \n","7685                                                NaN   \n","7686                                                NaN   \n","7687                                                NaN   \n","7688                                                NaN   \n","7689                                                NaN   \n","\n","                                              URL Recruitment Status  \\\n","0     https://ClinicalTrials.gov/show/NCT02538471         Terminated   \n","1     https://ClinicalTrials.gov/show/NCT01596530         Terminated   \n","2     https://ClinicalTrials.gov/show/NCT04194528         Terminated   \n","3     https://ClinicalTrials.gov/show/NCT02578459          Withdrawn   \n","4     https://ClinicalTrials.gov/show/NCT01987375         Terminated   \n","5     https://ClinicalTrials.gov/show/NCT04281290         Terminated   \n","6     https://ClinicalTrials.gov/show/NCT02244112         Terminated   \n","7     https://ClinicalTrials.gov/show/NCT03370302         Terminated   \n","8     https://ClinicalTrials.gov/show/NCT01060423         Terminated   \n","9     https://ClinicalTrials.gov/show/NCT03681951         Terminated   \n","10    https://ClinicalTrials.gov/show/NCT01038752         Terminated   \n","11    https://ClinicalTrials.gov/show/NCT00555984          Withdrawn   \n","12    https://ClinicalTrials.gov/show/NCT01915472          Withdrawn   \n","13    https://ClinicalTrials.gov/show/NCT00040391         Terminated   \n","14    https://ClinicalTrials.gov/show/NCT00200382         Terminated   \n","15    https://ClinicalTrials.gov/show/NCT00575978          Withdrawn   \n","16    https://ClinicalTrials.gov/show/NCT01575782         Terminated   \n","17    https://ClinicalTrials.gov/show/NCT01605318          Withdrawn   \n","18    https://ClinicalTrials.gov/show/NCT02087176         Terminated   \n","19    https://ClinicalTrials.gov/show/NCT03471286         Terminated   \n","20    https://ClinicalTrials.gov/show/NCT01329640         Terminated   \n","21    https://ClinicalTrials.gov/show/NCT01209832         Terminated   \n","22    https://ClinicalTrials.gov/show/NCT01823835         Terminated   \n","23    https://ClinicalTrials.gov/show/NCT03745690          Suspended   \n","24    https://ClinicalTrials.gov/show/NCT01632020         Terminated   \n","25    https://ClinicalTrials.gov/show/NCT00969306         Terminated   \n","26    https://ClinicalTrials.gov/show/NCT01804530         Terminated   \n","27    https://ClinicalTrials.gov/show/NCT04091711          Suspended   \n","28    https://ClinicalTrials.gov/show/NCT01086696         Terminated   \n","29    https://ClinicalTrials.gov/show/NCT00695370         Terminated   \n","...                                           ...                ...   \n","7660  https://ClinicalTrials.gov/show/NCT01013961                      \n","7661  https://ClinicalTrials.gov/show/NCT00265915                      \n","7662  https://ClinicalTrials.gov/show/NCT00036855                      \n","7663  https://ClinicalTrials.gov/show/NCT00022971                      \n","7664  https://ClinicalTrials.gov/show/NCT00005788                      \n","7665  https://ClinicalTrials.gov/show/NCT01820312                      \n","7666  https://ClinicalTrials.gov/show/NCT00004874                      \n","7667  https://ClinicalTrials.gov/show/NCT02922283                      \n","7668  https://ClinicalTrials.gov/show/NCT02345330                      \n","7669  https://ClinicalTrials.gov/show/NCT00724061                      \n","7670  https://ClinicalTrials.gov/show/NCT00722098                      \n","7671  https://ClinicalTrials.gov/show/NCT00706992                      \n","7672  https://ClinicalTrials.gov/show/NCT01758458                      \n","7673  https://ClinicalTrials.gov/show/NCT00085579                      \n","7674  https://ClinicalTrials.gov/show/NCT00945269                      \n","7675  https://ClinicalTrials.gov/show/NCT00006113                      \n","7676  https://ClinicalTrials.gov/show/NCT00588822                      \n","7677  https://ClinicalTrials.gov/show/NCT00054405                      \n","7678  https://ClinicalTrials.gov/show/NCT00005787                      \n","7679  https://ClinicalTrials.gov/show/NCT00676806                      \n","7680  https://ClinicalTrials.gov/show/NCT00357461                      \n","7681  https://ClinicalTrials.gov/show/NCT01307618                      \n","7682  https://ClinicalTrials.gov/show/NCT03422094                      \n","7683  https://ClinicalTrials.gov/show/NCT01644253                      \n","7684  https://ClinicalTrials.gov/show/NCT00052377                      \n","7685  https://ClinicalTrials.gov/show/NCT00863395                      \n","7686  https://ClinicalTrials.gov/show/NCT00052598                      \n","7687  https://ClinicalTrials.gov/show/NCT01579318                      \n","7688  https://ClinicalTrials.gov/show/NCT03316066                      \n","7689  https://ClinicalTrials.gov/show/NCT02221154                      \n","\n","                                  Reason for Inactivity  \n","0     The study was terminated due to lack of patien...  \n","1     All AstraZeneca sponsored clinical trials of A...  \n","2                       Study sponsor withdrew support.  \n","3     The study was never initiated by sponsor. Pati...  \n","4                                             logistics  \n","5     After enrolling 3 participants the safety and ...  \n","6     Why study stopped revised to \"A program evalua...  \n","7     More favorable safety profile was observed in ...  \n","8              Terminated due to poor subject enrolment  \n","9     The study was terminated following an internal...  \n","10                                                       \n","11    PI decision to terminate. No usable data colle...  \n","12                             No participants enrolled  \n","13                                                       \n","14    The study did not achieve the statistical succ...  \n","15                                          IRB request  \n","16                                         Poor accrual  \n","17    No patients are enrolled in any studies conduc...  \n","18       The study was terminated early by the sponsor.  \n","19    Deprioritization of drug in this patient popul...  \n","20                                                       \n","21    Terminated based on safety results from anothe...  \n","22    The Sponsor decided to halt the development of...  \n","23                                         Safety Issue  \n","24                                   Inadequate accrual  \n","25                                         Poor accrual  \n","26                                         Discontinued  \n","27                    Awaiting next model of the device  \n","28                                                       \n","29    Recruiting or enrolling participants has halte...  \n","...                                                 ...  \n","7660                                                     \n","7661                                                     \n","7662                                                     \n","7663                                                     \n","7664                                                     \n","7665                                                     \n","7666                                                     \n","7667                                                     \n","7668                                                     \n","7669                                                     \n","7670                                                     \n","7671                                                     \n","7672                                                     \n","7673                                                     \n","7674                                                     \n","7675                                                     \n","7676                                                     \n","7677                                                     \n","7678                                                     \n","7679                                                     \n","7680                                                     \n","7681                                                     \n","7682                                                     \n","7683                                                     \n","7684                                                     \n","7685                                                     \n","7686                                                     \n","7687                                                     \n","7688                                                     \n","7689                                                     \n","\n","[7690 rows x 29 columns]"]},"execution_count":93,"metadata":{},"output_type":"execute_result"}],"source":["# update df\n","df[\"Reason for Inactivity\"] = \"\"\n","df[\"Reason for Inactivity\"][start:end] = details\n","df"]},{"cell_type":"code","execution_count":null,"metadata":{"id":"gqq-qDV4wvJ0"},"outputs":[],"source":["# convert to csv \n","csv_name = \"clinicaltrials_data_\"+str(start)+\"_\"+str(end)+\".csv\"\n","path = \"Data/clinical_trials_orginal/\"\n","df.to_csv(os.path.join(path,csv_name),index=False)"]},{"cell_type":"code","source":[""],"metadata":{"id":"at5AhXfZhhmT"},"execution_count":null,"outputs":[]}],"metadata":{"kernelspec":{"display_name":"Python 3","language":"python","name":"python3"},"language_info":{"codemirror_mode":{"name":"ipython","version":3},"file_extension":".py","mimetype":"text/x-python","name":"python","nbconvert_exporter":"python","pygments_lexer":"ipython3","version":"3.7.4"},"colab":{"name":"Data Preparation_CilnicalTrials.ipynb","provenance":[],"collapsed_sections":[]}},"nbformat":4,"nbformat_minor":0}